data_1omu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1omu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.26 0.552 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.479 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.604 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.622 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.3 m-80 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.44 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 HG11 ' HA2' ' A' ' 46' ' ' GLY . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 26' ' ' SER . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.589 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.577 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.555 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.534 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.637 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.769 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.769 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.542 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.579 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 23' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.531 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.555 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.633 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.6 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 40' ' ' ALA . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.491 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.6 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.539 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.451 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.647 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CD2' HD11 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.539 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 21.0 p80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.415 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.594 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' OD2' HD11 ' A' ' 48' ' ' LEU . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 19.1 t-20 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 39' ' ' ASN . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' N ' HG21 ' A' ' 42' ' ' VAL . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.641 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.598 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.598 ' CD2' ' OG ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.754 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.754 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.473 HG21 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD2' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.305 0.574 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.545 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 31' ' ' TYR . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 5.4 m120 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.516 HG13 ' CB ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.558 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.558 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.576 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB3' ' A' ' 55' ' ' LYS . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.62 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.47 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.559 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.668 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.523 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' O ' HG21 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.427 HG11 ' HA2' ' A' ' 46' ' ' GLY . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 39' ' ' ASN . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 49' ' ' THR . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.554 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.566 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 7' ' ' ASP . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HB3' HG22 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.474 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.641 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.533 HG22 ' CG ' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.505 ' O ' HG21 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 38' ' ' CYS . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' O ' ' OG1' ' A' ' 49' ' ' THR . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.638 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.641 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.9 p80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' CG ' HG22 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' ' CG ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.1 t-20 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.477 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.574 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.263 0.554 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.687 ' O ' ' O ' ' A' ' 19' ' ' GLU . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.516 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.502 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.549 ' CE1' HD22 ' A' ' 50' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 7' ' ' ASP . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.575 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 18' ' ' LEU . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.697 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' CD ' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.57 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.607 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.478 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.787 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 44' ' ' SER . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 40' ' ' ALA . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.697 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.435 0.636 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.479 ' CG2' ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.567 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.9 m-80 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' CB ' HD21 ' A' ' 48' ' ' LEU . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' VAL . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' HG21 ' A' ' 49' ' ' THR . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.551 HD21 ' CB ' ' A' ' 40' ' ' ALA . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.544 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.658 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' CZ ' ' A' ' 37' ' ' PHE . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' HA2' ' A' ' 25' ' ' GLY . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.631 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 38' ' ' CYS . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' OG1' ' A' ' 49' ' ' THR . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.651 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.559 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 8' ' ' CYS . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.434 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.1 m120 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.463 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 23' ' ' LEU . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.68 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 7' ' ' ASP . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.593 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.684 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 18' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.518 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.587 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.563 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.551 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 51' ' ' SER . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.508 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 49' ' ' THR . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.617 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.452 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.646 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 49' ' ' THR . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.614 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' A' ' 23' ' ' LEU . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG12 ' HA2' ' A' ' 46' ' ' GLY . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 39' ' ' ASN . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.574 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.646 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 6' ' ' VAL . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.28 0.562 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.535 ' N ' HG11 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.564 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 55' ' ' LYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 46' ' ' GLY . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.554 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.556 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' N ' HG12 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.558 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' CYS . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 1.9 p30 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.6 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' CG1' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.556 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.548 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.548 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.618 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.5 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.553 ' CG2' ' CZ ' ' A' ' 53' ' ' PHE . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HA ' HG23 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' PRO . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m-80 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 45' ' ' ASN . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.573 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.606 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.617 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 0.3 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.528 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.671 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.449 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 7.5 m-80 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG21 ' CD2' ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 12' ' ' PRO . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.642 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.549 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.642 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HA ' HD22 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.6 t-20 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.628 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 8.3 m-80 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.542 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.791 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.68 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD21 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HB3' ' ND2' ' A' ' 28' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' CG1' ' SG ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.545 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.639 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.687 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 39' ' ' ASN . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.687 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.655 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.655 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 8.6 p80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' ASP . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.662 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 49' ' ' THR . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CG ' ' HB2' ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' HG11 ' A' ' 42' ' ' VAL . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' CYS . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.512 ' O ' ' CG2' ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.598 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.662 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.588 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.635 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.7 t-20 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.635 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.525 ' CD1' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.654 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.331 0.586 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.417 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.652 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.532 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CZ ' ' HA2' ' A' ' 25' ' ' GLY . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.633 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD13 ' CA ' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.532 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.631 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.652 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.8 p80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.591 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.507 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' HD13 ' A' ' 48' ' ' LEU . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.627 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.623 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' CG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.585 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.631 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.543 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.427 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.611 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.488 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 17.4 t-20 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' CD ' ' OD2' ' A' ' 27' ' ' ASP . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.504 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.64 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' OG ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.572 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.649 ' O ' ' O ' ' A' ' 19' ' ' GLU . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.602 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.553 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.601 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.644 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.581 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD22 ' CZ ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CG ' HD22 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.564 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 29' ' ' LYS . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.579 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HA ' HG23 ' A' ' 42' ' ' VAL . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 51' ' ' SER . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.609 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.451 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.312 0.577 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 9' ' ' SER . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.628 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.559 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 37' ' ' PHE . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.635 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.567 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 39' ' ' ASN . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD21 ' CB ' ' A' ' 40' ' ' ALA . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.634 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.3 p80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CB ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.574 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.421 0.629 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.518 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' HA ' HG23 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 39' ' ' ASN . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.758 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.455 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 6' ' ' VAL . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.56 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' CYS . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' A' ' 51' ' ' SER . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.666 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 49' ' ' THR . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CB ' HD13 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.701 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 12' ' ' PRO . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.701 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.593 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 2.2 t30 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.593 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD21 ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.243 0.544 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.428 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.582 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.48 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.583 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.666 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.539 ' HA ' HG23 ' A' ' 42' ' ' VAL . 1.1 m120 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.586 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 44' ' ' SER . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.642 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.642 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.417 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.583 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.513 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.639 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.555 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.555 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.646 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.646 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.7 p80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.538 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 7' ' ' ASP . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 55' ' ' LYS . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.653 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.594 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.652 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.652 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.0 p80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.27 0.557 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' GLU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 t-20 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.555 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' 12' ' ' PRO . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 26' ' ' SER . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.285 0.564 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.571 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.724 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.482 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.579 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.507 ' C ' HG21 ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.507 HG21 ' C ' ' A' ' 39' ' ' ASN . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.6 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.598 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.724 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.222 0.534 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG11 ' HA2' ' A' ' 46' ' ' GLY . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 11' ' ' TYR . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.269 0.557 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 53' ' ' PHE . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.532 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' HG23 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.754 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 48' ' ' LEU . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.574 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.754 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.698 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.715 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.1 p80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 6' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' CYS . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.531 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.562 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.737 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.567 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.518 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.544 ' CG2' ' CZ ' ' A' ' 53' ' ' PHE . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.559 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.628 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.666 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 38' ' ' CYS . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' CYS . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' SG ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.544 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.466 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.466 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.481 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.506 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.758 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.504 ' OG ' HG21 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 45' ' ' ASN . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 41' ' ' VAL . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.4 p80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 33' ' ' ASN . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.9 p30 -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.6 m-80 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 11' ' ' TYR . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 44' ' ' SER . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.553 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.323 0.583 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.567 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 31' ' ' TYR . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.64 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.784 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 39' ' ' ASN . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.784 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.577 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.577 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE1' HD22 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.588 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.629 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.6 t-20 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 55' ' ' LYS . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.465 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 23' ' ' LEU . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.451 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.19 -162.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.64 41.55 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.472 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 1.5 t -84.7 101.1 8.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 109.079 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t -129.84 153.18 48.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.479 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.604 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.622 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.3 m-80 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.44 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.583 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 HG11 ' HA2' ' A' ' 46' ' ' GLY . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG23 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 26' ' ' SER . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.577 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.43 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 1' ' ' LEU . . . 171.85 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.43 150.53 49.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.725 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 7.0 p -79.84 88.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 109.462 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.4 t 170.1 118.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' CG ' ' HD2' ' A' ' 55' ' ' LYS . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.637 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.769 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.769 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.542 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.579 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 23' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 75.81 129.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 2' ' ' ALA . . . 68.74 -176.32 0.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.893 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.498 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.4 p -152.05 69.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 21.4 p 173.43 141.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.472 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.531 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.555 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.633 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.6 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 40' ' ' ALA . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.491 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.6 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . 174.33 -83.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 72.22 147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.83 73.54 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -164.63 138.53 5.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.985 . . . . 0.0 109.631 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 HD11 ' CD2' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.539 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.451 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.647 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' CD2' HD11 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.511 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.539 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 21.0 p80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CE1' HD23 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.39 63.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.11 -176.2 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 t -96.69 81.39 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.622 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -167.37 149.91 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.415 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.622 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.638 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.594 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' OD2' HD11 ' A' ' 48' ' ' LEU . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 19.1 t-20 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 39' ' ' ASN . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' N ' HG21 ' A' ' 42' ' ' VAL . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.641 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.598 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.598 ' CD2' ' OG ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.18 -78.58 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.48 77.71 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -88.92 87.01 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.26 157.88 36.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.53 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.754 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.754 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.473 ' OG ' HG21 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 HG21 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD2' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.24 0.543 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.33 -176.26 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.559 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.97 177.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.3 m -113.12 84.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.932 . . . . 0.0 109.544 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.67 152.62 39.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.459 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.545 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 31' ' ' TYR . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 5.4 m120 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.593 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.516 HG13 ' CB ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.558 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.558 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.95 -65.06 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.673 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' O ' HG11 ' A' ' 4' ' ' VAL . . . -96.68 148.36 22.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.686 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -160.02 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 109.445 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -124.58 168.84 12.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.576 HG23 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.668 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB3' ' A' ' 55' ' ' LYS . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.62 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.47 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.559 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.668 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' HG23 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.279 0.561 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.17 69.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.62 179.69 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 12.7 p -91.89 104.55 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 109.362 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -96.7 167.42 11.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' O ' HG21 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.427 HG11 ' HA2' ' A' ' 46' ' ' GLY . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 39' ' ' ASN . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 49' ' ' THR . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.554 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.566 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' LEU . . . 55.72 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.56 91.48 3.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.866 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 21.0 m -87.1 72.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -153.9 147.91 25.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.288 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 7' ' ' ASP . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HB3' HG22 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.474 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.641 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.533 HG22 ' CG ' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.505 ' O ' HG21 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' N ' ' C ' ' A' ' 38' ' ' CYS . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.532 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' O ' ' OG1' ' A' ' 49' ' ' THR . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.52 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.638 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.641 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.9 p80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' CG ' HG22 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.56 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.02 178.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.92 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 HG11 HD22 ' A' ' 50' ' ' LEU . 1.7 t -141.71 74.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.272 -0.892 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -169.46 156.97 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.293 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.43 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.626 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' C ' ' CD1' ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HB2' ' CG ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.1 t-20 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.477 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.574 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -120.07 93.29 4.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 57.75 162.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.665 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 t -145.3 107.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.273 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -131.11 -154.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.551 ' N ' ' CG2' ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.687 ' O ' ' O ' ' A' ' 19' ' ' GLU . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.516 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.536 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.619 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.582 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.502 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.549 ' CE1' HD22 ' A' ' 50' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 74.81 33.36 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.62 43.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.74 65.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.0 143.36 14.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.449 -0.782 . . . . 0.0 109.242 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 7' ' ' ASP . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.575 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 18' ' ' LEU . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.697 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' CD ' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.57 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.607 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.787 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.478 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.575 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.787 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 44' ' ' SER . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 40' ' ' ALA . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.697 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . 61.04 42.47 12.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 2' ' ' ALA . . . 178.51 124.55 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.782 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -89.83 111.75 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.186 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.95 -175.52 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.479 ' CG2' ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.431 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.658 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.567 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.9 m-80 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' CB ' HD21 ' A' ' 48' ' ' LEU . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.42 ' O ' HG21 ' A' ' 42' ' ' VAL . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' O ' HG21 ' A' ' 49' ' ' THR . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.551 HD21 ' CB ' ' A' ' 40' ' ' ALA . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.544 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.658 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 124.93 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.419 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.98 148.38 48.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 5' ' ' SER . 7.1 p -158.36 89.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.583 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER 165.61 159.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.278 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.631 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.441 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.651 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.553 ' HA2' ' CZ ' ' A' ' 37' ' ' PHE . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CZ ' ' HA2' ' A' ' 25' ' ' GLY . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.631 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 38' ' ' CYS . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' OG1' ' A' ' 49' ' ' THR . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.515 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.651 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.559 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.89 56.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.46 170.03 18.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.99 99.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.001 -1.062 . . . . 0.0 110.223 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -109.49 172.3 6.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 108.814 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG12 ' SG ' ' A' ' 8' ' ' CYS . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.542 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.1 m120 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.504 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 23' ' ' LEU . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.68 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.539 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.542 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' HB1' ' A' ' 3' ' ' ALA . . . -127.3 -31.22 2.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.57 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 2' ' ' ALA . . . 60.1 87.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.487 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.45 HG21 HD21 ' A' ' 50' ' ' LEU . 2.3 p -136.11 81.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.175 -0.953 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 155.6 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.232 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 7' ' ' ASP . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.593 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.684 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 18' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.518 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.587 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.563 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.551 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 51' ' ' SER . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.587 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.684 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.567 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -112.56 15.08 20.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.411 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 56.43 167.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 90.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -154.75 115.03 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.57 HG23 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.508 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 49' ' ' THR . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.617 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.452 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.08 -92.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.81 148.45 31.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 m -123.19 103.29 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.92 168.48 17.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.597 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.646 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 49' ' ' THR . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.614 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' A' ' 23' ' ' LEU . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG12 ' HA2' ' A' ' 46' ' ' GLY . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 39' ' ' ASN . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.574 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.646 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 6' ' ' VAL . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . 47.96 -105.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . 42.66 61.34 2.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.959 -1.088 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 p -133.53 69.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.271 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.89 94.72 0.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 109.956 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.535 ' N ' HG11 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.429 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.564 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 55' ' ' LYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.493 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 46' ' ' GLY . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.554 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.556 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.525 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.32 0.581 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.5 55.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.2 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.78 9.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.608 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' HB ' HD22 ' A' ' 50' ' ' LEU . 4.9 m -112.04 109.68 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.266 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -155.3 162.44 40.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.266 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' N ' HG12 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.549 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.558 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.558 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.558 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 38' ' ' CYS . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 1.9 p30 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 44' ' ' SER . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.6 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.639 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.529 ' N ' ' OG1' ' A' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -100.97 -21.51 15.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 168.72 -167.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' HB ' HD22 ' A' ' 50' ' ' LEU . 8.4 m -129.88 74.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.959 . . . . 0.0 109.68 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -161.8 160.36 28.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.492 -0.755 . . . . 0.0 109.151 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' CG1' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.556 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.548 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.548 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.618 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.5 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CD2' HD21 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -136.83 90.72 2.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 45.78 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 5' ' ' SER . 47.2 t -118.66 56.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.615 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER 94.48 25.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.591 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.553 ' CG2' ' CZ ' ' A' ' 53' ' ' PHE . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' HA ' HG23 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' PRO . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m-80 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.412 HG22 ' HB2' ' A' ' 45' ' ' ASN . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.573 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.606 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.617 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 0.3 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.502 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.225 0.536 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . 75.72 143.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 76.26 114.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 5' ' ' SER . 1.4 m -99.43 73.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.278 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.3 t 167.37 137.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.975 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.612 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.528 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.671 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.449 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 7.5 m-80 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG21 ' CD2' ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 12' ' ' PRO . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.642 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.549 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.642 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HA ' HD22 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.54 43.34 2.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.01 137.91 5.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.32 110.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.49 156.9 2.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 108.907 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.538 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.68 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.537 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.6 t-20 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.628 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 8.3 m-80 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.542 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.791 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.569 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.68 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD21 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HB3' ' ND2' ' A' ' 28' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.4 tp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 81.32 -70.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.703 . . . . 0.0 109.559 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 177.53 147.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.371 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -114.22 109.17 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 -160.55 0.94 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.059 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' CG1' ' SG ' ' A' ' 8' ' ' CYS . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.545 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.639 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.687 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 39' ' ' ASN . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.687 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.427 ' CG2' ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.655 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.655 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 8.6 p80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.423 ' O ' HD22 ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.98 -92.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.32 61.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -128.62 66.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p -131.46 153.42 49.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.429 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' ASP . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.578 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.662 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' HA2' ' O ' ' A' ' 49' ' ' THR . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HD3' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.553 ' CG ' ' HB2' ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' O ' HG11 ' A' ' 42' ' ' VAL . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 38' ' ' CYS . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 39' ' ' ASN . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.512 ' O ' ' CG2' ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.54 ' CD1' ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.598 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.662 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -169.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.03 141.04 19.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -129.11 67.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.34 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER 167.1 123.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.432 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.588 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.635 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.509 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.7 t-20 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.454 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.635 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.525 ' CD1' ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.654 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.532 ' CB ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.41 -38.01 8.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.669 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.25 121.02 7.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG12 ' CB ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -129.15 98.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 109.634 179.876 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.21 142.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.586 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.633 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.417 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.652 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.532 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' C ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.535 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' CZ ' ' HA2' ' A' ' 25' ' ' GLY . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.633 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.452 HG21 ' HB2' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD13 ' CA ' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.532 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.631 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.652 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.8 p80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.8 tp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 70.72 -163.44 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.11 120.85 43.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 14.6 p -106.16 99.46 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.296 -0.878 . . . . 0.0 109.213 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER 170.37 135.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.304 -179.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.591 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.507 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.631 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' HD13 ' A' ' 48' ' ' LEU . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.407 HG22 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.627 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.627 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.623 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' CG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.585 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.631 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.543 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 45.58 1.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.57 50.83 16.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.0 74.14 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.9 173.07 17.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.413 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.427 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.611 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.488 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 17.4 t-20 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' CD ' ' OD2' ' A' ' 27' ' ' ASP . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.504 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.64 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' OG ' ' CG2' ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' OG ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.572 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.46 66.4 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.15 -172.32 3.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.57 95.65 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.24 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.224 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.547 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.644 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.649 ' O ' ' O ' ' A' ' 19' ' ' GLU . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.602 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.553 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.601 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CZ ' HD22 ' A' ' 48' ' ' LEU . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.644 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.581 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.442 HG21 HD21 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD22 ' CZ ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CG ' HD22 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 45.9 mt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.4 35.11 10.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.282 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.02 167.51 24.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.337 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -152.54 66.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.914 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' VAL . 32.2 t -45.08 141.8 2.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.885 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.564 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 29' ' ' LYS . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.552 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.579 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' HA ' HG23 ' A' ' 42' ' ' VAL . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 51' ' ' SER . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.609 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 4' ' ' VAL . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.451 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.315 0.579 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.47 -173.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.18 149.34 16.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 32.1 m -121.9 110.58 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -169.72 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 9' ' ' SER . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.628 ' CB ' ' ND2' ' A' ' 33' ' ' ASN . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.559 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 37' ' ' PHE . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.635 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.567 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 39' ' ' ASN . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD21 ' CB ' ' A' ' 40' ' ' ALA . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.634 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.3 p80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' CB ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.574 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.33 -169.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.36 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 4' ' ' VAL . 18.4 m -125.05 79.76 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p -137.73 178.35 7.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' N ' HG13 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CB ' HD11 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.518 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' HA ' HG23 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 39' ' ' ASN . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.758 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.455 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.654 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CE2' HG21 ' A' ' 6' ' ' VAL . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.3 0.571 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . 76.27 -158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 179.93 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 76.27 97.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' O ' HG21 ' A' ' 4' ' ' VAL . 17.2 m -104.85 68.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.542 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -165.39 153.08 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' N ' HG13 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.584 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.525 ' HA2' HD13 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.549 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.56 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' CYS . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' N ' ' A' ' 51' ' ' SER . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.666 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.5 tt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.94 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' LEU . . . -156.74 178.1 10.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 5' ' ' SER . 2.0 t -101.61 72.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 164.31 143.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 -179.952 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 49' ' ' THR . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.53 ' CB ' HD13 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.627 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.701 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 12' ' ' PRO . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.701 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.593 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 2.2 t30 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.593 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD21 ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.404 ' O ' HD11 ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.71 -5.33 45.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.823 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 118.92 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.715 -179.762 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.442 ' O ' HG21 ' A' ' 4' ' ' VAL . 27.7 m -91.73 85.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p 178.86 128.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.535 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.428 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.428 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.582 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.48 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.583 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.666 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.539 ' HA ' HG23 ' A' ' 42' ' ' VAL . 1.1 m120 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 44' ' ' SER . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.642 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.642 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 1' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.308 0.575 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 -79.98 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.74 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 167.35 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.97 . . . . 0.0 109.677 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.1 75.66 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 175.07 126.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.254 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.417 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.639 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.583 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.639 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.555 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.555 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.646 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.646 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.7 p80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.538 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 3.9 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 60.76 -179.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.26 -179.73 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.65 121.33 9.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 0.0 109.55 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 13.3 p -117.24 66.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.7 163.27 24.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.445 -0.785 . . . . 0.0 109.038 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' O ' ' O ' ' A' ' 7' ' ' ASP . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.653 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.616 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 55' ' ' LYS . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.653 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.594 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.652 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.652 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.0 p80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.61 -77.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.34 166.61 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.653 -179.886 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.41 95.35 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m -122.22 167.09 13.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.968 . . . . 0.0 109.865 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' GLU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 t-20 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.555 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' 12' ' ' PRO . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 26' ' ' SER . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 1' ' ' LEU . 2.4 pt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.244 0.545 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.39 75.47 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.564 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 99.17 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.348 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 4' ' ' VAL . 36.0 m -114.12 88.35 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t 179.63 120.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.525 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.579 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.571 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.724 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.403 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.482 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.579 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.507 ' C ' HG21 ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.581 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.507 HG21 ' C ' ' A' ' 39' ' ' ASN . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.6 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.598 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.724 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.482 ' SG ' ' OG1' ' A' ' 30' ' ' THR . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.503 ' HG ' ' N ' ' A' ' 2' ' ' ALA . 2.5 pt? . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -98.45 -155.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.58 -179.794 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 76.13 139.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.597 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.55 86.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 -179.908 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p -172.05 145.78 1.86 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.651 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.463 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.595 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG11 ' HA2' ' A' ' 46' ' ' GLY . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 11' ' ' TYR . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 2.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 76.31 -176.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.588 179.968 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.4 163.37 13.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.576 HG11 ' CE1' ' A' ' 53' ' ' PHE . 2.1 t -143.49 102.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.32 179.48 6.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.953 . . . . 0.0 109.719 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 53' ' ' PHE . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.532 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' CB ' ' CD1' ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.475 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' HG23 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.754 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 HG21 ' CD2' ' A' ' 48' ' ' LEU . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.574 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.754 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.698 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.715 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.1 p80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CE1' HG11 ' A' ' 4' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 58.29 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.347 179.964 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.72 166.37 11.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.428 179.879 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' O ' HG21 ' A' ' 4' ' ' VAL . 5.3 m -142.09 109.55 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p -124.77 176.23 6.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.83 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 24' ' ' CYS . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.531 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.737 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.737 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.567 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.518 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.465 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 167.55 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 -179.952 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.96 143.0 30.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.4 m -145.56 100.08 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.326 -179.98 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 6.0 m -167.11 115.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.362 179.961 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.544 ' CG2' ' CZ ' ' A' ' 53' ' ' PHE . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.559 ' CD2' ' CE2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.628 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.666 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 38' ' ' CYS . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' CYS . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG13 ' SG ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.544 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' CE2' ' CD2' ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -91.21 -69.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.412 179.804 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 168.39 154.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.335 179.89 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.37 79.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.37 -179.99 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t -122.98 -168.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.986 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.466 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.466 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.481 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.506 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.554 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.758 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.504 ' OG ' HG21 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 45' ' ' ASN . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 41' ' ' VAL . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.534 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.4 p80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.298 0.571 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -161.65 -167.98 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.274 -179.975 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 75.66 154.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.09 70.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.202 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -158.88 114.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.766 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 33' ' ' ASN . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.62 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.9 p30 -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.6 m-80 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 11' ' ' TYR . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 44' ' ' SER . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.553 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 4' ' ' VAL . . . -59.69 179.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 109.483 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -44.91 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 179.845 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ALA . 22.0 t -84.59 68.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.993 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.36 121.05 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.64 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.545 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.567 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 31' ' ' TYR . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 22' ' ' PRO . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.64 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.784 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 39' ' ' ASN . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.784 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.625 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.577 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.577 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE1' HD22 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 161.71 41.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.938 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.0 171.69 8.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 -179.821 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 50' ' ' LEU . 2.8 p -151.22 125.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.275 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -73.4 18.33 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' N ' ' CG1' ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.588 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.481 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.629 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.6 t-20 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 55' ' ' LYS . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 23' ' ' LEU . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.451 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.26 0.552 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.864 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.949 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 3.3 m120 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 37' ' ' PHE . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' A' ' 11' ' ' TYR . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 42' ' ' VAL . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 47' ' ' THR . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.949 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.629 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.555 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.697 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.602 ' HA ' ' C ' ' A' ' 12' ' ' PRO . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.825 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.726 ' O ' HG12 ' A' ' 42' ' ' VAL . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.46 HG22 ' CE2' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.97 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.685 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.927 ' CB ' HD12 ' A' ' 23' ' ' LEU . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' PHE . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.97 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' CE2' HG22 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 23' ' ' LEU . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.936 ' HB3' HG11 ' A' ' 42' ' ' VAL . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.918 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.732 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.747 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.557 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD11 ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.663 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.013 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' HG22 ' A' ' 42' ' ' VAL . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.979 HG22 HD23 ' A' ' 48' ' ' LEU . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 11' ' ' TYR . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.676 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.522 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.747 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 55.6 p-80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE1' HD21 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.652 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.931 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.2 t30 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.964 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.664 ' O ' HG22 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG22 HD23 ' A' ' 48' ' ' LEU . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.679 ' O ' HG22 ' A' ' 47' ' ' THR . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.931 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' LYS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG22 ' HE2' ' A' ' 53' ' ' PHE . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.577 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.631 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.882 HG22 HD23 ' A' ' 48' ' ' LEU . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.67 ' OG ' HG22 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.67 HG22 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.882 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 6' ' ' VAL . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.305 0.574 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.67 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 70.0 m-20 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' O ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.083 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.083 HG23 ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' C ' HG23 ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.723 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.057 ' O ' HG21 ' A' ' 42' ' ' VAL . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.591 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.761 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.057 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' ASP . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.653 ' H ' HG22 ' A' ' 6' ' ' VAL . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.911 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 37' ' ' PHE . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 44' ' ' SER . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 ' HA3' ' A' ' 25' ' ' GLY . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 51' ' ' SER . 14.4 p-80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.714 HG21 HD22 ' A' ' 23' ' ' LEU . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 6' ' ' VAL . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.549 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.688 HG21 ' HD2' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' C ' HG22 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' PHE . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 47' ' ' THR . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 44' ' ' SER . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.704 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.868 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 26.9 p-80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD2' HG21 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.868 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB2' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.845 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.005 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 t30 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.845 ' CB ' HD12 ' A' ' 23' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' PHE . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.74 ' O ' HG23 ' A' ' 47' ' ' THR . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 44' ' ' SER . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.005 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.623 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.263 0.554 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.066 ' O ' HG21 ' A' ' 42' ' ' VAL . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.817 HD13 ' HG2' ' A' ' 34' ' ' LYS . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.44 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.805 HD22 ' HD2' ' A' ' 53' ' ' PHE . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.83 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG2' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.066 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.98 ' O ' HG22 ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 37' ' ' PHE . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.805 ' HD2' HD22 ' A' ' 23' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 6' ' ' VAL . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.977 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.801 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.081 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HD3' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 11' ' ' TYR . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.732 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.435 0.636 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.608 ' N ' HG12 ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.703 ' C ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.642 ' HE2' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 2.3 m120 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.59 ' O ' HG22 ' A' ' 47' ' ' THR . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.545 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 7' ' ' ASP . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 6' ' ' VAL . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.714 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 37' ' ' PHE . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 11' ' ' TYR . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.909 ' O ' HG22 ' A' ' 47' ' ' THR . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.909 HG22 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.619 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.659 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 7' ' ' ASP . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.843 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.8 m-20 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.78 ' O ' HG23 ' A' ' 41' ' ' VAL . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.692 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.692 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 44' ' ' SER . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.843 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.903 HG21 HD22 ' A' ' 23' ' ' LEU . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.905 ' CB ' HG11 ' A' ' 42' ' ' VAL . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.43 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.903 HD22 HG21 ' A' ' 6' ' ' VAL . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.082 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.806 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.637 ' HG2' HD22 ' A' ' 18' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.611 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.905 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.96 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.96 HG23 ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.082 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.685 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.937 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.529 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.603 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 48' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' THR . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 37' ' ' PHE . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 24' ' ' CYS . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.565 ' H ' HD12 ' A' ' 50' ' ' LEU . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.937 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' LYS . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.851 HG21 HD22 ' A' ' 23' ' ' LEU . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.542 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.475 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.007 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.609 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.818 ' O ' HG23 ' A' ' 41' ' ' VAL . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 37' ' ' PHE . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.007 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.577 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.28 0.562 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.956 ' CB ' HG11 ' A' ' 42' ' ' VAL . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.843 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.593 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.842 ' O ' HG22 ' A' ' 42' ' ' VAL . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.865 HG22 HD23 ' A' ' 48' ' ' LEU . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.956 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' SER . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' HD22 ' A' ' 23' ' ' LEU . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.712 ' H ' HG22 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.993 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.974 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.828 ' CB ' HD12 ' A' ' 23' ' ' LEU . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' PHE . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.993 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.637 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.445 HG23 ' ND2' ' A' ' 45' ' ' ASN . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.974 HD11 ' HA3' ' A' ' 25' ' ' GLY . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.535 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.659 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.64 ' N ' HG13 ' A' ' 6' ' ' VAL . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.969 ' O ' HG21 ' A' ' 42' ' ' VAL . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.967 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 37' ' ' PHE . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 47' ' ' THR . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.967 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CD2' HD23 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.628 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG23 HD22 ' A' ' 50' ' ' LEU . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.715 ' HB3' HG11 ' A' ' 42' ' ' VAL . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 37' ' ' PHE . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.963 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.683 ' CB ' HD12 ' A' ' 23' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' O ' HG13 ' A' ' 42' ' ' VAL . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' C ' HG22 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 48' ' ' LEU . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 11' ' ' TYR . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.0 m120 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.585 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD22 HG23 ' A' ' 6' ' ' VAL . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.557 ' HB3' ' CA ' ' A' ' 25' ' ' GLY . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.963 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 7' ' ' ASP . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 6' ' ' VAL . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.692 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.6 m120 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 1.039 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.633 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.559 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 51' ' ' SER . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.592 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' HA ' HD23 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' LYS . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 23' ' ' LEU . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.977 ' HB3' HG11 ' A' ' 42' ' ' VAL . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 55.8 t30 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.64 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' HB3' ' A' ' 11' ' ' TYR . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.792 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 47' ' ' THR . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.49 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.719 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 55' ' ' LYS . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.683 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.683 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.88 ' O ' HG21 ' A' ' 42' ' ' VAL . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 37' ' ' PHE . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.788 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.726 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.727 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 37' ' ' PHE . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.698 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.827 ' O ' HG23 ' A' ' 47' ' ' THR . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.726 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.545 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.788 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 41.3 p-80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' HD11 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 6' ' ' VAL . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.851 ' O ' HG21 ' A' ' 42' ' ' VAL . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.112 ' O ' HD12 ' A' ' 50' ' ' LEU . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.887 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.849 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.8 ' CB ' HD12 ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.647 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' PHE . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.851 HG21 ' O ' ' A' ' 11' ' ' TYR . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.893 ' O ' HG22 ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.887 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.112 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.778 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 6' ' ' VAL . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.589 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 6' ' ' VAL . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.414 ' C ' ' OE1' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.765 ' HB3' HG11 ' A' ' 42' ' ' VAL . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.018 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.987 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.636 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.018 ' CB ' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.018 HD12 ' O ' ' A' ' 24' ' ' CYS . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.902 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.331 0.586 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.68 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CB ' HG11 ' A' ' 42' ' ' VAL . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.816 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 55' ' ' LYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.766 ' O ' HG22 ' A' ' 47' ' ' THR . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.816 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.885 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 31.0 p-80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.885 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.677 HG21 HD13 ' A' ' 23' ' ' LEU . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.694 ' CB ' HG11 ' A' ' 42' ' ' VAL . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.962 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.802 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.721 ' CB ' HD12 ' A' ' 23' ' ' LEU . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.944 HG22 HD23 ' A' ' 48' ' ' LEU . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.774 ' O ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 44' ' ' SER . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.962 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.746 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.921 ' CB ' HG11 ' A' ' 42' ' ' VAL . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.694 HD13 ' C ' ' A' ' 33' ' ' ASN . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' HE2' ' HB1' ' A' ' 40' ' ' ALA . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 23' ' ' LEU . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.772 ' HB1' ' HE2' ' A' ' 29' ' ' LYS . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 HD23 ' A' ' 48' ' ' LEU . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.921 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.656 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.979 ' O ' HG22 ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.828 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD22 ' CG ' ' A' ' 34' ' ' LYS . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.879 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.582 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.879 ' C ' HD12 ' A' ' 23' ' ' LEU . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.828 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.936 ' O ' HG22 ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.936 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.936 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.978 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.799 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.978 ' CB ' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 47' ' ' THR . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 44' ' ' SER . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.312 0.577 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.978 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 34' ' ' LYS . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.832 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.779 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.832 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.698 ' HB2' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' C ' HG22 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.978 HG21 ' HB3' ' A' ' 12' ' ' PRO . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 47' ' ' THR . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 44' ' ' SER . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.779 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.911 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 27.6 p-80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.911 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.421 0.629 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 42' ' ' VAL . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.874 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.803 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.794 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.874 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.959 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.909 ' O ' HG22 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.959 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 47' ' ' THR . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.803 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.803 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.803 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' N ' HD11 ' A' ' 50' ' ' LEU . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.647 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' N ' HG12 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.731 ' CB ' HG11 ' A' ' 42' ' ' VAL . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.73 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.509 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.017 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CB ' HD12 ' A' ' 23' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.693 HG13 ' HA2' ' A' ' 46' ' ' GLY . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.731 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 47' ' ' THR . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.693 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 44' ' ' SER . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.661 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.017 HD12 ' O ' ' A' ' 24' ' ' CYS . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.514 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.915 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.754 HG21 HD13 ' A' ' 23' ' ' LEU . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.83 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.889 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.525 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.645 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.889 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 48' ' ' LEU . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.705 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.778 ' O ' HG23 ' A' ' 47' ' ' THR . 0.6 OUTLIER 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.243 0.544 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 23' ' ' LEU . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.029 ' CB ' HG11 ' A' ' 42' ' ' VAL . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.514 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.615 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.687 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.743 ' O ' HG22 ' A' ' 42' ' ' VAL . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 10.8 m-20 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 HD23 ' A' ' 48' ' ' LEU . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.029 HG11 ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 7' ' ' ASP . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.003 ' O ' HG21 ' A' ' 42' ' ' VAL . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.761 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 37' ' ' PHE . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.761 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.1 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.1 HG23 ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.899 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 26.2 p-80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.899 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 23' ' ' LEU . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.954 ' CB ' HG11 ' A' ' 42' ' ' VAL . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 6' ' ' VAL . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.744 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.768 ' CE1' HD21 ' A' ' 48' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.7 m-20 -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.954 HG11 ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.768 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.893 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 22.2 p-80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.893 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.27 0.557 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 23' ' ' LEU . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.089 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' C ' HG22 ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 11' ' ' TYR . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.564 ' O ' HG22 ' A' ' 47' ' ' THR . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 44' ' ' SER . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 49' ' ' THR . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.589 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.089 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 23' ' ' LEU . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.597 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.285 0.564 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.836 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.915 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 55' ' ' LYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.7 ' CB ' HD12 ' A' ' 23' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HD23 ' A' ' 48' ' ' LEU . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.836 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.612 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.915 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' LYS . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.222 0.534 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 7' ' ' ASP . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 6' ' ' VAL . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.823 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.92 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 12' ' ' PRO . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' THR . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 44' ' ' SER . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.593 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.269 0.557 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.908 ' HB3' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.106 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 18' ' ' LEU . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.802 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.576 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.767 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.958 ' CB ' HD12 ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.797 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.752 ' O ' HG22 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.106 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.751 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.579 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.802 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 10.6 p-80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.622 ' HE2' HG22 ' A' ' 6' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.919 ' CB ' HG11 ' A' ' 42' ' ' VAL . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.924 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.97 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.688 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 48' ' ' LEU . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.919 HG11 ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 23' ' ' LEU . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE3' ' CZ ' ' A' ' 11' ' ' TYR . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.031 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.572 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 41' ' ' VAL . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.782 ' O ' HG12 ' A' ' 42' ' ' VAL . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 37' ' ' PHE . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.031 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.643 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.78 ' CD2' HD23 ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.685 ' H ' HG22 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.059 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.53 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' CB ' HD12 ' A' ' 23' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.059 HG21 ' O ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 44' ' ' SER . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.488 HD22 ' HB1' ' A' ' 40' ' ' ALA . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.654 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' C ' HD11 ' A' ' 50' ' ' LEU . 19.1 p-80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 53' ' ' PHE . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.705 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.936 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 1.064 ' HE2' HD13 ' A' ' 48' ' ' LEU . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.639 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.648 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 6.6 m120 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' CYS . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.064 HD13 ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.555 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.323 0.583 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 34' ' ' LYS . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 42' ' ' VAL . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.864 ' C ' HD12 ' A' ' 23' ' ' LEU . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.797 ' CE1' HD11 ' A' ' 48' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.705 ' O ' HG12 ' A' ' 42' ' ' VAL . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.789 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 52' ' ' HIS . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.916 ' O ' HD11 ' A' ' 50' ' ' LEU . 10.0 p-80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CD1' HD21 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.728 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.728 ' N ' HG13 ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.816 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.645 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.645 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' THR . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 44' ' ' SER . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.645 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.59 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.563 ' CE1' ' C ' ' A' ' 5' ' ' SER . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.19 -162.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.64 41.55 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.472 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 1.5 t -84.7 101.1 8.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 109.079 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t -129.84 153.18 48.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.864 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.949 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 3.3 m120 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 37' ' ' PHE . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' A' ' 11' ' ' TYR . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 42' ' ' VAL . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 47' ' ' THR . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.949 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.629 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 171.85 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.43 150.53 49.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.725 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.0 p -79.84 88.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 109.462 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.4 t 170.1 118.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.697 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.602 ' HA ' ' C ' ' A' ' 12' ' ' PRO . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.825 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.726 ' O ' HG12 ' A' ' 42' ' ' VAL . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.617 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 75.81 129.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 68.74 -176.32 0.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.893 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.4 p -152.05 69.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 21.4 p 173.43 141.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG22 ' CE2' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.97 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.685 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.927 ' CB ' HD12 ' A' ' 23' ' ' LEU . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' PHE . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' CE2' HG22 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 174.33 -83.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 72.22 147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.83 73.54 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -164.63 138.53 5.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.985 . . . . 0.0 109.631 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 23' ' ' LEU . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.936 ' HB3' HG11 ' A' ' 42' ' ' VAL . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.918 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.732 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.747 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.557 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD11 ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.663 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.013 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' HG22 ' A' ' 42' ' ' VAL . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.979 HG22 HD23 ' A' ' 48' ' ' LEU . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 11' ' ' TYR . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.676 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.522 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.747 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 55.6 p-80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE1' HD21 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.39 63.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.11 -176.2 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.475 HG12 ' HE1' ' A' ' 53' ' ' PHE . 9.0 t -96.69 81.39 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.622 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -167.37 149.91 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.652 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.931 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.2 t30 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.964 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.664 ' O ' HG22 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG22 HD23 ' A' ' 48' ' ' LEU . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.679 ' O ' HG22 ' A' ' 47' ' ' THR . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.931 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' HE1' HG12 ' A' ' 4' ' ' VAL . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' LYS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.18 -78.58 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.48 77.71 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 4' ' ' VAL . 17.2 m -88.92 87.01 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.26 157.88 36.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG22 ' HE2' ' A' ' 53' ' ' PHE . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.577 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.631 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.882 HG22 HD23 ' A' ' 48' ' ' LEU . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.67 ' OG ' HG22 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.67 HG22 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.882 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 6' ' ' VAL . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.816 HD13 ' N ' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.24 0.543 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.33 -176.26 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.559 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.97 177.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 4' ' ' VAL . 10.3 m -113.12 84.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.932 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.67 152.62 39.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.459 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.67 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 70.0 m-20 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' O ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.083 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.083 HG23 ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' C ' HG23 ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.723 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.95 -65.06 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.673 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -96.68 148.36 22.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.686 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -160.02 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 109.445 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -124.58 168.84 12.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.057 ' O ' HG21 ' A' ' 42' ' ' VAL . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.591 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.761 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.057 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.279 0.561 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.17 69.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.62 179.69 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 53' ' ' PHE . 12.7 p -91.89 104.55 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 109.362 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -96.7 167.42 11.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' ASP . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.653 ' H ' HG22 ' A' ' 6' ' ' VAL . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.911 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 37' ' ' PHE . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 44' ' ' SER . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 ' HA3' ' A' ' 25' ' ' GLY . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 51' ' ' SER . 14.4 p-80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HE1' HG22 ' A' ' 4' ' ' VAL . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' LEU . . . 55.72 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.56 91.48 3.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.866 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 4' ' ' VAL . 21.0 m -87.1 72.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -153.9 147.91 25.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.288 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.714 HG21 HD22 ' A' ' 23' ' ' LEU . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 6' ' ' VAL . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.549 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.688 HG21 ' HD2' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' C ' HG22 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' PHE . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 47' ' ' THR . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 44' ' ' SER . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.704 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.868 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 26.9 p-80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD2' HG21 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.868 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.56 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.02 178.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.92 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 50' ' ' LEU . 1.7 t -141.71 74.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.272 -0.892 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -169.46 156.97 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.293 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB2' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.845 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.005 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 t30 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.845 ' CB ' HD12 ' A' ' 23' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' PHE . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.74 ' O ' HG23 ' A' ' 47' ' ' THR . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 44' ' ' SER . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.005 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.623 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -120.07 93.29 4.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 57.75 162.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.665 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 ' CE1' ' A' ' 53' ' ' PHE . 3.1 t -145.3 107.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -131.11 -154.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.066 ' O ' HG21 ' A' ' 42' ' ' VAL . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.817 HD13 ' HG2' ' A' ' 34' ' ' LYS . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.44 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.805 HD22 ' HD2' ' A' ' 53' ' ' PHE . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.83 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG2' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.066 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.98 ' O ' HG22 ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 37' ' ' PHE . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.805 ' HD2' HD22 ' A' ' 23' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.691 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 74.81 33.36 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.62 43.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.74 65.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.0 143.36 14.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.449 -0.782 . . . . 0.0 109.242 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 6' ' ' VAL . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.977 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.801 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.081 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HD3' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 11' ' ' TYR . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.732 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . 61.04 42.47 12.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 178.51 124.55 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.782 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.516 HG12 HD21 ' A' ' 50' ' ' LEU . 1.6 t -89.83 111.75 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.186 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.95 -175.52 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.608 ' N ' HG12 ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.703 ' C ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.642 ' HE2' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 2.3 m120 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.59 ' O ' HG22 ' A' ' 47' ' ' THR . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.545 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 124.93 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.419 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.98 148.38 48.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.1 p -158.36 89.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.583 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER 165.61 159.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.278 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 7' ' ' ASP . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 6' ' ' VAL . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.714 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 37' ' ' PHE . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 11' ' ' TYR . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.909 ' O ' HG22 ' A' ' 47' ' ' THR . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.909 HG22 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.619 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.659 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.89 56.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.46 170.03 18.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.99 99.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.001 -1.062 . . . . 0.0 110.223 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -109.49 172.3 6.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 108.814 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 7' ' ' ASP . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.843 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.8 m-20 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.78 ' O ' HG23 ' A' ' 41' ' ' VAL . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.692 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.692 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 44' ' ' SER . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.843 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -127.3 -31.22 2.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.57 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 60.1 87.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.487 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.3 p -136.11 81.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.175 -0.953 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 155.6 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.232 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.903 HG21 HD22 ' A' ' 23' ' ' LEU . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.905 ' CB ' HG11 ' A' ' 42' ' ' VAL . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.43 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.903 HD22 HG21 ' A' ' 6' ' ' VAL . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.082 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.806 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' HG2' HD22 ' A' ' 18' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.611 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.905 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.96 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.96 HG23 ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.082 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.685 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -112.56 15.08 20.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.411 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 56.43 167.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 90.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -154.75 115.03 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.937 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.529 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.603 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 48' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' THR . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 37' ' ' PHE . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 24' ' ' CYS . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.565 ' H ' HD12 ' A' ' 50' ' ' LEU . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.937 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' LYS . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.08 -92.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.81 148.45 31.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 4' ' ' VAL . 7.7 m -123.19 103.29 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.92 168.48 17.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.851 HG21 HD22 ' A' ' 23' ' ' LEU . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.542 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.007 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.609 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.818 ' O ' HG23 ' A' ' 41' ' ' VAL . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 37' ' ' PHE . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.007 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.577 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . 47.96 -105.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . 42.66 61.34 2.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.959 -1.088 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.753 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.1 p -133.53 69.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.271 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.89 94.72 0.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 109.956 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.956 ' CB ' HG11 ' A' ' 42' ' ' VAL . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.843 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.593 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.842 ' O ' HG22 ' A' ' 42' ' ' VAL . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.865 HG22 HD23 ' A' ' 48' ' ' LEU . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.956 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' SER . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' HD22 ' A' ' 23' ' ' LEU . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.32 0.581 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 179.5 55.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.2 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.78 9.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.608 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 50' ' ' LEU . 4.9 m -112.04 109.68 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.266 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -155.3 162.44 40.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.266 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.712 ' H ' HG22 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.993 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.974 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.828 ' CB ' HD12 ' A' ' 23' ' ' LEU . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' PHE . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.993 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.637 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.445 HG23 ' ND2' ' A' ' 45' ' ' ASN . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.974 HD11 ' HA3' ' A' ' 25' ' ' GLY . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.535 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.659 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -100.97 -21.51 15.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 168.72 -167.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.658 ' O ' HD23 ' A' ' 50' ' ' LEU . 8.4 m -129.88 74.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.959 . . . . 0.0 109.68 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -161.8 160.36 28.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.492 -0.755 . . . . 0.0 109.151 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.64 ' N ' HG13 ' A' ' 6' ' ' VAL . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.969 ' O ' HG21 ' A' ' 42' ' ' VAL . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.967 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 37' ' ' PHE . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 47' ' ' THR . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.967 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CD2' HD23 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -136.83 90.72 2.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 45.78 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.692 ' HB ' HD23 ' A' ' 50' ' ' LEU . 47.2 t -118.66 56.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.628 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER 94.48 25.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.591 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG23 HD22 ' A' ' 50' ' ' LEU . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.715 ' HB3' HG11 ' A' ' 42' ' ' VAL . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 37' ' ' PHE . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.963 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.683 ' CB ' HD12 ' A' ' 23' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' O ' HG13 ' A' ' 42' ' ' VAL . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' C ' HG22 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 48' ' ' LEU . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 11' ' ' TYR . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.0 m120 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.585 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD22 HG23 ' A' ' 6' ' ' VAL . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.557 ' HB3' ' CA ' ' A' ' 25' ' ' GLY . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.963 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.69 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.225 0.536 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 75.72 143.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.26 114.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 5' ' ' SER . 1.4 m -99.43 73.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.278 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.3 t 167.37 137.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.975 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 7' ' ' ASP . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 6' ' ' VAL . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.692 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.6 m120 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 1.039 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.633 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.559 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 51' ' ' SER . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.592 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' HA ' HD23 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' LYS . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.54 43.34 2.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.01 137.91 5.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.32 110.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.49 156.9 2.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 108.907 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 23' ' ' LEU . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.977 ' HB3' HG11 ' A' ' 42' ' ' VAL . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 55.8 t30 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.64 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' HB3' ' A' ' 11' ' ' TYR . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.792 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 47' ' ' THR . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.49 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.719 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 55' ' ' LYS . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.716 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.4 tp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 81.32 -70.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.703 . . . . 0.0 109.559 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 177.53 147.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.371 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -114.22 109.17 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 -160.55 0.94 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.059 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.683 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.683 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.88 ' O ' HG21 ' A' ' 42' ' ' VAL . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 37' ' ' PHE . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.788 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.726 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.727 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 37' ' ' PHE . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.698 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.827 ' O ' HG23 ' A' ' 47' ' ' THR . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.726 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.545 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.788 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 41.3 p-80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' HD11 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.98 -92.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.32 61.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG12 HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -128.62 66.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p -131.46 153.42 49.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.429 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.7 ' O ' HG12 ' A' ' 6' ' ' VAL . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.851 ' O ' HG21 ' A' ' 42' ' ' VAL . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.112 ' O ' HD12 ' A' ' 50' ' ' LEU . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.887 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.849 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.8 ' CB ' HD12 ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.647 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' PHE . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.851 HG21 ' O ' ' A' ' 11' ' ' TYR . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.893 ' O ' HG22 ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.887 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.112 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.778 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 6' ' ' VAL . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.589 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -169.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.03 141.04 19.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -129.11 67.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.34 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER 167.1 123.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.432 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 6' ' ' VAL . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.414 ' C ' ' OE1' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.765 ' HB3' HG11 ' A' ' 42' ' ' VAL . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.018 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.987 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.636 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.018 ' CB ' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.018 HD12 ' O ' ' A' ' 24' ' ' CYS . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.902 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.41 -38.01 8.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.669 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.25 121.02 7.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -129.15 98.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 109.634 179.876 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.21 142.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.68 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CB ' HG11 ' A' ' 42' ' ' VAL . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 50' ' ' LEU . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.816 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 55' ' ' LYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.766 ' O ' HG22 ' A' ' 47' ' ' THR . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.816 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.553 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.885 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 31.0 p-80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.885 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.8 tp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 70.72 -163.44 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.11 120.85 43.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.78 ' O ' HG13 ' A' ' 4' ' ' VAL . 14.6 p -106.16 99.46 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.296 -0.878 . . . . 0.0 109.213 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER 170.37 135.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.304 -179.791 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.677 HG21 HD13 ' A' ' 23' ' ' LEU . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.694 ' CB ' HG11 ' A' ' 42' ' ' VAL . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.962 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.802 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.721 ' CB ' HD12 ' A' ' 23' ' ' LEU . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.944 HG22 HD23 ' A' ' 48' ' ' LEU . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.774 ' O ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 44' ' ' SER . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.962 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' HG23 ' A' ' 4' ' ' VAL . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 45.58 1.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.57 50.83 16.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.0 74.14 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.9 173.07 17.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.413 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.746 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.921 ' CB ' HG11 ' A' ' 42' ' ' VAL . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.453 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.694 HD13 ' C ' ' A' ' 33' ' ' ASN . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' HE2' ' HB1' ' A' ' 40' ' ' ALA . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 23' ' ' LEU . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.772 ' HB1' ' HE2' ' A' ' 29' ' ' LYS . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 HD23 ' A' ' 48' ' ' LEU . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.921 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.656 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.979 ' O ' HG22 ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.46 66.4 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.864 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.15 -172.32 3.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.57 95.65 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.24 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.224 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.828 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD22 ' CG ' ' A' ' 34' ' ' LYS . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.879 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.582 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.879 ' C ' HD12 ' A' ' 23' ' ' LEU . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.828 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.936 ' O ' HG22 ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.936 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 1' ' ' LEU . 45.9 mt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.4 35.11 10.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.282 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.02 167.51 24.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.337 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -152.54 66.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.914 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' VAL . 32.2 t -45.08 141.8 2.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.885 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.936 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.978 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.799 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.978 ' CB ' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 47' ' ' THR . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 44' ' ' SER . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 4' ' ' VAL . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.315 0.579 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.47 -173.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.18 149.34 16.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 4' ' ' VAL . 32.1 m -121.9 110.58 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -169.72 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.978 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 34' ' ' LYS . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.832 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.779 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.832 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.698 ' HB2' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' C ' HG22 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.978 HG21 ' HB3' ' A' ' 12' ' ' PRO . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 47' ' ' THR . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 44' ' ' SER . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.779 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.911 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 27.6 p-80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.911 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.33 -169.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.36 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 4' ' ' VAL . 18.4 m -125.05 79.76 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p -137.73 178.35 7.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 42' ' ' VAL . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.874 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.803 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.794 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.874 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.959 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.909 ' O ' HG22 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.959 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 47' ' ' THR . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.803 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.803 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.803 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' N ' HD11 ' A' ' 50' ' ' LEU . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.647 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.691 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.3 0.571 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 76.27 -158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 179.93 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.27 97.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 4' ' ' VAL . 17.2 m -104.85 68.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.542 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -165.39 153.08 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' N ' HG12 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.731 ' CB ' HG11 ' A' ' 42' ' ' VAL . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.73 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.509 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.017 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CB ' HD12 ' A' ' 23' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.693 HG13 ' HA2' ' A' ' 46' ' ' GLY . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.731 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 47' ' ' THR . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.693 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 44' ' ' SER . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.661 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.017 HD12 ' O ' ' A' ' 24' ' ' CYS . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.514 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.915 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.5 tt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.94 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' LEU . . . -156.74 178.1 10.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 5' ' ' SER . 2.0 t -101.61 72.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 164.31 143.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 -179.952 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.754 HG21 HD13 ' A' ' 23' ' ' LEU . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.83 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.889 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.525 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.645 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.889 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 48' ' ' LEU . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.705 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.778 ' O ' HG23 ' A' ' 47' ' ' THR . 0.6 OUTLIER 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.71 -5.33 45.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.823 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 118.92 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.715 -179.762 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 4' ' ' VAL . 27.7 m -91.73 85.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p 178.86 128.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.535 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 23' ' ' LEU . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.029 ' CB ' HG11 ' A' ' 42' ' ' VAL . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.514 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.615 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.687 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.743 ' O ' HG22 ' A' ' 42' ' ' VAL . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 10.8 m-20 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 HD23 ' A' ' 48' ' ' LEU . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.029 HG11 ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.308 0.575 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 -79.98 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.74 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 167.35 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.97 . . . . 0.0 109.677 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.1 75.66 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 175.07 126.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.254 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 7' ' ' ASP . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.003 ' O ' HG21 ' A' ' 42' ' ' VAL . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.761 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 37' ' ' PHE . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.761 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.1 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.1 HG23 ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.899 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 26.2 p-80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.899 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.9 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 60.76 -179.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.26 -179.73 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.65 121.33 9.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 0.0 109.55 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 4' ' ' VAL . 13.3 p -117.24 66.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.7 163.27 24.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.445 -0.785 . . . . 0.0 109.038 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 23' ' ' LEU . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.954 ' CB ' HG11 ' A' ' 42' ' ' VAL . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 6' ' ' VAL . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.744 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.768 ' CE1' HD21 ' A' ' 48' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.7 m-20 -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.954 HG11 ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.768 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.573 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.893 ' HE1' ' HA ' ' A' ' 56' ' ' CYS . 22.2 p-80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.893 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . -179.61 -77.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 179.992 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.34 166.61 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.653 -179.886 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.41 95.35 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m -122.22 167.09 13.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.968 . . . . 0.0 109.865 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 23' ' ' LEU . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.089 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' C ' HG22 ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 11' ' ' TYR . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.564 ' O ' HG22 ' A' ' 47' ' ' THR . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 44' ' ' SER . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 49' ' ' THR . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.589 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.089 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 23' ' ' LEU . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.597 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.688 HD23 ' N ' ' A' ' 1' ' ' LEU . 2.4 pt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.244 0.545 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.39 75.47 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.564 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 99.17 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.348 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 4' ' ' VAL . 36.0 m -114.12 88.35 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t 179.63 120.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.525 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.836 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.915 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 55' ' ' LYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' CB ' HD12 ' A' ' 23' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HD23 ' A' ' 48' ' ' LEU . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.836 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.612 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.915 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' LYS . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 1' ' ' LEU . 2.5 pt? . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -98.45 -155.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.58 -179.794 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.13 139.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.597 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.55 86.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 -179.908 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p -172.05 145.78 1.86 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 7' ' ' ASP . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 6' ' ' VAL . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.823 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.92 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 12' ' ' PRO . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' THR . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 44' ' ' SER . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.593 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.711 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 76.31 -176.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.588 179.968 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.4 163.37 13.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.726 HG12 ' CE1' ' A' ' 53' ' ' PHE . 2.1 t -143.49 102.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.32 179.48 6.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.953 . . . . 0.0 109.719 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 6' ' ' VAL . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.908 ' HB3' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.106 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 18' ' ' LEU . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.802 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.576 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.767 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.958 ' CB ' HD12 ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.797 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.752 ' O ' HG22 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.106 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.751 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.579 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.802 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 10.6 p-80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.726 ' CE1' HG12 ' A' ' 4' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 58.29 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.347 179.964 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.72 166.37 11.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.428 179.879 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 4' ' ' VAL . 5.3 m -142.09 109.55 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p -124.77 176.23 6.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.83 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.919 ' CB ' HG11 ' A' ' 42' ' ' VAL . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.924 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.97 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.688 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 48' ' ' LEU . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.919 HG11 ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 167.55 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 -179.952 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.96 143.0 30.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.4 m -145.56 100.08 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.326 -179.98 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 6.0 m -167.11 115.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.362 179.961 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 23' ' ' LEU . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE3' ' CZ ' ' A' ' 11' ' ' TYR . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.031 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.572 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 41' ' ' VAL . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.782 ' O ' HG12 ' A' ' 42' ' ' VAL . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 37' ' ' PHE . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.031 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.643 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.78 ' CD2' HD23 ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -91.21 -69.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.412 179.804 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 168.39 154.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.335 179.89 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.37 79.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.37 -179.99 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t -122.98 -168.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.986 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.685 ' H ' HG22 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.059 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.53 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' CB ' HD12 ' A' ' 23' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.059 HG21 ' O ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 44' ' ' SER . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.488 HD22 ' HB1' ' A' ' 40' ' ' ALA . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.654 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.654 ' C ' HD11 ' A' ' 50' ' ' LEU . 19.1 p-80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.298 0.571 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -161.65 -167.98 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.274 -179.975 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 75.66 154.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.09 70.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.202 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -158.88 114.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.766 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 53' ' ' PHE . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.705 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.936 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.064 ' HE2' HD13 ' A' ' 48' ' ' LEU . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.639 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.648 ' C ' HD21 ' A' ' 33' ' ' ASN . 0.1 OUTLIER -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 6.6 m120 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' CYS . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.064 HD13 ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.555 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 4' ' ' VAL . . . -59.69 179.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 109.483 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -44.91 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 179.845 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 2' ' ' ALA . 22.0 t -84.59 68.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.993 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.36 121.05 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 34' ' ' LYS . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 42' ' ' VAL . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.864 ' C ' HD12 ' A' ' 23' ' ' LEU . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.797 ' CE1' HD11 ' A' ' 48' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.705 ' O ' HG12 ' A' ' 42' ' ' VAL . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.789 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 52' ' ' HIS . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.916 ' O ' HD11 ' A' ' 50' ' ' LEU . 10.0 p-80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CD1' HD21 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 1' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 161.71 41.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.938 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.0 171.69 8.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 -179.821 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.134 HG23 ' CD2' ' A' ' 50' ' ' LEU . 2.8 p -151.22 125.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.275 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -73.4 18.33 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.818 ' H ' HG22 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.728 ' N ' HG13 ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.816 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.645 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.645 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' THR . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 44' ' ' SER . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.134 ' CD2' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.59 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.563 ' CE1' ' C ' ' A' ' 5' ' ' SER . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.26 0.552 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.864 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.949 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.3 m-80 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 37' ' ' PHE . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' A' ' 11' ' ' TYR . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 42' ' ' VAL . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 47' ' ' THR . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.949 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.629 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.267 0.555 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.697 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.602 ' HA ' ' C ' ' A' ' 12' ' ' PRO . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.825 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.726 ' O ' HG12 ' A' ' 42' ' ' VAL . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.617 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.46 HG22 ' CE2' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.97 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.685 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.927 ' CB ' HD12 ' A' ' 23' ' ' LEU . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' PHE . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.97 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' CE2' HG22 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.343 0.592 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 23' ' ' LEU . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.936 ' HB3' HG11 ' A' ' 42' ' ' VAL . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.918 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.732 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.557 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD11 ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.663 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.013 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' HG22 ' A' ' 42' ' ' VAL . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.979 HG22 HD23 ' A' ' 48' ' ' LEU . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 11' ' ' TYR . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.676 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.522 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 21.0 p80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE1' HD21 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.652 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 19.1 t-20 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.964 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.664 ' O ' HG22 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG22 HD23 ' A' ' 48' ' ' LEU . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.679 ' O ' HG22 ' A' ' 47' ' ' THR . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.598 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG22 ' HE2' ' A' ' 53' ' ' PHE . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.577 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.631 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.882 HG22 HD23 ' A' ' 48' ' ' LEU . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.67 ' OG ' HG22 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.67 HG22 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.882 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 6' ' ' VAL . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.305 0.574 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.67 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 5.4 m120 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' O ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.083 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.083 HG23 ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' C ' HG23 ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.723 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.057 ' O ' HG21 ' A' ' 42' ' ' VAL . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.591 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.761 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.057 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' ASP . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.653 ' H ' HG22 ' A' ' 6' ' ' VAL . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.911 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 37' ' ' PHE . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 44' ' ' SER . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 ' HA3' ' A' ' 25' ' ' GLY . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.566 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.714 HG21 HD22 ' A' ' 23' ' ' LEU . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 6' ' ' VAL . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.688 HG21 ' HD2' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' C ' HG22 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' PHE . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 47' ' ' THR . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 44' ' ' SER . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.704 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.647 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.9 p80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD2' HG21 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB2' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.845 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.005 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.1 t-20 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.845 ' CB ' HD12 ' A' ' 23' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' PHE . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.74 ' O ' HG23 ' A' ' 47' ' ' THR . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 44' ' ' SER . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.005 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.623 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.263 0.554 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.066 ' O ' HG21 ' A' ' 42' ' ' VAL . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.817 HD13 ' HG2' ' A' ' 34' ' ' LYS . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.44 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.805 HD22 ' HD2' ' A' ' 53' ' ' PHE . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.83 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG2' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.066 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.98 ' O ' HG22 ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 37' ' ' PHE . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.805 ' HD2' HD22 ' A' ' 23' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 6' ' ' VAL . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.977 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.801 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.081 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HD3' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 11' ' ' TYR . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.732 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.435 0.636 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.608 ' N ' HG12 ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.703 ' C ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.642 ' HE2' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.9 m-80 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.59 ' O ' HG22 ' A' ' 47' ' ' THR . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.545 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.682 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 7' ' ' ASP . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 6' ' ' VAL . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.714 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 37' ' ' PHE . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 11' ' ' TYR . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.909 ' O ' HG22 ' A' ' 47' ' ' THR . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.909 HG22 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.619 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 7' ' ' ASP . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.843 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.1 m120 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.78 ' O ' HG23 ' A' ' 41' ' ' VAL . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.692 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.692 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 44' ' ' SER . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.843 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.903 HG21 HD22 ' A' ' 23' ' ' LEU . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.905 ' CB ' HG11 ' A' ' 42' ' ' VAL . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.43 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.903 HD22 HG21 ' A' ' 6' ' ' VAL . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.082 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.806 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.637 ' HG2' HD22 ' A' ' 18' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.611 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.905 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.96 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.96 HG23 ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.082 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.685 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' O ' HD12 ' A' ' 50' ' ' LEU . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.529 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.603 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 48' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' THR . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 37' ' ' PHE . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 24' ' ' CYS . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.617 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' LYS . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.851 HG21 HD22 ' A' ' 23' ' ' LEU . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.542 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.475 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.007 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.609 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.635 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.818 ' O ' HG23 ' A' ' 41' ' ' VAL . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 37' ' ' PHE . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.007 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.577 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.646 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.28 0.562 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.956 ' CB ' HG11 ' A' ' 42' ' ' VAL . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.843 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.593 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.842 ' O ' HG22 ' A' ' 42' ' ' VAL . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.865 HG22 HD23 ' A' ' 48' ' ' LEU . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.956 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' SER . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' HD22 ' A' ' 23' ' ' LEU . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.712 ' H ' HG22 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.993 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.974 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.828 ' CB ' HD12 ' A' ' 23' ' ' LEU . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' PHE . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.993 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 1.9 p30 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.442 HG23 ' ND2' ' A' ' 45' ' ' ASN . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.974 HD11 ' HA3' ' A' ' 25' ' ' GLY . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.535 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.659 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.64 ' N ' HG13 ' A' ' 6' ' ' VAL . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.969 ' O ' HG21 ' A' ' 42' ' ' VAL . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.967 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 37' ' ' PHE . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 47' ' ' THR . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.967 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.585 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CD2' HD23 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.628 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.032 0.444 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG23 HD22 ' A' ' 50' ' ' LEU . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.715 ' HB3' HG11 ' A' ' 42' ' ' VAL . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 37' ' ' PHE . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.683 ' CB ' HD12 ' A' ' 23' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' O ' HG13 ' A' ' 42' ' ' VAL . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.533 ' C ' HG22 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 48' ' ' LEU . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 11' ' ' TYR . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m-80 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.585 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.765 HD22 HG23 ' A' ' 6' ' ' VAL . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.606 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.621 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 7' ' ' ASP . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 6' ' ' VAL . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.692 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.733 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 7.5 m-80 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 1.039 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.633 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.755 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.559 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 51' ' ' SER . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.642 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.733 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' HA ' HD23 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' LYS . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 23' ' ' LEU . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.977 ' HB3' HG11 ' A' ' 42' ' ' VAL . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.6 t-20 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.64 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.487 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 8.3 m-80 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' HB3' ' A' ' 11' ' ' TYR . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.792 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 47' ' ' THR . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.49 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.719 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HB3' ' ND2' ' A' ' 28' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.683 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.683 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.88 ' O ' HG21 ' A' ' 42' ' ' VAL . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 37' ' ' PHE . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.726 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.727 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 37' ' ' PHE . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.698 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.827 ' O ' HG23 ' A' ' 47' ' ' THR . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.726 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.657 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.657 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 8.6 p80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' HD11 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 6' ' ' VAL . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.851 ' O ' HG21 ' A' ' 42' ' ' VAL . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.112 ' O ' HD12 ' A' ' 50' ' ' LEU . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.887 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.849 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.8 ' CB ' HD12 ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.647 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' PHE . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.851 HG21 ' O ' ' A' ' 11' ' ' TYR . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.893 ' O ' HG22 ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.887 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.112 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.778 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 6' ' ' VAL . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.589 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 6' ' ' VAL . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.414 ' C ' ' OE1' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.765 ' HB3' HG11 ' A' ' 42' ' ' VAL . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.018 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.7 t-20 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.987 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.636 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.018 ' CB ' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.018 HD12 ' O ' ' A' ' 24' ' ' CYS . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.654 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.331 0.586 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.68 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CB ' HG11 ' A' ' 42' ' ' VAL . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.816 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 55' ' ' LYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.766 ' O ' HG22 ' A' ' 47' ' ' THR . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.816 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.629 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.8 p80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.677 HG21 HD13 ' A' ' 23' ' ' LEU . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.694 ' CB ' HG11 ' A' ' 42' ' ' VAL . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.802 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.721 ' CB ' HD12 ' A' ' 23' ' ' LEU . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.944 HG22 HD23 ' A' ' 48' ' ' LEU . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.774 ' O ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 44' ' ' SER . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.547 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.746 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.921 ' CB ' HG11 ' A' ' 42' ' ' VAL . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.694 HD13 ' C ' ' A' ' 33' ' ' ASN . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 17.4 t-20 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.772 ' HE2' ' HB1' ' A' ' 40' ' ' ALA . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 23' ' ' LEU . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.548 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.772 ' HB1' ' HE2' ' A' ' 29' ' ' LYS . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 HD23 ' A' ' 48' ' ' LEU . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.921 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.656 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.979 ' O ' HG22 ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.828 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.714 HD22 ' CG ' ' A' ' 34' ' ' LYS . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.879 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.582 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.633 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.879 ' C ' HD12 ' A' ' 23' ' ' LEU . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.828 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.936 ' O ' HG22 ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.936 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.936 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.978 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.799 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.978 ' CB ' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 47' ' ' THR . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 44' ' ' SER . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.435 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.312 0.577 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.978 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 34' ' ' LYS . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.832 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.779 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.832 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.698 ' HB2' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' C ' HG22 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.978 HG21 ' HB3' ' A' ' 12' ' ' PRO . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 47' ' ' THR . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 44' ' ' SER . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.779 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.64 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.651 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.3 p80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.587 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.421 0.629 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 42' ' ' VAL . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.874 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.677 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.803 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.794 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.874 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.959 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.909 ' O ' HG22 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.959 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 47' ' ' THR . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.803 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.803 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.803 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' N ' HD11 ' A' ' 50' ' ' LEU . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.647 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' N ' HG12 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.731 ' CB ' HG11 ' A' ' 42' ' ' VAL . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.73 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.509 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.668 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.017 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CB ' HD12 ' A' ' 23' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.693 HG13 ' HA2' ' A' ' 46' ' ' GLY . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.731 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 47' ' ' THR . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.693 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 44' ' ' SER . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.661 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.017 HD12 ' O ' ' A' ' 24' ' ' CYS . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.666 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.869 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.754 HG21 HD13 ' A' ' 23' ' ' LEU . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.83 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.889 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.527 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.525 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.645 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.889 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 48' ' ' LEU . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.705 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.778 ' O ' HG23 ' A' ' 47' ' ' THR . 2.2 t30 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.243 0.544 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 23' ' ' LEU . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.029 ' CB ' HG11 ' A' ' 42' ' ' VAL . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.514 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.615 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.687 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.743 ' O ' HG22 ' A' ' 42' ' ' VAL . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 1.1 m120 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 HD23 ' A' ' 48' ' ' LEU . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.029 HG11 ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 7' ' ' ASP . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.003 ' O ' HG21 ' A' ' 42' ' ' VAL . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.641 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.761 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 37' ' ' PHE . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.761 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.1 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.1 HG23 ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.656 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.656 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.7 p80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 23' ' ' LEU . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.954 ' CB ' HG11 ' A' ' 42' ' ' VAL . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 6' ' ' VAL . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.744 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.768 ' CE1' HD21 ' A' ' 48' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.954 HG11 ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.768 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.662 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.662 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.0 p80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.538 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.27 0.557 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 23' ' ' LEU . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.089 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.514 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 t-20 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' C ' HG22 ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 11' ' ' TYR . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.564 ' O ' HG22 ' A' ' 47' ' ' THR . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 44' ' ' SER . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 49' ' ' THR . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.589 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.089 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 23' ' ' LEU . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.597 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.285 0.564 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.836 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.762 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 55' ' ' LYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.7 ' CB ' HD12 ' A' ' 23' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HD23 ' A' ' 48' ' ' LEU . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.836 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.612 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.762 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' LYS . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.222 0.534 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 7' ' ' ASP . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 6' ' ' VAL . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.823 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.92 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 12' ' ' PRO . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' THR . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 44' ' ' SER . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.593 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.269 0.557 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 6' ' ' VAL . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.908 ' HB3' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.106 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 18' ' ' LEU . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.576 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.767 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.958 ' CB ' HD12 ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.797 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.752 ' O ' HG22 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.106 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.751 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.734 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.734 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 2.1 p80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.622 ' HE2' HG22 ' A' ' 6' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.919 ' CB ' HG11 ' A' ' 42' ' ' VAL . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.924 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.97 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.688 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 48' ' ' LEU . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.919 HG11 ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 23' ' ' LEU . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.572 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE3' ' CZ ' ' A' ' 11' ' ' TYR . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.78 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.031 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.572 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 41' ' ' VAL . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.782 ' O ' HG12 ' A' ' 42' ' ' VAL . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 37' ' ' PHE . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.031 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.643 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.78 ' CD2' HD23 ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.685 ' H ' HG22 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.059 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.53 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' CB ' HD12 ' A' ' 23' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.059 HG21 ' O ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 44' ' ' SER . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.488 HD22 ' HB1' ' A' ' 40' ' ' ALA . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.654 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.534 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' C ' HD11 ' A' ' 50' ' ' LEU . 9.4 p80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 53' ' ' PHE . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 33' ' ' ASN . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.705 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.936 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 1.064 ' HE2' HD13 ' A' ' 48' ' ' LEU . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.639 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.9 p30 -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.6 m-80 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' CYS . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.064 HD13 ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.555 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.323 0.583 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 34' ' ' LYS . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 42' ' ' VAL . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.864 ' C ' HD12 ' A' ' 23' ' ' LEU . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.797 ' CE1' HD11 ' A' ' 48' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.705 ' O ' HG12 ' A' ' 42' ' ' VAL . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.789 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 52' ' ' HIS . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.577 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.916 ' O ' HD11 ' A' ' 50' ' ' LEU . 9.0 p80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CD1' HD21 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.728 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.728 ' N ' HG13 ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.816 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.645 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.6 t-20 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.645 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' THR . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 44' ' ' SER . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.645 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.59 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.563 ' CE1' ' C ' ' A' ' 5' ' ' SER . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.19 -162.75 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.64 41.55 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.472 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 1.5 t -84.7 101.1 8.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 109.079 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 t -129.84 153.18 48.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.325 -0.859 . . . . 0.0 109.861 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 7' ' ' ASP . 92.3 t -85.82 166.84 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.624 ' N ' HG12 ' A' ' 6' ' ' VAL . 37.5 t70 -110.45 138.21 47.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 7.1 m -135.22 49.4 2.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.7 t -82.14 9.02 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.232 -0.918 . . . . 0.0 109.871 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -126.46 21.16 7.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.864 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.6 m-85 -105.54 166.58 11.1 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.1 Cg_endo -89.95 160.65 34.71 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.542 -1.441 . . . . 0.0 110.976 0.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -117.41 146.17 37.8 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.457 -0.777 . . . . 0.0 109.189 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.45 14.1 1.69 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.621 2.214 . . . . 0.0 110.938 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.81 126.01 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 109.331 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -96.71 -13.07 22.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.077 -1.015 . . . . 0.0 110.089 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.615 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER 86.68 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.836 -0.54 . . . . 0.0 109.67 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.615 ' CB ' ' O ' ' A' ' 17' ' ' THR . 9.3 mt 105.36 4.5 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 7.1 mm-40 -59.67 -159.91 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 119.99 -1.694 . . . . 0.0 108.329 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -148.06 83.16 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.671 -1.268 . . . . 0.0 110.708 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.04 85.79 30.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -65.55 96.71 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.102 1.868 . . . . 0.0 111.621 -177.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -97.41 123.17 41.16 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 31.1 m -89.64 116.01 27.46 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.143 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.949 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.53 179.73 0.02 OUTLIER Glycine 0 N--CA 1.48 1.567 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.4 0.93 35.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.53 -1.57 . . . . 0.0 108.073 177.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 55.5 p30 -107.13 -1.06 22.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -0.826 . . . . 0.0 109.533 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.5 t30 88.1 40.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.841 -0.537 . . . . 0.0 110.792 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.83 113.32 25.59 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -77.99 127.87 33.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.023 -1.048 . . . . 0.0 111.472 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 29.9 m-85 -114.65 123.12 48.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.76 -58.01 0.96 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.939 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.3 p-10 -141.13 -168.59 2.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.568 -1.548 . . . . 0.0 111.216 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.14 -43.44 82.42 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.314 -178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.641 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 p -69.3 -47.07 65.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.781 -1.199 . . . . 0.0 109.569 -178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.3 m-80 -57.3 -37.26 72.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.813 -1.179 . . . . 0.0 108.952 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.674 ' O ' HG23 ' A' ' 41' ' ' VAL . 58.9 t80 -77.44 -27.88 52.32 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.974 1.369 . . . . 0.0 109.947 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.606 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 3.9 m -80.42 -23.66 40.17 Favored 'General case' 0 C--N 1.267 -2.98 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.795 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.6 m-20 -74.44 -24.88 59.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -79.38 -39.55 32.29 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 37' ' ' PHE . 45.1 t -63.02 -36.29 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.864 HG11 ' CB ' ' A' ' 11' ' ' TYR . 30.9 m -76.63 -39.13 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.543 -0.723 . . . . 0.0 110.392 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 42' ' ' VAL . 1.8 tp10 -90.68 14.88 12.2 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 47' ' ' THR . 29.4 t -128.58 4.1 5.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.958 . . . . 0.0 109.813 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 68.81 11.96 8.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 0.0 108.997 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.83 14.58 75.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 44' ' ' SER . 30.9 p -80.18 -6.78 58.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.313 -1.11 . . . . 0.0 108.823 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.949 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.5 tp -80.41 -77.61 0.19 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.764 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 65.8 176.53 0.22 Allowed 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 -179.095 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.629 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -130.28 165.34 22.66 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.865 -1.147 . . . . 0.0 109.916 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.54 -23.67 8.15 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 24' ' ' CYS . 2.6 p80 -162.23 138.75 7.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.253 -0.905 . . . . 0.0 110.209 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -77.78 114.72 16.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.419 -0.801 . . . . 0.0 109.113 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.9 -175.62 23.69 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 108.636 -1.785 . . . . 0.0 108.636 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.29 150.67 29.89 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.622 -0.928 . . . . 0.0 108.669 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.664 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.696 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 2.3 pp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 171.85 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.43 150.53 49.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.16 -0.963 . . . . 0.0 109.725 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 4' ' ' VAL . 7.0 p -79.84 88.77 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.888 . . . . 0.0 109.462 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.4 t 170.1 118.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.697 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -81.62 -168.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.2 -0.938 . . . . 0.0 109.268 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.4 t0 -113.36 117.61 32.27 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.7 m -120.54 40.9 3.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 110.543 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -91.2 4.5 52.11 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 14.7 mp0 -150.43 58.77 0.95 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.353 -0.842 . . . . 0.0 110.386 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.602 ' HA ' ' C ' ' A' ' 12' ' ' PRO . 87.1 m-85 -151.17 146.49 19.14 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 120.861 -1.149 . . . . 0.0 109.181 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -71.02 138.84 54.72 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 -1.865 . . . . 0.0 112.256 1.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -100.43 146.64 32.36 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.87 13.95 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 110.656 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.2 111.49 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 59.1 m -93.13 137.59 32.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 110.165 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -55.85 -167.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -119.44 -16.24 8.96 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.915 -1.116 . . . . 0.0 109.879 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 mt-10 -45.41 125.06 5.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 108.885 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -82.48 95.6 7.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.335 -0.853 . . . . 0.0 110.021 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.35 91.12 46.1 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.82 101.28 0.77 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 122.021 1.814 . . . . 0.0 110.848 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -98.65 122.76 42.28 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.41 -0.806 . . . . 0.0 109.027 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -81.59 134.72 35.53 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 109.586 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.804 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.61 -178.94 3.07 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 107.397 -2.281 . . . . 0.0 107.397 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.53 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 16.5 t -88.9 -8.24 54.59 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.232 -1.746 . . . . 0.0 109.793 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p-10 -92.45 -38.61 11.88 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.098 -1.001 . . . . 0.0 108.301 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.586 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.0 p30 143.62 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -105.19 -172.31 2.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 109.417 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -155.61 136.77 13.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.096 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.6 m-85 -125.4 140.64 52.62 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.6 -53.84 15.52 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.569 -1.301 . . . . 0.0 111.022 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p-10 -142.71 -168.16 2.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.709 -1.465 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 14.6 pttt -65.63 -24.23 66.99 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.717 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 46.7 t -76.0 -41.26 51.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.854 -1.154 . . . . 0.0 109.669 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.576 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.6 m-80 -77.72 -31.76 52.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.825 ' O ' HG23 ' A' ' 41' ' ' VAL . 40.7 t80 -79.21 -32.56 44.03 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.566 1.174 . . . . 0.0 109.796 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.726 ' O ' HG12 ' A' ' 42' ' ' VAL . 35.6 t -78.69 -52.07 8.93 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.259 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-20 -53.16 -43.89 67.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.016 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.04 -34.2 74.49 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 37' ' ' PHE . 41.8 t -69.57 -37.28 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 110.205 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.2 OUTLIER -89.07 -13.55 9.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.339 -0.85 . . . . 0.0 110.394 -177.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.767 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.83 -23.41 18.15 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.796 -1.19 . . . . 0.0 108.258 178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' HG23 ' A' ' 47' ' ' THR . 5.7 p -94.66 17.18 13.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.749 -0.595 . . . . 0.0 109.801 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 66.03 15.84 10.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.099 -1.001 . . . . 0.0 108.801 -179.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.83 72.26 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 44' ' ' SER . 69.3 p -82.23 -15.61 52.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -1.08 . . . . 0.0 108.649 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.804 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.8 tp -79.85 -78.16 0.17 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.672 0.748 . . . . 0.0 109.056 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 66.35 173.16 0.24 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -118.94 166.48 12.79 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.887 -1.133 . . . . 0.0 109.705 -178.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.64 -32.95 5.69 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.1 p80 -162.04 136.88 7.05 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.55 ' CE1' HD21 ' A' ' 50' ' ' LEU . 20.7 m-85 -69.9 114.29 7.94 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.967 -1.083 . . . . 0.0 109.084 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 153.54 -174.99 32.08 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.617 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.12 98.52 11.59 Favored 'General case' 0 C--N 1.292 -1.927 0 O-C-N 121.397 -1.06 . . . . 0.0 108.532 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.684 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 75.81 129.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.329 -0.857 . . . . 0.0 109.516 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 68.74 -176.32 0.2 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.893 . . . . 0.0 109.484 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.4 p -152.05 69.89 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 21.4 p 173.43 141.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.46 HG22 ' CE2' ' A' ' 53' ' ' PHE . 5.1 t -112.3 155.95 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.887 . . . . 0.0 109.453 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.8 t70 -93.95 138.11 32.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.295 -0.878 . . . . 0.0 109.272 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 8.4 m -147.31 52.21 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 0.0 109.778 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 20.76 4.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 109.833 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -134.2 19.41 3.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.025 -1.047 . . . . 0.0 109.842 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.97 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.1 m-85 -101.12 161.55 23.33 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.254 -0.904 . . . . 0.0 108.87 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.78 171.88 65.88 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.744 -1.773 . . . . 0.0 111.422 2.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.477 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -118.98 147.6 42.86 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.43 13.27 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.366 2.044 . . . . 0.0 110.521 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.87 110.5 0.21 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -79.17 129.87 34.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.096 -1.003 . . . . 0.0 109.532 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.501 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 40.1 p -43.0 159.83 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.5 mp -90.24 -29.04 18.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.078 -1.014 . . . . 0.0 109.403 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.69 124.46 4.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.933 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.6 t80 -82.64 86.9 6.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.906 . . . . 0.0 109.675 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -110.38 85.4 4.53 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -67.2 107.12 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.345 2.03 . . . . 0.0 111.097 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.927 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -104.58 122.69 46.13 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.954 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.685 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.67 118.87 20.47 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.49 -162.01 0.12 Allowed Glycine 0 C--N 1.295 -1.714 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 3.9 p -90.57 -11.12 40.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.018 -1.283 . . . . 0.0 108.853 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 10.8 p-10 -103.96 21.63 16.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.683 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 2.9 m120 71.01 28.09 3.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.837 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.549 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -99.92 94.82 6.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.198 -0.939 . . . . 0.0 109.294 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -63.06 134.2 55.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.301 -0.875 . . . . 0.0 110.279 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 63.6 m-85 -111.2 126.95 55.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.78 -61.99 0.46 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.9 p30 -141.51 -162.03 1.32 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.217 -1.166 . . . . 0.0 109.764 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.07 -32.36 73.78 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.713 -0.617 . . . . 0.0 111.07 -178.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 15.6 t -72.53 -26.63 61.83 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.743 -1.223 . . . . 0.0 109.401 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.7 m-80 -79.72 -43.1 23.27 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.927 ' CB ' HD12 ' A' ' 23' ' ' LEU . 31.8 t80 -65.67 -37.82 87.57 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.882 1.325 . . . . 0.0 108.935 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.656 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.6 m -71.1 -44.65 65.23 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.515 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 66.3 m-20 -51.19 -50.38 59.15 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.01 -33.3 68.79 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.412 0.625 . . . . 0.0 109.879 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' PHE . 69.3 t -70.94 -37.07 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -89.9 -11.69 9.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.274 -0.891 . . . . 0.0 111.09 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -92.19 -14.08 29.57 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.655 -1.278 . . . . 0.0 108.85 179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.6 p -107.18 21.04 18.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.444 -0.785 . . . . 0.0 109.963 -179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 72.19 12.39 5.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.131 -0.981 . . . . 0.0 108.823 -179.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.23 20.59 79.62 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -88.28 -7.37 56.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.284 -1.127 . . . . 0.0 108.915 179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tp -82.59 132.71 35.19 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.323 -0.86 . . . . 0.0 109.778 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 168.38 10.15 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.98 -174.35 2.49 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.03 -1.668 . . . . 0.0 110.365 -178.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.83 -30.49 3.27 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 120.969 -1.082 . . . . 0.0 109.124 -179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.685 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.6 p80 179.82 134.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.644 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' CE2' HG22 ' A' ' 6' ' ' VAL . 54.3 m-85 -59.84 123.41 16.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.734 . . . . 0.0 109.699 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 133.23 -178.33 18.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -89.01 113.9 25.04 Favored 'General case' 0 C--N 1.289 -2.025 0 O-C-N 121.664 -0.904 . . . . 0.0 108.694 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.643 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 174.33 -83.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 72.22 147.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.519 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 m -127.83 73.54 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -164.63 138.53 5.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.985 . . . . 0.0 109.631 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.787 HG21 HD13 ' A' ' 23' ' ' LEU . 10.8 t -83.76 157.9 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 0.0 109.661 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -76.39 153.64 35.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 109.04 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.03 34.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.016 -1.053 . . . . 0.0 110.232 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 11.3 t -90.6 -4.49 56.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.11 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 2.5 mm-40 -119.42 33.98 5.41 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.936 ' HB3' HG11 ' A' ' 42' ' ' VAL . 68.4 m-85 -131.02 162.62 54.5 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 121.335 -0.853 . . . . 0.0 109.272 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.918 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -85.61 143.64 34.63 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.952 -1.687 . . . . 0.0 110.775 1.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -98.82 148.34 34.43 Favored Pre-proline 0 N--CA 1.493 1.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.732 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.7 Cg_endo -77.33 12.78 1.73 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.663 2.242 . . . . 0.0 111.642 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.732 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 159.67 146.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.441 -0.787 . . . . 0.0 109.632 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -124.42 175.55 7.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.109 -0.994 . . . . 0.0 109.83 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 16' ' ' CYS . 81.4 p -62.2 -139.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -139.81 10.35 2.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.659 -1.276 . . . . 0.0 110.458 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 1.1 mm-40 -53.28 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.9 t80 -136.79 89.87 2.49 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.168 -1.413 . . . . 0.0 111.425 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.7 mmm180 -116.37 73.48 5.48 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.6 Cg_endo -64.16 107.07 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 111.853 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.5 mt -103.55 114.09 28.1 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.003 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 2.8 m -78.96 113.38 17.02 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.38 -163.76 0.03 OUTLIER Glycine 0 C--N 1.298 -1.539 0 C-N-CA 118.718 -1.706 . . . . 0.0 109.224 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.557 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.6 t -90.19 -8.92 49.98 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.202 -1.175 . . . . 0.0 108.673 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -99.09 0.99 44.77 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.569 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.1 t-20 86.65 29.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.85 -0.531 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 6.7 ttmt -103.53 107.43 18.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.979 -1.076 . . . . 0.0 108.638 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 55.5 m -75.33 120.62 21.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.35 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.613 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 45.6 m-85 -99.46 127.76 45.53 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.32 -58.64 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.6 p30 -142.37 -165.52 2.05 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.941 -1.329 . . . . 0.0 110.646 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD11 ' A' ' 23' ' ' LEU . 1.3 ptmt -60.04 -36.06 76.45 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.294 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.663 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 1.3 m -64.62 -61.71 2.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.696 -1.253 . . . . 0.0 109.536 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.592 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.7 m-80 -51.93 -38.06 55.0 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.755 -0.591 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.013 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.1 t80 -64.78 -41.72 95.62 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.657 -1.277 . . . . 0.0 109.26 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' HG22 ' A' ' 42' ' ' VAL . 51.4 t -72.47 -21.2 61.26 Favored 'General case' 0 C--N 1.28 -2.428 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.784 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.7 m-20 -65.34 -21.04 66.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -85.98 -39.12 17.21 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.979 HG22 HD23 ' A' ' 48' ' ' LEU . 50.0 t -66.49 -25.68 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.694 0.759 . . . . 0.0 109.148 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' HB3' ' A' ' 11' ' ' TYR . 35.7 m -90.57 -31.6 5.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.59 9.9 30.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 0.0 109.295 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.5 t -127.13 27.93 5.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.632 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 44' ' ' SER . 20.1 m-80 62.13 21.37 12.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 109.069 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 59.66 30.34 68.76 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 p -104.37 -2.83 24.93 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.442 -1.034 . . . . 0.0 108.512 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.69 125.47 29.68 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 121.44 -0.787 . . . . 0.0 109.595 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.676 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -172.14 2.06 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.902 -178.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.522 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 85.0 p -116.55 -52.35 2.56 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.373 1.082 . . . . 0.0 108.608 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.547 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 21.0 p80 -151.1 139.96 20.89 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.242 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE1' HD21 ' A' ' 50' ' ' LEU . 40.2 m-85 -74.61 110.8 9.2 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 142.4 -178.09 21.18 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.9 148.38 29.9 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.502 -0.999 . . . . 0.0 108.875 179.025 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.677 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 81.8 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.14 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.39 63.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.423 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.11 -176.2 6.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.475 HG12 ' HE1' ' A' ' 53' ' ' PHE . 9.0 t -96.69 81.39 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.622 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -167.37 149.91 6.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.3 p -98.57 -160.5 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.702 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.1 t70 -135.93 149.66 49.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 109.455 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.0 m -137.87 48.79 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -86.64 1.73 50.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.147 -0.971 . . . . 0.0 109.904 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 40.3 mp0 -121.7 -7.05 9.1 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.403 -0.811 . . . . 0.0 109.095 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.652 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 49.8 m-85 -81.78 165.81 41.39 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.498 -0.751 . . . . 0.0 109.005 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -84.13 143.56 42.78 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 C-N-CA 123.46 -1.475 . . . . 0.0 111.126 1.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.4 mttt -88.14 142.83 32.13 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 109.667 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.75 14.29 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.595 2.197 . . . . 0.0 110.691 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.58 138.09 1.11 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.386 -0.821 . . . . 0.0 109.318 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 58.0 m -109.7 153.19 24.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.6 p -64.01 -158.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.009 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pp -123.77 -30.43 3.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.878 -1.139 . . . . 0.0 110.167 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 10.0 pm0 -46.96 159.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.2 t80 -111.28 91.03 3.5 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.437 -1.305 . . . . 0.0 111.123 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.7 mmt180 -113.65 76.12 2.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -63.9 116.93 3.98 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 123.485 2.79 . . . . 0.0 114.388 -175.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 4.5 mp -104.47 157.39 17.19 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.598 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.9 t -123.61 140.49 52.94 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.236 -1.54 . . . . 0.0 109.127 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.811 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -100.02 163.69 19.33 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.878 -1.153 . . . . 0.0 113.612 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.5 t -63.55 -18.96 64.4 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.321 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 3.4 p30 -79.35 5.86 11.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.018 -1.051 . . . . 0.0 109.247 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 19.1 t-20 71.13 25.67 3.61 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.518 -0.739 . . . . 0.0 109.47 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.9 112.51 23.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 m -75.34 126.99 32.14 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.008 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.846 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.5 121.89 39.92 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.574 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -21.8 -59.01 0.02 OUTLIER Glycine 0 N--CA 1.504 3.215 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.2 p30 -158.46 -164.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.394 -1.063 . . . . 0.0 110.266 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -44.23 -53.51 6.54 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.066 -177.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 35.5 t -58.74 -57.36 13.36 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.719 -1.238 . . . . 0.0 109.999 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 9.8 m-80 -55.74 -18.38 8.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.135 -0.978 . . . . 0.0 108.972 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.846 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.0 t80 -81.92 -69.59 0.61 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.468 -1.293 . . . . 0.0 110.197 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.964 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -46.11 -24.96 0.51 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.664 ' O ' HG22 ' A' ' 42' ' ' VAL . 73.1 m-20 -73.91 -47.48 37.57 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -55.66 -26.61 45.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.94 . . . . 0.0 108.558 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG22 HD23 ' A' ' 48' ' ' LEU . 75.6 t -79.04 -47.79 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-O 121.675 0.75 . . . . 0.0 109.183 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.8 m -65.23 -23.18 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.626 -0.671 . . . . 0.0 110.434 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -92.75 -7.35 46.84 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.679 ' O ' HG22 ' A' ' 47' ' ' THR . 1.3 p -114.02 19.68 16.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.939 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.1 p30 58.89 13.72 2.92 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.617 -0.677 . . . . 0.0 110.489 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.414 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 77.97 6.41 87.31 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 121.151 -0.968 . . . . 0.0 111.357 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.679 HG22 ' O ' ' A' ' 44' ' ' SER . 15.2 t -79.04 -1.87 37.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.856 -1.379 . . . . 0.0 108.598 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.811 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -79.65 -79.67 0.14 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.85 0.833 . . . . 0.0 109.208 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.9 p 91.07 137.39 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.611 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.9 tp -54.85 163.23 1.02 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 27.0 p -112.98 -52.08 2.8 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.598 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.2 151.8 4.0 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.475 ' HE1' HG12 ' A' ' 4' ' ' VAL . 83.8 m-85 -76.89 110.57 11.61 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.908 -1.12 . . . . 0.0 109.769 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.05 -177.98 19.83 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.53 131.11 36.45 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.6 -0.941 . . . . 0.0 108.604 178.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.3 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.813 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.18 -78.58 0.19 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.335 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.48 77.71 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 0.0 109.467 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 4' ' ' VAL . 17.2 m -88.92 87.01 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.952 . . . . 0.0 109.494 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.26 157.88 36.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.291 -0.881 . . . . 0.0 109.468 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG22 ' HE2' ' A' ' 53' ' ' PHE . 13.4 t -125.89 156.41 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.676 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 4.5 t70 -61.93 142.2 57.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 108.727 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' O ' ' A' ' 38' ' ' CYS . 1.5 t -160.52 24.4 0.15 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.956 -1.09 . . . . 0.0 110.192 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.6 t -91.23 16.39 10.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.119 -0.988 . . . . 0.0 110.146 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 11.6 mp0 -135.25 -11.7 2.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 111.248 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.705 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.4 m-85 -86.82 161.02 48.68 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 120.827 -1.171 . . . . 0.0 108.872 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.6 Cg_endo -70.97 145.13 81.33 Favored 'Cis proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.885 -1.715 . . . . 0.0 111.898 2.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -110.2 147.54 36.5 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.39 14.84 1.51 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.509 2.139 . . . . 0.0 110.904 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.25 106.04 1.17 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.413 -0.804 . . . . 0.0 109.064 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.6 m -79.93 138.01 37.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 16' ' ' CYS . 3.3 p -46.94 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.1 mp -111.83 -33.72 6.23 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.798 -1.189 . . . . 0.0 110.204 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -45.44 145.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 0.0 108.449 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -91.8 104.07 16.55 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.962 -1.086 . . . . 0.0 110.851 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.4 mmt85 -132.17 85.79 48.61 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -68.24 110.99 2.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.453 2.102 . . . . 0.0 111.247 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -101.07 117.75 35.64 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.543 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.784 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.7 m -87.02 119.46 27.25 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -57.75 -164.45 0.07 OUTLIER Glycine 0 C--N 1.297 -1.636 0 C-N-CA 118.558 -1.782 . . . . 0.0 108.788 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.577 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.4 t -91.66 -3.71 56.0 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.332 -1.099 . . . . 0.0 109.123 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -100.19 -27.88 13.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.186 -0.947 . . . . 0.0 109.402 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.695 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 52.1 t30 118.76 38.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.145 0.498 . . . . 0.0 109.677 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.7 OUTLIER -110.1 121.92 46.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 108.703 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.469 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 92.3 m -87.66 122.71 31.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.1 -1.0 . . . . 0.0 110.796 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.473 ' O ' ' C ' ' A' ' 32' ' ' GLY . 64.2 m-85 -106.24 125.45 51.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.86 -58.65 0.95 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.7 p30 -142.55 -164.0 1.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.856 -1.379 . . . . 0.0 110.556 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.63 -34.31 77.6 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.296 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.547 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.9 t -65.71 -25.75 67.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.201 -1.562 . . . . 0.0 108.526 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -86.75 -40.16 15.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.777 . . . . 0.0 110.727 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.631 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.9 t80 -74.4 -34.78 63.38 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 122.97 1.367 . . . . 0.0 109.588 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.5 t -74.0 -47.35 37.76 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.414 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 18.0 m-20 -51.81 -44.22 63.42 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.615 -1.303 . . . . 0.0 107.907 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -61.97 -32.79 73.26 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.882 HG22 HD23 ' A' ' 48' ' ' LEU . 42.4 t -70.63 -39.29 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.552 -0.718 . . . . 0.0 110.296 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.4 p -87.55 -11.93 10.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.959 -1.088 . . . . 0.0 110.422 -178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -93.01 -16.67 24.78 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.809 -1.182 . . . . 0.0 108.634 178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.67 ' OG ' HG22 ' A' ' 47' ' ' THR . 9.8 t -104.97 27.86 7.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m-80 69.09 9.48 7.41 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.045 -1.035 . . . . 0.0 109.331 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 73.54 14.06 79.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.67 HG22 ' OG ' ' A' ' 44' ' ' SER . 7.3 t -79.84 -12.51 59.75 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.242 -1.152 . . . . 0.0 108.754 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.882 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.81 123.82 28.06 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.4 p -116.07 154.05 30.62 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -101.4 175.0 5.72 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.624 -1.231 . . . . 0.0 110.117 -178.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -115.37 -41.91 3.22 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.117 -0.99 . . . . 0.0 109.382 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.594 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.1 p80 -152.94 135.92 15.52 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.2 -0.937 . . . . 0.0 110.474 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 6' ' ' VAL . 62.6 m-85 -73.89 112.24 9.82 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.357 -0.839 . . . . 0.0 109.236 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 148.77 -177.0 27.3 Favored Glycine 0 N--CA 1.48 1.584 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.7 ttpt -82.03 150.54 27.53 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.784 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.6 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.682 -176.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.816 ' N ' HD13 ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.24 0.543 . . . . 0.0 109.797 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.33 -176.26 3.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.338 -0.851 . . . . 0.0 109.559 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 52.97 177.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.414 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 4' ' ' VAL . 10.3 m -113.12 84.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.932 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.67 152.62 39.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.915 . . . . 0.0 109.459 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.7 t -113.9 150.45 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.436 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -97.45 127.1 43.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 3.5 m -141.8 52.67 1.5 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.431 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.97 17.98 6.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.783 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.9 pm0 -137.4 6.18 2.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.3 m-85 -84.17 163.18 49.16 Favored Pre-proline 0 C--N 1.302 -1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.462 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.79 -175.41 16.25 Favored 'Cis proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.952 -1.686 . . . . 0.0 111.575 2.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 3.0 mttp -136.72 142.59 39.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.637 -0.665 . . . . 0.0 109.309 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.48 14.61 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.59 2.193 . . . . 0.0 110.829 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.57 101.31 1.67 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.193 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 87.0 m -90.53 133.02 35.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.886 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.56 169.26 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 108.783 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -103.3 -31.11 10.23 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.996 -1.065 . . . . 0.0 109.844 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -43.98 126.86 5.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 108.823 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.8 t80 -80.18 84.56 5.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.7 mtp180 -112.42 80.35 3.46 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.524 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -65.16 127.63 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 111.653 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -115.59 124.49 51.09 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.6 0.714 . . . . 0.0 109.447 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -80.11 135.19 36.26 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.61 -177.29 31.04 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 107.651 -2.179 . . . . 0.0 107.651 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 28.7 t -88.7 24.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.541 -1.564 . . . . 0.0 108.763 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.7 p-10 -142.91 14.38 1.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.409 -0.807 . . . . 0.0 109.198 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 t30 84.22 30.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.775 -0.578 . . . . 0.0 110.336 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -105.97 93.17 4.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.96 -1.087 . . . . 0.0 109.758 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 4.2 m -70.05 141.66 52.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.198 -0.939 . . . . 0.0 110.288 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.9 m-85 -122.23 138.28 54.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.28 -55.7 2.98 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.504 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.627 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.1 p30 -151.05 -155.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.974 -1.31 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.13 -38.95 69.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 111.115 -178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 26.1 t -64.05 -35.42 80.68 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.791 -1.193 . . . . 0.0 109.66 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -79.13 -53.4 7.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.984 -1.072 . . . . 0.0 109.122 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 48.5 t80 -53.12 -31.84 44.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.749 1.261 . . . . 0.0 109.539 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.67 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.7 m -76.42 -39.37 53.73 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.824 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 5.4 m120 -55.17 -34.91 64.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 108.381 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -69.7 -49.45 53.29 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 37' ' ' PHE . 86.4 t -49.16 -57.36 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-O 121.657 0.741 . . . . 0.0 109.472 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' O ' ' A' ' 11' ' ' TYR . 4.0 p -67.34 -21.74 28.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.653 -0.654 . . . . 0.0 110.7 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.1 tt0 -92.03 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.646 -1.284 . . . . 0.0 108.893 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.7 t -124.07 -7.34 7.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.319 -0.863 . . . . 0.0 109.754 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.083 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER 82.93 0.69 1.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.561 -0.712 . . . . 0.0 109.646 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.41 9.1 42.23 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.083 HG23 ' OD1' ' A' ' 45' ' ' ASN . 39.2 p -79.66 -9.62 59.67 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.139 -1.213 . . . . 0.0 108.903 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' C ' HG23 ' A' ' 49' ' ' THR . 2.8 tp -78.1 -75.59 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.723 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 71.95 173.88 0.3 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -124.96 171.92 9.82 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.536 -1.353 . . . . 0.0 110.013 -178.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.11 -22.01 8.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.714 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.5 p80 -177.26 143.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.472 -0.767 . . . . 0.0 109.45 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -72.28 112.73 8.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.838 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 149.71 -176.87 28.21 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 108.203 -1.959 . . . . 0.0 108.203 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -88.87 102.13 14.73 Favored 'General case' 0 C--N 1.291 -1.944 0 O-C-N 121.586 -0.949 . . . . 0.0 109.038 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.668 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.95 -65.06 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.673 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -96.68 148.36 22.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.0 109.686 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -160.02 101.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 109.445 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 t -124.58 168.84 12.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 3.8 t -124.34 154.39 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.701 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 12.5 t0 -110.36 127.83 55.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 108.787 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -145.1 47.15 1.32 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.029 -1.044 . . . . 0.0 110.235 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -90.71 14.14 14.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -0.977 . . . . 0.0 109.606 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.487 ' HG3' ' HE3' ' A' ' 13' ' ' LYS . 1.4 pm0 -128.86 -2.36 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.982 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.057 ' O ' HG21 ' A' ' 42' ' ' VAL . 95.3 m-85 -79.72 160.46 69.35 Favored Pre-proline 0 C--N 1.303 -1.429 0 O-C-N 121.27 -0.894 . . . . 0.0 109.178 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -75.28 150.72 95.49 Favored 'Cis proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.818 -1.743 . . . . 0.0 111.582 2.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -99.15 144.93 29.14 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.36 13.93 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.42 107.12 0.19 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 83.6 m -79.47 134.38 36.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 109.823 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -48.51 175.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.324 -0.86 . . . . 0.0 108.898 179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -104.52 -27.27 11.99 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.5 mt-10 -44.87 137.84 3.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 108.542 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.8 t80 -92.69 87.49 5.91 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.044 -1.035 . . . . 0.0 110.393 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.4 mtt180 -111.69 83.77 4.76 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -67.59 104.42 0.94 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.35 2.033 . . . . 0.0 111.39 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.907 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.7 mt -99.79 117.71 34.71 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.719 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.707 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.9 t -77.78 115.4 17.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -57.17 -166.96 0.08 OUTLIER Glycine 0 C--N 1.297 -1.597 0 C-N-CA 117.578 -2.249 . . . . 0.0 108.406 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.591 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.8 t -90.54 -4.01 57.2 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.962 -1.317 . . . . 0.0 109.427 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.69 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.6 p30 -98.12 -29.41 13.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.167 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.69 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.8 t30 120.37 31.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -107.14 100.33 9.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 109.036 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.4 m -64.88 122.4 16.88 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.186 -0.946 . . . . 0.0 109.917 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 63.0 m-85 -99.88 124.71 45.49 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.4 -60.64 0.74 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 5.3 p-10 -140.89 -168.43 2.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.016 -1.285 . . . . 0.0 109.782 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.761 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.42 -33.57 72.71 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.494 -0.754 . . . . 0.0 111.198 -178.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 34.8 t -68.56 -29.06 67.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.859 -1.15 . . . . 0.0 109.637 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -78.9 -51.86 9.1 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.101 -0.999 . . . . 0.0 108.406 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.907 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.3 t80 -56.82 -34.15 67.43 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.849 1.309 . . . . 0.0 109.231 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.6 m -72.23 -54.65 8.98 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.321 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.3 m-20 -43.46 -33.78 1.17 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 108.974 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.68 57.73 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.398 -0.814 . . . . 0.0 108.91 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.4 t -57.29 -37.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.522 -0.736 . . . . 0.0 109.859 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.057 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -88.98 -19.12 7.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 110.853 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 9.3 tt0 -91.3 6.69 44.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.7 -1.25 . . . . 0.0 108.852 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 47' ' ' THR . 90.4 p -128.8 23.77 5.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.636 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 68.52 10.38 7.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.045 -1.034 . . . . 0.0 108.873 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 77.01 16.41 80.79 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 6.2 t -83.82 -9.7 58.58 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.254 -1.145 . . . . 0.0 108.954 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -79.93 124.86 29.06 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.424 -0.797 . . . . 0.0 109.587 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.3 p -111.77 160.82 16.96 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.52 -167.41 1.37 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.272 -1.518 . . . . 0.0 110.817 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLY . 0.3 OUTLIER -127.73 -32.49 2.36 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.084 -1.01 . . . . 0.0 109.104 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.707 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.7 p80 178.65 132.92 0.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.164 -0.96 . . . . 0.0 109.876 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 6' ' ' VAL . 11.1 m-85 -60.88 109.62 1.11 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.415 -0.803 . . . . 0.0 109.54 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 156.36 -177.45 33.36 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -90.99 123.33 34.38 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.6 -0.941 . . . . 0.0 108.848 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.473 ' HB3' ' OD1' ' A' ' 28' ' ' ASN . 14.4 m . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.642 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.279 0.561 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.17 69.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.62 179.69 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.735 HG22 ' HE1' ' A' ' 53' ' ' PHE . 12.7 p -91.89 104.55 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 0.0 109.362 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 p -96.7 167.42 11.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.218 -0.926 . . . . 0.0 109.492 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 7' ' ' ASP . 5.8 p -88.15 174.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 109.938 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.653 ' H ' HG22 ' A' ' 6' ' ' VAL . 27.2 t0 -93.28 125.54 37.93 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.0 m -134.5 46.74 2.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' CD ' ' A' ' 10' ' ' GLU . 2.6 m -91.61 -8.81 46.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.037 -1.039 . . . . 0.0 110.241 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 3.8 mm-40 -117.49 13.62 14.43 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.451 -0.781 . . . . 0.0 109.754 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.5 m-85 -112.8 161.26 27.36 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.278 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.8 Cg_endo -81.44 141.96 53.16 Favored 'Cis proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.015 -1.661 . . . . 0.0 111.079 2.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 0.1 OUTLIER -103.8 141.73 23.12 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.564 -0.71 . . . . 0.0 109.396 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.1 Cg_endo -79.95 13.57 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.518 2.146 . . . . 0.0 110.467 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.12 127.17 3.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.09 145.06 26.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 110.18 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 18' ' ' LEU . 1.9 p -68.23 -148.3 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' N ' ' OG1' ' A' ' 17' ' ' THR . 2.1 pp -130.85 -16.02 3.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mt-10 -44.03 145.97 0.68 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.899 -1.126 . . . . 0.0 109.038 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -103.85 88.65 3.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 110.217 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtt180 -116.49 91.6 34.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.8 Cg_endo -68.06 99.84 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 121.982 1.788 . . . . 0.0 110.919 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 37' ' ' PHE . 1.3 mt -96.67 118.14 32.5 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.98 108.13 14.39 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.548 -177.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.911 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -44.72 167.69 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.2 t -76.37 -8.27 56.78 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 119.922 -1.928 . . . . 0.0 108.481 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.548 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 28.6 p30 -99.25 6.85 46.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.341 -0.849 . . . . 0.0 109.243 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 3.4 m-20 84.9 26.81 0.07 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.646 -0.658 . . . . 0.0 110.987 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.0 tttt -103.52 95.78 6.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.917 -1.115 . . . . 0.0 108.571 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 36.6 m -69.98 140.11 52.9 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 111.372 -178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 50.4 m-85 -120.45 135.77 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -44.92 -52.93 7.66 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.779 -1.2 . . . . 0.0 111.795 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.0 p-10 -144.25 -169.8 3.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.501 -1.587 . . . . 0.0 111.412 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -63.13 -26.76 68.97 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.885 -178.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 41.5 t -79.63 -33.17 41.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.496 -1.378 . . . . 0.0 109.188 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.596 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 16.5 m-80 -80.48 -25.86 38.59 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 50' ' ' LEU . 42.0 t80 -88.67 -29.88 19.57 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.419 1.104 . . . . 0.0 109.863 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 54.0 t -83.59 -49.31 9.32 Favored 'General case' 0 C--N 1.273 -2.728 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' C ' HG22 ' A' ' 42' ' ' VAL . 71.9 m-20 -46.02 -25.04 0.5 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.714 -1.241 . . . . 0.0 108.528 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -83.45 -47.06 11.78 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 37' ' ' PHE . 62.4 t -57.04 -39.11 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -69.49 -44.58 79.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.55 -0.719 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.27 16.87 10.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 82.7 p -124.47 11.77 8.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 110.157 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.5 m120 64.35 13.76 8.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.391 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.35 21.96 79.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 44' ' ' SER . 16.4 p -84.89 -4.45 59.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.387 -1.067 . . . . 0.0 108.788 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.911 HD11 ' HA3' ' A' ' 25' ' ' GLY . 6.1 tp -83.88 -80.68 0.18 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.453 -0.78 . . . . 0.0 109.07 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.695 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 62.02 172.69 0.13 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 -179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.752 HD12 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -129.88 159.93 35.09 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.328 -1.482 . . . . 0.0 111.919 -179.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.566 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 46.8 t -79.01 -7.6 58.23 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.467 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.566 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.0 p80 160.17 160.01 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.874 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.735 ' HE1' HG22 ' A' ' 4' ' ' VAL . 15.8 m-85 -82.81 109.54 17.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.694 0.759 . . . . 0.0 109.197 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.61 -176.68 21.74 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.69 152.28 33.8 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.296 -1.12 . . . . 0.0 108.841 178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 39.8 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.783 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' LEU . . . 55.72 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.37 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.56 91.48 3.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.314 -0.866 . . . . 0.0 109.54 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 4' ' ' VAL . 21.0 m -87.1 72.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -153.9 147.91 25.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.288 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.714 HG21 HD22 ' A' ' 23' ' ' LEU . 63.7 t -101.43 14.19 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.203 -0.936 . . . . 0.0 109.821 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 6' ' ' VAL . 21.0 t70 59.32 147.59 0.01 OUTLIER 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.362 0.601 . . . . 0.0 109.812 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.94 28.18 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.139 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.3 t -83.74 13.54 4.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.888 . . . . 0.0 109.921 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -144.19 42.18 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.88 . . . . 0.0 108.875 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 57.5 m-85 -135.92 161.87 60.14 Favored Pre-proline 0 C--N 1.305 -1.337 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.585 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.3 Cg_endo -87.1 142.87 25.46 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.204 -1.582 . . . . 0.0 110.718 2.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 9.0 mttt -90.95 141.48 26.64 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 109.228 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.69 1.79 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.591 2.194 . . . . 0.0 111.133 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.84 117.78 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.438 -0.789 . . . . 0.0 109.207 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.2 m -95.0 139.03 31.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.137 -0.977 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 47.8 p -56.78 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.366 -0.834 . . . . 0.0 108.853 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' GLU . 12.0 mt -130.43 -15.53 3.6 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.015 -1.053 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.8 mm-40 -52.73 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.796 -1.19 . . . . 0.0 108.727 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.7 t80 -129.76 78.28 1.84 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.806 -1.184 . . . . 0.0 110.882 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mtp180 -113.09 82.99 5.82 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.57 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.6 Cg_endo -67.61 124.58 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.539 2.159 . . . . 0.0 112.533 -177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 6' ' ' VAL . 1.7 mt -110.48 123.54 50.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -79.32 139.63 37.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 0.0 108.907 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.32 -176.6 14.65 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 6.8 t -90.13 2.09 55.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.728 -1.454 . . . . 0.0 109.209 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 12.1 p-10 -99.76 -36.29 9.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.2 t-20 131.16 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE2' ' OH ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -113.98 174.41 5.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 108.917 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.688 HG21 ' HD2' ' A' ' 55' ' ' LYS . 82.5 m -130.73 135.76 48.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.938 -1.101 . . . . 0.0 110.717 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 33.2 m-85 -116.34 135.62 53.71 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.56 -55.9 5.12 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.664 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p-10 -149.1 -165.64 2.34 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.751 -1.44 . . . . 0.0 111.008 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -60.71 -36.17 78.15 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.187 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 45.6 t -67.79 -40.32 83.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.545 -1.347 . . . . 0.0 110.473 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 31.2 m-80 -79.51 -30.23 41.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.043 -1.036 . . . . 0.0 109.953 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 40.5 t80 -73.61 -39.76 64.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.09 0.947 . . . . 0.0 110.515 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 51.7 t -81.17 -40.75 23.45 Favored 'General case' 0 C--N 1.278 -2.513 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.288 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' C ' HG22 ' A' ' 42' ' ' VAL . 43.6 m-20 -50.62 -23.68 2.76 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -84.67 -41.42 16.32 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 37' ' ' PHE . 66.3 t -62.41 -21.68 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.6 m -90.81 -34.17 6.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.22 14.19 15.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.252 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 47' ' ' THR . 30.1 t -132.98 15.58 4.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 109.889 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 66.11 12.02 8.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.153 -0.967 . . . . 0.0 109.196 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.37 20.55 71.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 44' ' ' SER . 13.7 p -88.41 -1.33 57.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -1.118 . . . . 0.0 109.054 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.704 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.7 tp -80.1 -64.11 1.26 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.441 -0.787 . . . . 0.0 109.607 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.1 p 54.63 174.07 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.64 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.49 159.16 25.73 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 110.177 -177.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.647 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.4 p -96.63 -55.41 2.91 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.9 p80 -141.07 151.86 44.35 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.26 114.3 12.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.913 -1.117 . . . . 0.0 109.012 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 139.38 -177.61 20.23 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.688 ' HD2' HG21 ' A' ' 30' ' ' THR . 5.1 tttm -79.72 124.23 28.4 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.381 -1.07 . . . . 0.0 108.787 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.565 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.29 -1.978 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.361 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -178.56 -38.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 109.476 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.02 178.06 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.92 . . . . 0.0 109.481 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.526 HG12 HD21 ' A' ' 50' ' ' LEU . 1.7 t -141.71 74.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.272 -0.892 . . . . 0.0 109.442 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.7 t -169.46 156.97 7.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.293 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.62 HG22 ' N ' ' A' ' 7' ' ' ASP . 12.7 p -112.3 168.84 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 109.563 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' N ' HG22 ' A' ' 6' ' ' VAL . 26.8 t0 -103.25 143.71 32.29 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.542 -0.723 . . . . 0.0 109.131 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.5 m -148.68 55.7 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.162 -0.961 . . . . 0.0 109.628 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.15 13.54 14.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.219 -0.925 . . . . 0.0 109.784 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.81 -8.01 7.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB2' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -81.92 157.96 68.27 Favored Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.175 -0.953 . . . . 0.0 109.269 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -75.15 162.8 92.04 Favored 'Cis proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.639 -1.817 . . . . 0.0 111.867 1.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 1.5 mtmt -123.36 142.39 38.56 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.73 14.64 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.406 2.071 . . . . 0.0 111.075 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.55 93.41 1.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.408 -0.808 . . . . 0.0 109.627 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 96.3 m -80.27 126.73 31.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -47.31 172.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.041 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.732 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.5 pp -103.14 -22.68 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.042 -1.036 . . . . 0.0 109.599 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -43.01 126.94 4.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.35 -0.844 . . . . 0.0 109.142 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -89.09 99.17 12.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.093 -1.005 . . . . 0.0 110.318 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -130.37 95.56 26.95 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.5 Cg_endo -69.63 104.98 1.38 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.096 1.864 . . . . 0.0 110.871 -178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.845 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -98.26 122.15 41.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.766 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 18.1 m -89.11 115.36 26.58 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.983 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.005 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -49.6 178.69 0.02 OUTLIER Glycine 0 C--N 1.298 -1.544 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.4 2.46 24.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.49 -1.594 . . . . 0.0 108.253 178.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.592 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.1 p30 -113.91 2.7 15.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.705 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.592 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.1 t-20 89.28 35.73 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.945 -0.472 . . . . 0.0 110.526 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -103.45 102.7 12.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 108.807 179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.409 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 82.4 m -75.23 126.78 31.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.02 -1.05 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 10.7 m-85 -116.63 128.43 55.37 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.57 -58.07 1.45 Allowed Glycine 0 N--CA 1.492 2.369 0 O-C-N 121.405 -0.809 . . . . 0.0 112.0 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.9 p-10 -140.56 -166.94 2.23 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.73 -1.453 . . . . 0.0 110.956 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' HD11 ' A' ' 23' ' ' LEU . 12.9 ptmt -59.59 -36.19 75.78 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.369 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 53.0 t -72.99 -35.67 66.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.835 -1.166 . . . . 0.0 110.053 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.1 m-80 -78.13 -24.07 47.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.132 -0.98 . . . . 0.0 109.33 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.845 ' CB ' HD12 ' A' ' 23' ' ' LEU . 61.2 t80 -85.16 -31.77 23.07 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.857 1.313 . . . . 0.0 109.254 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.2 m -76.85 -55.46 5.46 Favored 'General case' 0 C--N 1.272 -2.782 0 CA-C-N 114.242 -1.344 . . . . 0.0 109.7 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 92.9 m-20 -42.56 -30.75 0.38 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.952 . . . . 0.0 109.03 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.01 -45.76 26.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' PHE . 52.9 t -54.16 -38.29 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.513 0.673 . . . . 0.0 109.833 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 11' ' ' TYR . 2.2 p -88.05 -25.11 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.58 -0.7 . . . . 0.0 110.161 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.4 tt0 -92.27 15.73 13.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.014 -1.054 . . . . 0.0 108.93 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.74 ' O ' HG23 ' A' ' 47' ' ' THR . 24.2 p -135.07 19.32 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.96 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.9 m120 62.23 23.33 13.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.068 -1.02 . . . . 0.0 108.939 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.1 29.45 74.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 44' ' ' SER . 23.8 p -94.61 -4.24 48.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -1.07 . . . . 0.0 108.904 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.005 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.8 tp -82.09 -77.42 0.23 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.515 -0.741 . . . . 0.0 109.258 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 64.4 179.25 0.17 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.76 164.57 26.5 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.827 -1.171 . . . . 0.0 110.219 -178.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.623 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.91 -26.6 7.28 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.9 p80 -158.64 138.76 12.25 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.766 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -79.21 112.83 16.82 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.304 -0.872 . . . . 0.0 109.554 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.56 -176.31 25.53 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.17 149.52 30.48 Favored 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.541 -0.976 . . . . 0.0 108.633 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.766 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.299 -1.617 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.699 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -120.07 93.29 4.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 57.75 162.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.882 . . . . 0.0 109.665 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.626 HG12 ' CE1' ' A' ' 53' ' ' PHE . 3.1 t -145.3 107.84 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.273 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -131.11 -154.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -0.959 . . . . 0.0 109.629 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 7' ' ' ASP . 2.0 p -142.58 166.28 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.573 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 6' ' ' VAL . 13.8 t70 -90.55 160.98 15.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.266 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.61 44.17 1.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.137 -0.977 . . . . 0.0 109.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.503 ' CB ' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -90.92 13.2 17.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 109.706 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.537 ' C ' ' CG ' ' A' ' 11' ' ' TYR . 11.7 mp0 -149.01 48.17 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.264 -0.898 . . . . 0.0 110.259 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.066 ' O ' HG21 ' A' ' 42' ' ' VAL . 27.4 m-85 -152.6 154.42 31.64 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.899 -1.126 . . . . 0.0 108.898 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.94 166.11 84.1 Favored 'Cis proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.45 -1.896 . . . . 0.0 111.308 2.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 5.5 mttt -126.27 144.15 48.24 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.627 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -79.96 15.2 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.641 2.227 . . . . 0.0 110.59 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.03 135.88 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 m -141.16 119.46 12.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.769 -1.207 . . . . 0.0 111.547 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.1 p -83.91 -111.79 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.817 HD13 ' HG2' ' A' ' 34' ' ' LYS . 5.9 mt 58.38 97.16 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 118.794 -1.162 . . . . 0.0 107.927 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' O ' ' O ' ' A' ' 18' ' ' LEU . 6.7 mm-40 -39.31 -173.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.659 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.44 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 2.9 t80 -77.48 106.49 9.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.182 -1.574 . . . . 0.0 111.635 -178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.4 mmp_? -142.16 74.88 20.77 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.07 135.61 44.51 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 123.738 2.958 . . . . 0.0 114.25 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.805 HD22 ' HD2' ' A' ' 53' ' ' PHE . 13.9 mt -116.82 112.72 21.51 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 4.1 m -79.32 119.39 22.3 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.618 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.56 -162.27 0.03 OUTLIER Glycine 0 N--CA 1.478 1.457 0 C-N-CA 119.34 -1.41 . . . . 0.0 109.918 -178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 2.9 p -90.52 -20.38 22.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.621 -0.929 . . . . 0.0 109.305 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -93.45 3.21 55.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 109.925 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.9 t30 87.42 35.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.797 -0.564 . . . . 0.0 110.334 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.4 104.7 14.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 108.65 178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 96.0 m -71.38 117.88 13.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -0.902 . . . . 0.0 110.673 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.83 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 19.6 m-85 -99.36 133.51 43.55 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -29.47 -55.34 0.18 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 53.1 p-10 -161.04 -137.77 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.069 -1.254 . . . . 0.0 110.521 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.817 ' HG2' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.45 -43.12 51.3 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.381 -0.824 . . . . 0.0 111.335 -177.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 18.4 t -65.84 -35.77 81.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.618 -1.301 . . . . 0.0 109.702 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 7.2 m-80 -77.42 -40.12 44.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.227 -0.92 . . . . 0.0 109.832 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 25.8 t80 -61.18 -45.25 95.39 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.323 1.059 . . . . 0.0 109.685 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 13.6 t -71.16 -45.65 63.08 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.218 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 84.2 m-20 -43.16 -29.95 0.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.67 -48.88 23.62 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 67.9 t -58.15 -65.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.428 0.633 . . . . 0.0 110.059 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.066 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -57.1 -26.59 25.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 O-C-N 121.43 -0.794 . . . . 0.0 112.163 -178.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.27 -12.83 31.51 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.22 -1.55 . . . . 0.0 109.041 179.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.98 ' O ' HG22 ' A' ' 47' ' ' THR . 77.4 p -105.82 40.98 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.486 -0.759 . . . . 0.0 109.56 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.8 p-10 45.7 45.81 11.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 37.69 46.81 1.65 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.98 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -107.74 -8.4 16.08 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.676 -0.897 . . . . 0.0 109.192 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 37' ' ' PHE . 4.8 tp -87.1 131.81 34.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.201 -0.937 . . . . 0.0 110.023 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.53 162.64 17.29 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.727 HD21 ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -111.27 -179.93 3.86 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.172 -1.58 . . . . 0.0 110.257 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -125.56 -32.65 2.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.614 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.2 p80 -163.6 131.99 3.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.963 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.805 ' HD2' HD22 ' A' ' 23' ' ' LEU . 42.1 m-85 -73.54 113.55 10.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 109.938 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 146.99 -175.46 26.36 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.87 147.6 29.23 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.775 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 19.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 118.127 -0.94 . . . . 0.0 109.857 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.691 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 74.81 33.36 0.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 0.0 109.414 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.62 43.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.895 . . . . 0.0 109.544 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -96.74 65.48 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.0 143.36 14.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.449 -0.782 . . . . 0.0 109.242 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 6' ' ' VAL . 58.5 t -108.06 14.94 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.0 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' VAL . 35.9 t70 55.38 109.57 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.756 -0.59 . . . . 0.0 109.642 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -123.29 40.78 3.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.35 18.08 6.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.983 -1.073 . . . . 0.0 110.506 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 20.3 pm0 -149.95 13.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.963 -1.086 . . . . 0.0 110.447 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.977 ' CB ' HG11 ' A' ' 42' ' ' VAL . 62.6 m-85 -104.03 160.6 25.54 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.801 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.3 Cg_endo -85.63 160.58 60.78 Favored 'Cis proline' 0 C--N 1.307 -1.64 0 C-N-CA 123.007 -1.664 . . . . 0.0 110.881 1.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.595 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -127.69 145.07 53.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.639 2.226 . . . . 0.0 111.11 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.66 139.27 29.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.852 . . . . 0.0 109.307 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 62.8 m -129.48 136.17 49.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.898 . . . . 0.0 109.528 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.0 p -56.05 -166.58 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.241 -0.912 . . . . 0.0 108.928 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.35 -23.72 4.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.881 -1.137 . . . . 0.0 110.337 -179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 6.2 pm0 -45.35 141.09 2.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.452 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.505 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 6.7 t80 -90.47 81.4 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 0.0 110.937 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -113.49 77.94 3.4 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.1 Cg_endo -65.41 132.55 31.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.99 2.46 . . . . 0.0 112.438 -177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.668 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -118.01 119.19 34.06 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.081 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.23 134.78 36.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.598 -1.241 . . . . 0.0 108.246 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -59.67 -165.37 0.16 Allowed Glycine 0 C--N 1.298 -1.56 0 C-N-CA 117.42 -2.324 . . . . 0.0 107.427 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.517 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 23.0 t -93.83 -13.12 27.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.726 -1.455 . . . . 0.0 109.827 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.5 p30 -89.51 -39.01 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.598 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 22.1 p-10 143.34 34.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -99.43 171.5 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.79 -1.194 . . . . 0.0 107.982 179.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HD3' ' A' ' 55' ' ' LYS . 18.9 m -137.75 116.42 12.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.915 -1.116 . . . . 0.0 109.717 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 37.9 m-85 -99.97 133.18 44.73 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.93 -55.77 2.24 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -146.8 -156.36 0.71 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.011 -1.288 . . . . 0.0 110.155 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.668 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -71.54 -45.31 62.72 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.59 -0.693 . . . . 0.0 111.153 -178.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.583 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.4 t -54.48 -30.51 53.37 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 120.202 -1.562 . . . . 0.0 109.426 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.3 m-80 -84.19 -46.91 11.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 110.766 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.3 t80 -61.35 -47.02 87.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.884 -1.135 . . . . 0.0 110.359 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.5 t -70.31 -38.53 74.98 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 119.454 -0.898 . . . . 0.0 108.99 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.539 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 27.9 m-20 -52.79 -22.86 5.85 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.888 -1.133 . . . . 0.0 108.067 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.786 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -83.95 -37.34 22.41 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 66.5 t -67.8 -25.04 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.748 0.785 . . . . 0.0 109.264 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' CB ' ' A' ' 11' ' ' TYR . 33.0 m -90.85 -26.57 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.555 -0.716 . . . . 0.0 109.532 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.786 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -90.31 -12.02 39.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.37 -0.831 . . . . 0.0 109.268 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 79.3 p -111.26 29.04 8.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.165 -0.959 . . . . 0.0 110.302 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 44' ' ' SER . 25.6 m-20 64.33 11.36 6.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.94 23.63 74.15 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -89.06 -12.28 41.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.2 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.2 tp -81.68 128.75 34.29 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.312 -0.867 . . . . 0.0 109.04 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 24.4 p -108.88 177.55 4.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 108.737 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.081 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -115.53 165.28 13.19 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.093 -1.004 . . . . 0.0 109.289 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -117.37 -23.99 7.57 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.107 -0.995 . . . . 0.0 108.827 -179.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.732 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER 176.06 150.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 0.0 109.645 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -76.34 109.7 10.26 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.321 -0.862 . . . . 0.0 109.798 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.579 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.07 -177.99 22.38 Favored Glycine 0 C--N 1.297 -1.62 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -82.33 149.34 27.8 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.775 0 O-C-N 121.067 -1.02 . . . . 0.0 109.567 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.3 mp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . 61.04 42.47 12.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 178.51 124.55 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.782 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.516 HG12 HD21 ' A' ' 50' ' ' LEU . 1.6 t -89.83 111.75 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.838 . . . . 0.0 109.186 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.95 -175.52 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 109.847 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 7' ' ' ASP . 71.7 t -128.0 167.63 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 0.0 109.516 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.608 ' N ' HG12 ' A' ' 6' ' ' VAL . 14.0 t0 -70.49 154.5 41.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.141 -0.974 . . . . 0.0 109.82 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 13.6 m -160.0 34.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.954 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -90.2 19.02 5.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 3.2 pm0 -143.22 -13.9 0.7 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.009 -1.057 . . . . 0.0 111.714 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.4 m-85 -79.06 155.94 77.1 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 120.682 -1.261 . . . . 0.0 109.896 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -71.8 145.52 83.18 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.716 -1.785 . . . . 0.0 111.973 2.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -109.42 143.58 28.06 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.69 13.13 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.483 2.122 . . . . 0.0 111.122 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.58 128.05 9.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.845 . . . . 0.0 109.17 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.703 ' C ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -100.33 -7.77 24.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.042 -1.036 . . . . 0.0 109.867 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.703 HG23 ' C ' ' A' ' 16' ' ' CYS . 1.1 p 69.07 -152.49 0.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.048 -1.033 . . . . 0.0 108.46 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' N ' ' OG1' ' A' ' 17' ' ' THR . 1.1 pp -139.72 -13.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.88 -1.137 . . . . 0.0 111.623 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 3.1 mt-10 -46.3 128.36 9.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.476 -1.39 . . . . 0.0 108.645 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.6 t80 -92.47 83.73 5.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.054 -1.029 . . . . 0.0 110.726 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -111.29 84.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -64.15 104.06 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.118 1.879 . . . . 0.0 111.047 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.48 129.0 47.45 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.368 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.682 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -85.63 129.66 34.77 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.498 -0.752 . . . . 0.0 108.99 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.905 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -61.04 -179.86 2.88 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 177.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.497 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 17.2 t -87.45 0.59 55.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 119.961 -1.906 . . . . 0.0 109.074 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.0 p-10 -107.83 -30.83 8.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.284 -0.885 . . . . 0.0 109.062 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 37.4 t30 133.05 37.06 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.602 0 CA-C-O 120.899 0.381 . . . . 0.0 110.534 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.642 ' HE2' HD13 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -112.97 102.37 10.36 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.488 -1.382 . . . . 0.0 109.781 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.5 m -72.88 132.13 43.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.893 . . . . 0.0 110.16 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -114.83 138.18 51.07 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.12 -52.02 5.97 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 120.073 -1.061 . . . . 0.0 111.576 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.8 p-10 -149.06 -167.58 2.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.532 -1.57 . . . . 0.0 111.531 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -56.39 -50.31 71.94 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.806 -178.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 5.1 p -64.07 -51.76 62.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.745 -1.222 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.588 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.9 m-80 -56.08 -31.78 63.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.579 -1.326 . . . . 0.0 110.029 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 49.5 t80 -77.52 -34.68 53.95 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.54 1.162 . . . . 0.0 110.941 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 35.6 t -75.05 -50.74 15.49 Favored 'General case' 0 C--N 1.269 -2.923 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.301 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.6 m-20 -40.53 -30.04 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.927 -1.108 . . . . 0.0 108.221 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.93 -50.44 14.96 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.99 -60.63 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.486 0.66 . . . . 0.0 109.93 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.7 p -63.05 -29.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.645 -0.659 . . . . 0.0 111.257 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -92.52 7.8 41.62 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.456 -1.402 . . . . 0.0 109.417 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.59 ' O ' HG22 ' A' ' 47' ' ' THR . 25.1 p -125.95 3.06 7.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.674 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 44' ' ' SER . 3.2 t-20 76.42 4.2 3.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.178 -0.951 . . . . 0.0 109.374 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.84 13.35 58.06 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -78.88 -8.38 58.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -1.17 . . . . 0.0 108.662 178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.905 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.6 tp -85.68 -68.68 0.71 Allowed 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.545 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 11.3 p 56.48 179.38 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -121.65 165.54 15.59 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -178.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.85 -20.67 11.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.682 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -175.98 140.6 0.43 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.749 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -70.72 112.23 6.79 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.279 -0.888 . . . . 0.0 108.951 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 152.62 -176.84 30.65 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.56 100.09 12.16 Favored 'General case' 0 C--N 1.291 -1.94 0 O-C-N 121.489 -1.007 . . . . 0.0 109.02 179.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.593 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.748 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 124.93 37.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.419 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.98 148.38 48.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.714 HG13 ' O ' ' A' ' 4' ' ' VAL . 7.1 p -158.36 89.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 109.583 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.1 OUTLIER 165.61 159.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.194 -0.941 . . . . 0.0 109.278 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 7' ' ' ASP . 33.8 t -126.3 162.54 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG12 ' A' ' 6' ' ' VAL . 29.8 t0 -87.98 123.05 32.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.285 -0.884 . . . . 0.0 109.263 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.2 m -146.65 33.8 0.94 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -89.96 18.86 5.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 109.792 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -132.75 8.99 4.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 109.327 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 80.8 m-85 -89.49 162.47 36.57 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.293 -0.879 . . . . 0.0 108.718 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.79 148.18 91.27 Favored 'Cis proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.076 -1.635 . . . . 0.0 111.936 3.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -98.02 146.36 31.37 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.48 13.78 1.77 Allowed 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.621 2.214 . . . . 0.0 110.991 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.17 120.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.421 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 98.4 m -95.41 132.34 40.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.551 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 40.0 p -46.04 170.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.809 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 38.9 mt -109.14 -37.62 5.75 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.029 -1.045 . . . . 0.0 110.09 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 8.5 pm0 -45.05 148.3 0.59 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.004 -1.06 . . . . 0.0 108.786 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -89.91 113.11 24.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 110.401 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.6 mmt180 -136.83 85.0 24.64 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.0 Cg_endo -66.96 106.62 1.17 Allowed 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.288 1.992 . . . . 0.0 111.77 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mt -100.9 120.72 40.57 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.714 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.45 139.44 36.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.456 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.829 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -63.72 -175.66 3.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 107.416 -2.273 . . . . 0.0 107.416 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -91.69 -8.95 45.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.463 -1.61 . . . . 0.0 109.503 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 9.4 p-10 -93.85 -37.51 11.71 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 108.675 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 18.3 p30 144.27 37.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.31 -177.46 3.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.356 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 m -150.69 138.02 19.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 29.7 m-85 -127.58 136.5 51.77 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -43.81 -56.51 5.05 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.693 -1.241 . . . . 0.0 111.021 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.5 p30 -140.92 -163.72 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.671 -1.487 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.4 -36.82 83.79 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.648 -178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.3 t -69.44 -32.25 71.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.699 -1.25 . . . . 0.0 110.415 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 24.7 m-80 -79.65 -42.84 23.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.97 -1.081 . . . . 0.0 108.899 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 41' ' ' VAL . 49.5 t80 -68.77 -28.98 67.27 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.755 1.264 . . . . 0.0 109.793 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 15.9 m -82.79 -37.54 24.37 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.363 -178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 70.2 m-20 -58.72 -30.12 67.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.85 -42.48 27.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 37' ' ' PHE . 75.7 t -56.47 -37.34 51.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.668 -0.645 . . . . 0.0 109.764 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.786 HG11 ' CB ' ' A' ' 11' ' ' TYR . 5.7 p -87.05 -25.02 6.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.513 -0.742 . . . . 0.0 110.17 -178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -92.14 10.51 29.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.027 -1.046 . . . . 0.0 108.955 179.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.909 ' O ' HG22 ' A' ' 47' ' ' THR . 73.5 p -131.94 11.35 4.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.328 -0.858 . . . . 0.0 109.84 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 77.15 -0.77 2.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.349 -0.845 . . . . 0.0 109.662 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.38 11.53 64.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.909 HG22 ' O ' ' A' ' 44' ' ' SER . 3.5 t -81.9 -2.33 50.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.519 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.6 tp -80.75 -60.56 2.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.341 -0.849 . . . . 0.0 108.843 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.518 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 33.2 p 54.07 173.6 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.714 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -112.34 159.65 18.46 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 109.734 -178.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.619 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.58 -23.36 11.15 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.683 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.1 p80 -175.91 147.06 0.75 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.8 115.32 14.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.243 -0.911 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 143.3 -176.43 22.77 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.83 109.44 16.97 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.728 -0.866 . . . . 0.0 109.232 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.545 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.89 56.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.46 170.03 18.93 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.99 99.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.001 -1.062 . . . . 0.0 110.223 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -109.49 172.3 6.93 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.89 . . . . 0.0 108.814 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.755 HG22 ' H ' ' A' ' 7' ' ' ASP . 3.1 p -101.24 -175.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.992 -1.068 . . . . 0.0 109.419 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.755 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 t0 -122.26 135.15 54.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.321 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 9.7 m -150.01 55.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.929 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.418 ' C ' ' OE2' ' A' ' 10' ' ' GLU . 14.4 t -90.58 17.86 6.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.546 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 9' ' ' SER . 3.1 mp0 -127.63 -3.07 6.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.327 -0.858 . . . . 0.0 109.643 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 91.3 m-85 -85.74 160.38 53.17 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.228 -0.92 . . . . 0.0 109.149 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -71.2 136.11 40.07 Favored 'Cis proline' 0 C--N 1.309 -1.511 0 C-N-CA 123.002 -1.666 . . . . 0.0 112.057 2.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -85.85 145.5 41.42 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -78.48 14.64 1.57 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.578 2.185 . . . . 0.0 110.85 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.71 120.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.3 m -91.59 135.02 34.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.3 p -57.84 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.086 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -111.35 -21.96 11.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.119 -0.988 . . . . 0.0 109.667 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.57 129.25 6.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.206 -0.934 . . . . 0.0 108.882 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -89.42 90.39 8.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.038 -1.038 . . . . 0.0 110.033 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.1 mmm180 -120.25 91.54 46.29 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 28.1 Cg_endo -67.15 106.36 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.196 1.93 . . . . 0.0 110.595 -178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -99.97 134.58 42.67 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 20.8 m -102.82 123.31 46.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.859 -1.151 . . . . 0.0 111.114 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.843 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -46.57 178.89 0.01 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.539 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 8.7 t -78.96 0.13 28.75 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.817 -1.402 . . . . 0.0 107.714 177.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.1 p30 -116.3 1.65 13.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.47 -0.769 . . . . 0.0 109.701 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.1 m120 90.95 38.54 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.942 -0.473 . . . . 0.0 111.052 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -99.86 112.9 25.14 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.861 -1.15 . . . . 0.0 108.523 178.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.437 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 87.7 m -80.96 127.37 32.5 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.619 -1.301 . . . . 0.0 112.037 -178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 9.2 m-85 -118.15 132.01 56.37 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.12 -55.56 2.37 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.434 -0.889 . . . . 0.0 111.995 -176.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.5 p-10 -145.1 -162.2 1.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.686 -1.479 . . . . 0.0 111.413 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.17 -30.01 70.41 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.93 -0.481 . . . . 0.0 111.651 -177.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 35.0 t -79.08 -34.97 43.15 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.827 -1.171 . . . . 0.0 109.408 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 m-80 -77.41 -25.37 50.71 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.209 -0.932 . . . . 0.0 108.773 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.78 ' O ' HG23 ' A' ' 41' ' ' VAL . 56.7 t80 -87.8 -31.19 19.72 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 122.912 1.339 . . . . 0.0 108.96 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.6 m -72.35 -48.75 39.44 Favored 'General case' 0 C--N 1.273 -2.743 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.97 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.3 m-20 -53.05 -56.05 19.07 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.692 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -51.85 -29.07 18.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.547 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.8 t -76.51 -38.12 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.249 -0.907 . . . . 0.0 110.454 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.7 p -87.14 -10.08 11.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.239 -0.913 . . . . 0.0 110.552 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.692 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.3 -18.88 22.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.962 -1.087 . . . . 0.0 108.53 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 93.8 p -105.39 23.17 14.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.121 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 70.0 m-20 64.27 14.04 8.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.78 19.96 72.0 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 44' ' ' SER . 51.8 p -84.5 -9.14 58.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -1.165 . . . . 0.0 108.545 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.843 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.2 tp -79.24 -73.87 0.32 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.56 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER 60.08 166.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.767 -0.583 . . . . 0.0 109.92 178.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' N ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -106.65 150.96 25.69 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.1 -1.0 . . . . 0.0 110.037 -178.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.32 -28.62 9.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.6 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 3.3 p80 -155.55 134.91 12.37 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.396 0.617 . . . . 0.0 109.41 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -74.63 115.24 13.98 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.895 . . . . 0.0 109.419 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 143.22 -177.17 22.28 Favored Glycine 0 C--N 1.3 -1.463 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.4 ttpt -80.34 151.77 29.29 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.736 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.735 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -127.3 -31.22 2.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.57 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 60.1 87.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.19 -0.944 . . . . 0.0 109.487 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.3 p -136.11 81.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.175 -0.953 . . . . 0.0 109.564 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 155.6 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.232 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.903 HG21 HD22 ' A' ' 23' ' ' LEU . 59.8 t -118.78 11.42 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' O ' ' O ' ' A' ' 6' ' ' VAL . 11.4 t70 41.35 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.402 0.62 . . . . 0.0 110.364 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 32.6 m -114.9 40.63 2.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.004 -1.06 . . . . 0.0 109.265 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -76.16 1.88 14.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.964 . . . . 0.0 109.984 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -118.64 34.99 4.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.905 ' CB ' HG11 ' A' ' 42' ' ' VAL . 30.7 m-85 -119.77 169.68 8.01 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.866 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -89.63 -172.18 6.38 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 O-C-N 123.604 1.318 . . . . 0.0 111.137 0.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -134.99 142.05 40.63 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.442 -0.786 . . . . 0.0 108.991 -179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -79.36 14.35 1.81 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.646 2.23 . . . . 0.0 111.141 -179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' SG ' ' A' ' 16' ' ' CYS . . . -172.24 152.98 2.91 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.426 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 20.1 m -151.49 119.49 6.24 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.096 -1.441 . . . . 0.0 112.429 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -89.78 -106.72 0.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 104.797 -2.298 . . . . 0.0 104.797 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.704 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER 55.28 95.34 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.014 -1.053 . . . . 0.0 108.379 177.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.704 ' O ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mp0 -41.17 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.209 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.43 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 4.3 t80 -76.98 86.08 3.51 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 119.598 -1.939 . . . . 0.0 111.515 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.567 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -120.48 76.69 26.37 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 27.9 Cg_endo -68.55 136.67 37.06 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.583 2.855 . . . . 0.0 114.447 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.903 HD22 HG21 ' A' ' 6' ' ' VAL . 1.1 mt -121.52 123.17 41.36 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.082 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.5 t -78.67 157.83 28.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.105 -0.997 . . . . 0.0 110.147 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.65 170.37 17.11 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -2.38 49.77 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.305 -1.115 . . . . 0.0 109.527 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -100.57 6.34 44.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 109.481 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 34.7 t-20 81.98 25.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.0 110.521 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -114.17 125.71 54.24 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.978 -1.076 . . . . 0.0 109.043 179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -89.42 128.76 35.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 0.0 110.162 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.635 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.8 m-85 -101.18 137.26 39.76 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.61 -47.75 1.22 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.806 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -168.99 -142.41 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.153 -1.204 . . . . 0.0 110.785 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.637 ' HG2' HD22 ' A' ' 18' ' ' LEU . 8.5 pttt -74.49 -38.91 62.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.512 -0.743 . . . . 0.0 112.217 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.4 t -69.75 -34.84 74.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.205 -1.559 . . . . 0.0 109.702 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -77.87 -45.56 23.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 0.0 108.711 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.649 ' O ' HG23 ' A' ' 41' ' ' VAL . 53.0 t80 -62.62 -31.47 72.32 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.913 1.339 . . . . 0.0 109.031 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.611 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 39.7 m -79.77 -34.09 40.07 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.872 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 91.9 m-20 -62.8 -19.02 63.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.54 -39.32 13.37 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 37' ' ' PHE . 60.3 t -63.18 -26.42 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.905 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -90.34 -32.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.779 -0.576 . . . . 0.0 109.741 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.99 16.24 9.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 108.929 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 26.3 t -133.59 6.72 3.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 109.393 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.96 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.85 2.01 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 108.995 -179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.58 17.5 58.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.96 HG23 ' OD1' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -79.43 -16.48 56.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -1.141 . . . . 0.0 108.895 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 37' ' ' PHE . 9.4 tp -78.61 141.8 37.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -130.44 139.9 50.57 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.082 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -65.02 159.47 23.04 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.07 -24.04 7.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.993 -1.067 . . . . 0.0 108.669 -179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.709 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.4 p80 -179.4 129.12 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.448 -0.783 . . . . 0.0 109.015 178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -58.73 116.57 3.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.17 -177.48 21.48 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.51 102.21 14.69 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.867 -0.784 . . . . 0.0 109.069 179.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.685 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.65 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -112.56 15.08 20.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.875 . . . . 0.0 109.411 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 56.43 167.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.73 90.19 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.1 t -154.75 115.03 3.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' CE2' ' A' ' 53' ' ' PHE . 4.6 t -87.23 152.47 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.318 -0.864 . . . . 0.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 53.1 t0 -57.04 128.86 39.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 108.595 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -148.09 18.65 1.1 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.022 -1.048 . . . . 0.0 110.165 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.29 18.8 6.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.144 -0.972 . . . . 0.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 7' ' ' ASP . 1.1 pm0 -134.79 -14.35 2.14 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.749 -1.219 . . . . 0.0 111.264 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.646 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 93.3 m-85 -80.07 161.63 64.93 Favored Pre-proline 0 C--N 1.305 -1.336 0 O-C-N 120.765 -1.209 . . . . 0.0 109.005 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -71.74 160.18 93.62 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.049 -1.646 . . . . 0.0 112.165 3.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.17 144.93 55.17 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.14 14.27 1.59 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.458 2.105 . . . . 0.0 111.029 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.12 105.95 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.421 -0.799 . . . . 0.0 109.326 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 85.5 m -80.26 134.74 36.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.318 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 38.9 p -44.61 163.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.3 pp -104.0 -33.47 8.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.938 -1.102 . . . . 0.0 109.572 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' HG3' ' A' ' 21' ' ' ARG . 4.4 pm0 -45.5 138.54 4.3 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -82.41 95.77 7.76 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 110.547 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -117.02 75.67 7.78 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.8 Cg_endo -64.63 110.05 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.466 2.111 . . . . 0.0 111.427 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -103.76 118.97 37.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' O ' HD12 ' A' ' 50' ' ' LEU . 40.3 t -78.7 114.97 18.08 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.529 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -54.61 -170.75 0.06 OUTLIER Glycine 0 C--N 1.297 -1.608 0 C-N-CA 118.341 -1.885 . . . . 0.0 108.701 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 49' ' ' THR . 26.0 t -88.38 -1.52 58.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.425 . . . . 0.0 109.385 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.512 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 2.7 p30 -111.48 10.38 21.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.171 -0.956 . . . . 0.0 109.561 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.8 OUTLIER 80.01 34.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.61 -0.681 . . . . 0.0 110.652 179.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' CE ' ' OH ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -111.31 92.36 4.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.015 -1.053 . . . . 0.0 108.454 178.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.8 m -57.38 136.5 56.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.7 0.762 . . . . 0.0 110.678 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' OH ' ' CE ' ' A' ' 29' ' ' LYS . 14.9 m-85 -117.22 129.27 55.82 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.49 -58.56 1.37 Allowed Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.029 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -145.97 -162.54 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.313 . . . . 0.0 110.644 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.11 -39.32 79.03 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.951 -0.468 . . . . 0.0 111.473 -178.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.603 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 11.6 t -61.03 -24.06 65.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.081 -1.637 . . . . 0.0 108.556 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.401 ' HB3' ' HD1' ' A' ' 31' ' ' TYR . 14.3 m-80 -86.3 -54.8 4.23 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 48' ' ' LEU . 36.8 t80 -57.86 -37.87 74.69 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.662 1.22 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 2.5 t -72.65 -59.01 2.93 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 -178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 26.7 m-20 -38.79 -30.39 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.274 -0.891 . . . . 0.0 108.924 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.99 -51.05 13.2 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 94.9 t -54.67 -60.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-O 121.523 0.678 . . . . 0.0 110.063 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.2 p -60.4 -31.15 47.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.452 -0.78 . . . . 0.0 111.669 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.7 2.5 56.7 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.511 -1.368 . . . . 0.0 109.94 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.531 ' O ' HG23 ' A' ' 47' ' ' THR . 86.5 p -115.21 25.4 10.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.172 -0.955 . . . . 0.0 109.902 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.4 m-20 64.72 12.27 7.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.097 -1.002 . . . . 0.0 108.909 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.44 24.34 75.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 44' ' ' SER . 19.5 p -84.03 -9.93 58.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -1.064 . . . . 0.0 108.974 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 37' ' ' PHE . 10.2 tp -85.02 133.29 34.25 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.317 -0.864 . . . . 0.0 109.323 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 52.6 p -113.2 151.85 30.46 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 24' ' ' CYS . 9.0 tp -92.08 164.06 13.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.184 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.617 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 81.0 p -104.36 -47.11 4.21 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.553 1.168 . . . . 0.0 108.119 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -173.93 159.47 3.36 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.007 -178.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 6' ' ' VAL . 15.1 m-85 -82.58 105.4 13.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.129 -0.982 . . . . 0.0 109.115 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.64 -177.48 30.34 Favored Glycine 0 C--N 1.295 -1.698 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.88 136.07 34.25 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.642 -0.916 . . . . 0.0 109.322 179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 55' ' ' LYS . 17.4 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.51 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.08 -92.94 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.211 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.81 148.45 31.91 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 4' ' ' VAL . 7.7 m -123.19 103.29 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.399 -0.813 . . . . 0.0 109.375 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.92 168.48 17.56 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.851 HG21 HD22 ' A' ' 23' ' ' LEU . 48.6 t -108.18 167.12 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.86 . . . . 0.0 109.145 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 6' ' ' VAL . 48.8 t0 -107.71 140.37 40.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.6 m -148.33 55.93 1.04 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.575 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 7.2 t -85.89 7.71 23.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.161 -0.962 . . . . 0.0 109.88 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.1 mp0 -117.75 -1.56 11.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 108.769 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.786 ' CB ' HG11 ' A' ' 42' ' ' VAL . 51.8 m-85 -85.95 166.74 27.56 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.819 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -85.06 157.18 64.27 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.529 -1.446 . . . . 0.0 111.015 1.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.6 mttm -127.69 136.26 28.7 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.413 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -81.25 15.68 1.83 Allowed 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.492 2.128 . . . . 0.0 110.531 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.3 102.07 4.03 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.0 m -85.63 142.49 29.04 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.125 -0.985 . . . . 0.0 109.636 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.5 p -56.77 -163.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -125.94 -28.75 3.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.963 -1.086 . . . . 0.0 109.861 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.542 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -48.85 163.77 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.724 -1.214 . . . . 0.0 107.724 179.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 13.0 t80 -112.93 116.56 30.19 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.671 -1.268 . . . . 0.0 110.793 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.0 mmm180 -141.88 81.58 14.51 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.475 ' CG ' ' HG3' ' A' ' 55' ' ' LYS . 24.6 Cg_endo -64.47 109.14 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.375 2.05 . . . . 0.0 110.94 -178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.851 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -102.59 122.27 44.05 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.246 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -82.26 136.72 35.01 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.15 -179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.007 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -66.7 -174.25 6.07 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.609 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -91.75 7.35 42.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.246 -1.738 . . . . 0.0 109.34 178.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.2 p30 -114.12 -30.06 6.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.0 109.597 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.656 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 39.0 t30 132.1 31.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.04 0.448 . . . . 0.0 110.322 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.635 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -109.3 106.06 15.73 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.512 -1.368 . . . . 0.0 109.32 179.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 15.2 m -76.14 137.46 40.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.254 -0.904 . . . . 0.0 110.104 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.624 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.6 m-85 -118.36 132.73 56.26 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.79 -58.03 1.2 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 6.2 p-10 -151.93 -169.78 3.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.981 -1.305 . . . . 0.0 110.633 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.24 -35.59 50.08 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.958 -0.464 . . . . 0.0 112.25 -178.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.8 t -71.58 -41.55 68.86 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.632 -1.293 . . . . 0.0 110.819 -178.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.3 m-80 -73.9 -31.31 63.05 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.896 -1.127 . . . . 0.0 109.229 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.818 ' O ' HG23 ' A' ' 41' ' ' VAL . 43.5 t80 -78.68 -30.2 46.01 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.661 1.22 . . . . 0.0 109.802 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.8 m -82.4 -28.86 31.17 Favored 'General case' 0 C--N 1.271 -2.84 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.638 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HA ' HG22 ' A' ' 42' ' ' VAL . 79.9 m-20 -72.49 -20.18 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -88.03 -32.66 18.67 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 37' ' ' PHE . 96.8 t -68.75 -32.45 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.819 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.7 m -82.89 -31.7 9.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.24 14.34 16.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.426 -0.796 . . . . 0.0 109.601 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.7 t -135.82 10.07 3.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.032 . . . . 0.0 109.997 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 69.06 12.83 8.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.932 . . . . 0.0 109.117 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 80.13 9.98 86.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 47' ' ' THR . 3.4 m -81.06 -1.17 43.04 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.159 -1.201 . . . . 0.0 109.457 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.007 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.29 -53.79 6.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 108.559 179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.577 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 55.56 170.85 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.166 0.508 . . . . 0.0 109.831 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -115.73 156.08 26.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.508 -0.745 . . . . 0.0 109.717 -178.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -109.33 -27.13 9.67 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.66 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.6 p80 -173.78 142.24 0.89 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -72.56 113.35 9.5 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 150.57 -176.26 29.23 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.369 -1.892 . . . . 0.0 108.369 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.646 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.51 102.42 13.48 Favored 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.41 -1.053 . . . . 0.0 109.103 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.612 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . 47.96 -105.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . 42.66 61.34 2.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.959 -1.088 . . . . 0.0 109.555 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.1 p -133.53 69.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.271 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.89 94.72 0.26 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.266 -0.896 . . . . 0.0 109.956 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 7' ' ' ASP . 2.1 p -90.09 -166.34 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 108.666 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.731 ' H ' HG22 ' A' ' 6' ' ' VAL . 32.9 t70 -137.74 115.01 11.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.847 -1.158 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 8.8 m -133.73 46.64 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.861 . . . . 0.0 109.199 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.13 7.34 13.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 0.0 109.923 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -118.07 -7.82 10.78 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.956 ' CB ' HG11 ' A' ' 42' ' ' VAL . 50.5 m-85 -79.41 167.1 36.95 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.858 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -85.22 171.19 44.16 Favored 'Cis proline' 0 C--N 1.307 -1.61 0 C-N-CA 123.591 -1.42 . . . . 0.0 111.113 1.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -135.13 145.6 54.88 Favored Pre-proline 0 N--CA 1.491 1.594 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.18 13.95 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.586 2.191 . . . . 0.0 110.506 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.15 130.4 9.6 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.398 -0.814 . . . . 0.0 109.15 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.0 m -103.8 127.34 51.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.7 p -50.1 174.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.287 -0.883 . . . . 0.0 108.691 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -98.69 -18.1 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.021 -1.049 . . . . 0.0 109.976 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -45.89 129.28 9.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.037 -1.039 . . . . 0.0 108.255 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.462 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.5 t80 -93.82 82.03 4.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.888 -1.132 . . . . 0.0 111.094 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 21.8 mtm180 -112.85 85.8 8.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -66.97 111.56 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.945 2.43 . . . . 0.0 112.082 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.843 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.2 mt -105.43 113.63 27.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 118.88 -1.128 . . . . 0.0 108.673 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.609 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -81.51 125.12 30.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 50' ' ' LEU . . . -65.61 -166.71 1.79 Allowed Glycine 0 N--CA 1.479 1.523 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.201 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.593 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 7.7 t -88.69 2.89 52.48 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -102.52 -6.14 23.2 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.3 m-20 88.25 19.06 0.06 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.96 -0.462 . . . . 0.0 110.646 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 2.3 mttt -98.8 119.55 37.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.966 -1.084 . . . . 0.0 108.306 178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 78.6 m -79.79 128.16 33.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.362 -0.836 . . . . 0.0 111.074 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 73.6 m-85 -101.88 122.7 44.51 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.4 -59.95 0.28 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.8 p30 -145.58 -164.46 1.95 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.169 -1.195 . . . . 0.0 110.166 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -59.98 -31.57 70.02 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.913 -0.492 . . . . 0.0 110.897 -179.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 26.5 t -71.62 -36.76 70.87 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.725 -1.234 . . . . 0.0 109.731 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 4.0 m-80 -71.51 -41.17 69.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.083 -1.01 . . . . 0.0 108.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.843 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -67.6 -36.09 80.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 122.599 1.19 . . . . 0.0 109.47 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.842 ' O ' HG22 ' A' ' 42' ' ' VAL . 97.8 m -75.84 -28.68 58.33 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.517 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 58.4 m-20 -65.54 -20.8 66.48 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.55 -44.31 10.18 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.865 HG22 HD23 ' A' ' 48' ' ' LEU . 45.2 t -60.89 -26.04 37.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.956 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.9 m -91.71 -30.34 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.691 -0.631 . . . . 0.0 110.225 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 14.1 tt0 -87.76 12.91 11.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.217 -0.927 . . . . 0.0 109.201 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 15.4 t -134.24 22.4 3.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.468 -0.77 . . . . 0.0 109.33 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' SER . 4.7 m-20 62.72 18.76 10.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.082 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.29 73.68 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' SER . 33.6 p -93.78 -8.7 39.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -1.134 . . . . 0.0 109.281 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.865 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -82.19 136.74 35.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.333 -0.855 . . . . 0.0 110.075 -179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.8 p -120.05 149.69 41.77 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -95.52 -167.01 1.54 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.732 -1.23 . . . . 0.0 110.836 -178.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -127.66 -33.84 2.26 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.191 -0.943 . . . . 0.0 109.093 -179.425 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.609 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -170.43 131.06 0.92 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.818 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' HD22 ' A' ' 23' ' ' LEU . 91.2 m-85 -63.21 109.61 1.6 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.551 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 146.16 -176.89 24.86 Favored Glycine 0 C--N 1.297 -1.614 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.49 152.02 23.01 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 178.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 36.4 m . . . . . 0 C--N 1.299 -1.601 0 O-C-N 120.879 -1.138 . . . . 0.0 109.576 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.32 0.581 . . . . 0.0 109.484 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 179.5 55.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.2 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.23 176.78 9.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.608 -179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 50' ' ' LEU . 4.9 m -112.04 109.68 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.266 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.9 m -155.3 162.44 40.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 109.266 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -115.38 -167.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.712 ' H ' HG22 ' A' ' 6' ' ' VAL . 60.2 t0 -116.93 129.39 56.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.3 m -148.71 53.75 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 9' ' ' SER . 1.2 t -89.66 15.28 9.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.452 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -133.5 23.34 4.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.81 . . . . 0.0 109.312 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.993 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.3 m-85 -107.01 160.28 26.93 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.403 -0.811 . . . . 0.0 108.992 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.14 167.01 81.41 Favored 'Cis proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.615 -1.827 . . . . 0.0 111.48 2.093 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.517 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -113.98 144.62 31.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -78.32 13.95 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.518 2.145 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -169.27 101.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.137 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' THR . 97.0 m -79.71 138.85 37.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.955 . . . . 0.0 109.329 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.2 p -55.83 -165.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.256 -0.902 . . . . 0.0 108.933 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.4 mt -120.74 -22.52 6.27 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.976 -1.078 . . . . 0.0 109.912 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.1 mt-10 -44.28 130.02 6.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 108.689 179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 13.6 t80 -89.97 79.98 6.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.088 -1.007 . . . . 0.0 110.146 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 23.4 mtp85 -110.41 89.0 8.1 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 178.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.9 Cg_endo -68.47 110.04 2.19 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.231 1.954 . . . . 0.0 110.898 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.828 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -103.66 123.16 46.48 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.049 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.0 OUTLIER -79.75 131.71 35.99 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.326 -0.859 . . . . 0.0 108.937 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.974 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -71.12 -175.62 21.54 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 107.688 -2.165 . . . . 0.0 107.688 178.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.52 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 18.3 t -90.2 4.81 49.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.463 -1.61 . . . . 0.0 108.674 178.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.6 p-10 -111.78 6.26 19.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 0.0 109.616 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.559 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.0 t-20 84.24 36.61 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.752 -0.593 . . . . 0.0 110.203 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.11 108.16 14.86 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.037 -1.039 . . . . 0.0 108.993 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.9 m -74.12 140.61 45.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 46.1 m-85 -118.61 128.62 54.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.62 -59.07 1.36 Allowed Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.722 -0.752 . . . . 0.0 111.401 -177.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.7 p-10 -142.71 -164.84 1.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.875 -1.368 . . . . 0.0 110.691 -179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.51 -38.31 86.9 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.911 -0.493 . . . . 0.0 111.221 -179.202 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 44.4 t -68.52 -40.17 80.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.041 -1.037 . . . . 0.0 110.495 -178.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 17.5 m-80 -72.53 -36.38 68.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.881 -1.137 . . . . 0.0 109.008 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.828 ' CB ' HD12 ' A' ' 23' ' ' LEU . 43.2 t80 -70.26 -32.22 69.95 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.774 1.273 . . . . 0.0 109.811 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 4.8 m -74.49 -55.85 5.49 Favored 'General case' 0 C--N 1.271 -2.83 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.562 -178.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 80.3 m-20 -41.09 -37.53 0.88 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.272 -0.893 . . . . 0.0 109.014 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -67.79 -48.69 65.59 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' PHE . 84.6 t -53.23 -57.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.621 0.724 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.993 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -65.41 -26.11 38.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.471 -0.768 . . . . 0.0 110.891 -178.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.99 3.38 55.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.824 -1.172 . . . . 0.0 109.017 179.437 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.485 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.9 p -125.78 4.2 7.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.376 -0.828 . . . . 0.0 109.613 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 1.9 p30 60.86 17.22 7.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.701 -0.624 . . . . 0.0 110.01 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.43 18.74 40.79 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 178.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.442 HG23 ' ND2' ' A' ' 45' ' ' ASN . 25.8 p -84.16 -16.83 42.06 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.418 -1.049 . . . . 0.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.974 HD11 ' HA3' ' A' ' 25' ' ' GLY . 4.8 tp -79.21 -68.7 0.63 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.87 0.843 . . . . 0.0 108.922 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.535 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 59.44 179.04 0.08 Allowed 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -123.79 165.68 16.89 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.855 -1.153 . . . . 0.0 110.143 -178.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -113.88 -21.42 10.65 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.264 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.659 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 5.0 p80 -179.1 141.26 0.17 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.692 -0.63 . . . . 0.0 109.664 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -69.05 116.1 9.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.589 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.03 -178.53 24.61 Favored Glycine 0 C--N 1.301 -1.409 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -86.3 99.04 11.31 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 121.447 -1.031 . . . . 0.0 109.03 179.385 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.736 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -100.97 -21.51 15.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 168.72 -167.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.658 ' O ' HD23 ' A' ' 50' ' ' LEU . 8.4 m -129.88 74.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -0.959 . . . . 0.0 109.68 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -161.8 160.36 28.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.492 -0.755 . . . . 0.0 109.151 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -109.33 -166.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.13 -0.981 . . . . 0.0 109.551 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.64 ' N ' HG13 ' A' ' 6' ' ' VAL . 27.4 t70 -116.56 129.2 56.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.342 -0.849 . . . . 0.0 109.198 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.8 m -147.48 53.98 1.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 t -90.76 18.86 5.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 23.0 mp0 -140.08 9.79 2.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.739 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.969 ' O ' HG21 ' A' ' 42' ' ' VAL . 77.7 m-85 -87.18 159.4 50.99 Favored Pre-proline 0 C--N 1.304 -1.382 0 O-C-N 121.269 -0.894 . . . . 0.0 108.995 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -75.13 173.47 57.73 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.669 -1.805 . . . . 0.0 111.372 2.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -126.54 145.06 51.75 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.59 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.7 Cg_endo -78.24 13.57 1.77 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.52 2.147 . . . . 0.0 110.965 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.58 104.56 0.61 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.327 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.8 m -80.6 144.69 32.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.483 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.3 p -54.74 -169.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.377 -0.827 . . . . 0.0 108.912 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.1 pp -122.64 -28.26 4.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.044 -1.035 . . . . 0.0 109.785 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -44.3 124.6 4.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.121 -0.987 . . . . 0.0 108.83 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -81.39 79.72 7.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.071 -1.018 . . . . 0.0 110.294 -179.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mmt180 -114.59 92.4 28.71 Favored Pre-proline 0 C--N 1.3 -1.549 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -68.64 109.5 2.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.16 1.906 . . . . 0.0 111.036 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -98.28 134.34 41.44 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.158 -0.963 . . . . 0.0 108.628 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.732 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 21.3 m -102.81 121.8 43.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 110.29 -178.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.967 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -55.34 -170.62 0.08 OUTLIER Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -89.76 12.68 16.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.83 -1.394 . . . . 0.0 108.453 178.371 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.582 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.0 p30 -122.92 1.49 9.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 109.61 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 11.8 t-20 88.74 35.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.768 -0.582 . . . . 0.0 110.91 179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.0 OUTLIER -102.07 132.74 47.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.307 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.3 m -100.57 135.64 41.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.658 -1.276 . . . . 0.0 111.737 -178.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 59.3 m-85 -123.94 124.8 43.4 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -35.38 -59.23 0.82 Allowed Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.524 -0.735 . . . . 0.0 111.269 -177.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.9 p30 -138.26 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.932 -1.334 . . . . 0.0 110.208 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -70.53 -29.62 66.15 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.65 -0.656 . . . . 0.0 110.799 -178.527 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 33.9 t -71.56 -31.26 66.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.923 -1.111 . . . . 0.0 109.493 -179.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.495 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.1 m-80 -78.83 -45.54 20.61 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 58.5 t80 -65.68 -28.97 69.47 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.816 1.294 . . . . 0.0 109.334 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -74.73 -56.41 4.82 Favored 'General case' 0 C--N 1.27 -2.866 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.424 -178.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 91.7 m-20 -41.5 -33.01 0.39 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.94 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.13 -47.03 38.78 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 37' ' ' PHE . 78.3 t -52.07 -55.06 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.564 0.697 . . . . 0.0 109.519 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.969 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.4 p -66.61 -26.27 36.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.651 -0.655 . . . . 0.0 110.445 -179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -91.84 6.42 46.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.817 -1.177 . . . . 0.0 108.929 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 47' ' ' THR . 44.8 p -127.36 -1.24 6.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.65 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 72.11 13.94 5.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.223 -0.923 . . . . 0.0 108.902 -179.444 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.27 14.44 64.09 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 44' ' ' SER . 35.0 p -80.0 -8.27 59.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.319 -1.106 . . . . 0.0 109.05 179.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.967 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.8 tp -79.85 -81.28 0.12 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 74.4 161.44 0.24 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.698 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -118.74 159.88 22.88 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.756 -1.215 . . . . 0.0 109.412 -179.03 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.585 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -115.17 -21.64 9.86 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.604 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.3 p80 -166.66 142.86 4.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.545 -0.722 . . . . 0.0 109.714 -179.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CD2' HD23 ' A' ' 23' ' ' LEU . 33.1 m-85 -74.07 173.88 9.43 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.053 -1.029 . . . . 0.0 108.622 179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 83.47 179.09 52.22 Favored Glycine 0 C--N 1.304 -1.208 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 -179.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 155.24 26.21 Favored 'General case' 0 C--N 1.287 -2.145 0 O-C-N 121.719 -0.871 . . . . 0.0 108.878 178.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.732 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.296 -1.723 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.789 -177.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 3' ' ' ALA . . . -136.83 90.72 2.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.568 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . 45.78 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.692 ' HB ' HD23 ' A' ' 50' ' ' LEU . 47.2 t -118.66 56.94 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.078 -1.014 . . . . 0.0 109.642 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.628 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . 0.4 OUTLIER 94.48 25.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.591 179.262 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG23 HD22 ' A' ' 50' ' ' LEU . 90.8 t -134.29 165.65 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.904 -1.122 . . . . 0.0 109.646 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.613 ' N ' HG12 ' A' ' 6' ' ' VAL . 26.6 t0 -151.97 142.13 22.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.18 53.45 1.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.072 -1.017 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.96 12.14 8.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.163 -0.96 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -136.83 8.46 3.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.379 -0.825 . . . . 0.0 109.453 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.715 ' HB3' HG11 ' A' ' 42' ' ' VAL . 22.9 m-85 -88.29 168.3 16.8 Favored Pre-proline 0 C--N 1.297 -1.69 0 O-C-N 121.657 -0.652 . . . . 0.0 109.59 -179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.677 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -89.89 -166.03 2.79 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.3 0.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 11' ' ' TYR . 12.7 mtpp -137.23 138.12 24.4 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -80.31 15.31 1.76 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.564 2.176 . . . . 0.0 110.832 -179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 176.43 112.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -0.792 . . . . 0.0 109.049 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 17' ' ' THR . 48.2 t -96.05 160.69 14.32 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.089 -1.007 . . . . 0.0 110.297 -179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' CYS . 64.4 p -63.69 -133.77 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.8 pp -142.02 6.87 1.79 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.752 -1.217 . . . . 0.0 111.098 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 12.3 mm-40 -52.56 -177.68 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.832 -1.167 . . . . 0.0 107.944 179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 7.8 t80 -146.53 76.52 1.44 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.418 -1.313 . . . . 0.0 111.516 179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -109.84 82.02 2.23 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.28 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 20' ' ' TYR . 21.6 Cg_endo -63.22 105.86 0.51 Allowed 'Trans proline' 0 C--O 1.197 -1.546 0 C-N-CA 122.923 2.415 . . . . 0.0 112.208 -177.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.683 HD12 ' CB ' ' A' ' 37' ' ' PHE . 5.3 mt -103.06 116.82 33.24 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.492 178.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 6.5 t -77.52 161.78 27.64 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' HB3' ' A' ' 51' ' ' SER . . . -126.91 161.9 21.11 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 119.1 -1.524 . . . . 0.0 111.759 -177.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.3 t -55.89 -16.39 4.59 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.649 -0.913 . . . . 0.0 109.506 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD1' ' HG3' ' A' ' 29' ' ' LYS . 1.5 p30 -85.92 20.2 2.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.202 -0.936 . . . . 0.0 110.127 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 m120 57.27 19.11 4.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 110.742 179.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -112.12 134.96 53.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.822 -1.174 . . . . 0.0 109.403 179.701 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 3.2 m -93.89 142.6 27.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.237 -0.914 . . . . 0.0 109.663 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.4 m-85 -111.48 124.51 52.43 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.19 -61.29 0.54 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.1 p-10 -144.04 -171.21 3.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.085 -1.244 . . . . 0.0 110.481 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.71 -49.91 14.23 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.697 -178.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.62 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -57.89 -66.69 0.43 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.819 -1.175 . . . . 0.0 109.858 -178.748 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.568 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.2 m-80 -43.45 -30.87 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.993 . . . . 0.0 110.075 -179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.683 ' CB ' HD12 ' A' ' 23' ' ' LEU . 28.8 t80 -70.3 -45.44 66.29 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 122.819 1.295 . . . . 0.0 108.797 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' O ' HG13 ' A' ' 42' ' ' VAL . 43.4 m -65.33 -27.35 68.53 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.792 -179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.533 ' C ' HG22 ' A' ' 42' ' ' VAL . 1.9 m-20 -64.23 -23.78 67.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.0 -40.52 19.86 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 48' ' ' LEU . 67.6 t -64.82 -24.64 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.694 0.759 . . . . 0.0 109.138 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 11' ' ' TYR . 26.8 m -90.46 -33.94 6.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.548 -0.72 . . . . 0.0 110.431 -178.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -91.16 8.28 36.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.476 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.1 p -121.69 17.49 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m-80 64.3 26.1 13.62 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.02 18.33 47.4 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.6 p -88.22 -10.39 49.92 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -1.063 . . . . 0.0 108.637 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.685 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.37 150.17 31.46 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.369 -0.832 . . . . 0.0 108.79 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.585 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 17.8 p -124.13 139.64 53.74 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.476 -0.889 . . . . 0.0 109.219 178.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.765 HD22 HG23 ' A' ' 6' ' ' VAL . 3.6 tp -59.13 137.47 57.95 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.606 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 4.2 p -85.11 -59.58 2.29 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.208 -0.933 . . . . 0.0 109.738 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.621 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -169.04 146.08 3.6 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.658 -0.651 . . . . 0.0 109.409 -179.317 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' CE1' ' HB3' ' A' ' 5' ' ' SER . 23.0 m-85 -69.48 106.64 3.05 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.773 -1.204 . . . . 0.0 109.979 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.7 176.2 18.51 Favored Glycine 0 C--N 1.293 -1.812 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.96 131.81 36.34 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.479 -1.012 . . . . 0.0 108.767 178.857 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.436 ' C ' ' O ' ' A' ' 55' ' ' LYS . 1.3 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.633 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.69 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.225 0.536 . . . . 0.0 109.57 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 75.72 143.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.714 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.26 114.58 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.541 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 5' ' ' SER . 1.4 m -99.43 73.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.932 . . . . 0.0 109.278 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 1.3 t 167.37 137.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.361 -0.837 . . . . 0.0 108.975 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 7' ' ' ASP . 46.7 t -117.0 164.28 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.089 -1.007 . . . . 0.0 109.895 -179.467 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' HG12 ' A' ' 6' ' ' VAL . 19.6 t70 -108.57 165.95 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.409 -0.807 . . . . 0.0 109.037 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 15.6 m -144.57 53.78 1.25 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.98 3.17 35.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 109.827 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.09 -7.29 6.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.513 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 37.1 m-85 -82.17 166.62 35.87 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.275 -0.891 . . . . 0.0 108.753 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -88.19 173.36 29.27 Favored 'Cis proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.523 -1.449 . . . . 0.0 110.819 1.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -127.81 141.0 39.7 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.555 -0.716 . . . . 0.0 109.411 -179.264 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.76 14.52 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.654 2.236 . . . . 0.0 110.84 -179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.61 104.09 2.15 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 93.7 m -81.9 148.58 28.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.743 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 22.6 p -55.96 -166.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.727 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -117.82 -29.44 5.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.803 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -50.53 134.02 24.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 14.1 t80 -90.53 83.93 5.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.847 -1.158 . . . . 0.0 111.003 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.2 mtm180 -112.3 77.65 2.27 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.8 Cg_endo -65.82 122.22 9.76 Favored 'Trans proline' 0 C--O 1.202 -1.289 0 C-N-CA 123.651 2.9 . . . . 0.0 114.235 -176.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.692 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 39.4 mt -103.26 156.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.733 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 11.8 t -119.53 140.51 50.4 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 119.753 -1.842 . . . . 0.0 109.917 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -99.55 147.25 18.25 Favored Glycine 0 N--CA 1.494 2.527 0 O-C-N 120.049 -1.657 . . . . 0.0 111.238 -179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -46.46 -20.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 122.101 -0.647 . . . . 0.0 110.709 -178.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -88.14 26.34 1.41 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.936 -1.103 . . . . 0.0 109.634 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 24.3 t30 55.22 21.81 4.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.339 -0.851 . . . . 0.0 109.533 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -99.37 100.27 11.32 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 108.677 179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.2 m -73.43 123.99 24.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.845 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.815 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.66 115.19 27.45 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -16.05 -58.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.231 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -177.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 2.1 p-10 -161.52 -168.5 2.01 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.416 -1.049 . . . . 0.0 109.904 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -40.84 -52.76 2.99 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.695 -0.628 . . . . 0.0 111.605 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.9 t -59.29 -52.9 63.66 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.551 -1.343 . . . . 0.0 110.242 -179.157 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 7.5 m-80 -58.68 -21.64 54.98 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.953 -1.092 . . . . 0.0 109.376 -179.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.815 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t80 -79.8 -64.85 1.09 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.17 -178.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 1.039 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.0 OUTLIER -45.29 -26.2 0.48 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.698 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 12.3 m-20 -71.44 -52.15 20.04 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -53.3 -20.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.618 HG22 HD23 ' A' ' 48' ' ' LEU . 47.0 t -87.88 -35.43 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.039 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.2 m -80.84 -11.83 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.409 -0.807 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.633 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.94 -18.71 24.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 12.6 t -108.71 15.89 23.29 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.746 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 71.55 5.28 5.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.164 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 89.23 9.27 67.5 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 m -79.72 -15.27 57.84 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.755 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -79.67 147.43 31.99 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.2 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.559 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.6 p -122.18 145.53 48.1 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.194 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 51' ' ' SER . 10.7 tp -61.33 171.27 1.45 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.642 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 22.4 p -116.22 -51.41 2.62 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.798 -1.189 . . . . 0.0 108.089 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.733 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -172.63 155.14 3.24 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' HA ' HD23 ' A' ' 23' ' ' LEU . 19.9 m-85 -73.66 105.35 4.94 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.856 -1.153 . . . . 0.0 109.407 179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.46 -176.67 24.34 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.16 141.56 30.97 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.557 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' LYS . 18.8 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.626 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.54 43.34 2.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.471 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -46.01 137.91 5.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.32 110.22 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.49 156.9 2.55 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 108.907 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 23' ' ' LEU . 48.0 t -90.77 162.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.777 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 6' ' ' VAL . 11.7 t70 -84.42 143.53 29.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 m -137.89 40.61 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.108 -0.995 . . . . 0.0 109.603 -179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 t -91.25 5.45 49.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.066 -1.021 . . . . 0.0 110.756 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -137.09 1.16 2.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.945 . . . . 0.0 110.286 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.977 ' HB3' HG11 ' A' ' 42' ' ' VAL . 38.0 m-85 -83.98 165.45 39.08 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.161 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.919 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.02 -178.5 19.41 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.297 -1.543 . . . . 0.0 111.101 1.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.51 139.68 34.61 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.541 -0.724 . . . . 0.0 109.46 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.25 13.88 2.1 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.48 2.12 . . . . 0.0 110.652 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.53 116.6 2.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.469 -0.769 . . . . 0.0 109.07 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -79.56 145.95 32.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 109.769 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 12.0 p -60.1 -148.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.425 -0.797 . . . . 0.0 109.189 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.765 HD12 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -134.22 -38.69 0.85 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.042 -1.036 . . . . 0.0 109.98 179.841 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -44.32 141.99 1.68 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.084 -1.01 . . . . 0.0 108.632 -179.983 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.1 t80 -92.5 105.29 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.832 -1.167 . . . . 0.0 111.134 -178.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -128.8 75.56 79.86 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 23.9 Cg_endo -65.52 110.03 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.772 2.314 . . . . 0.0 112.078 -177.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.027 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -102.8 119.28 38.57 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 118.709 -1.197 . . . . 0.0 108.529 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.719 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 44.1 t -76.91 117.54 18.61 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -59.78 -165.75 0.19 Allowed Glycine 0 C--N 1.293 -1.84 0 C-N-CA 117.083 -2.484 . . . . 0.0 107.449 -178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 35.8 t -91.55 -18.08 24.65 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.983 -1.304 . . . . 0.0 108.629 178.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -88.47 3.31 50.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.407 -0.808 . . . . 0.0 109.799 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.6 t-20 84.77 30.53 0.05 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.701 -0.624 . . . . 0.0 110.46 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -109.5 104.12 13.12 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.967 -1.083 . . . . 0.0 108.48 178.695 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.3 m -67.4 133.24 49.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 110.746 -178.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 21.3 m-85 -107.81 124.62 50.34 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.256 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.87 -59.3 0.34 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -178.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 39.5 p30 -145.57 -163.97 1.84 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.122 -1.222 . . . . 0.0 110.6 179.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.99 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.0 -60.59 3.54 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.769 -0.582 . . . . 0.0 111.186 -178.432 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.64 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.6 p -49.16 -44.99 43.31 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.551 -1.343 . . . . 0.0 110.43 -178.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.487 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 8.3 m-80 -59.13 -47.28 85.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.806 -1.184 . . . . 0.0 109.823 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.027 ' CB ' HD12 ' A' ' 23' ' ' LEU . 46.9 t80 -59.63 -43.83 93.68 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 122.084 0.945 . . . . 0.0 110.597 -179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' O ' HG22 ' A' ' 42' ' ' VAL . 53.8 t -73.21 -22.3 60.47 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.624 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 51.0 m-20 -65.52 -22.88 66.76 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.792 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.49 -36.36 20.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.566 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 58.1 t -69.67 -23.28 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG11 ' HB3' ' A' ' 11' ' ' TYR . 27.4 m -90.84 -31.05 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.548 0.689 . . . . 0.0 109.378 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.792 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -84.09 -10.38 57.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.533 -0.73 . . . . 0.0 109.132 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 47' ' ' THR . 86.3 p -112.49 17.53 19.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.771 -179.419 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.7 OUTLIER 70.55 4.77 5.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.168 -0.958 . . . . 0.0 109.073 -179.273 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.83 14.52 67.31 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -81.0 -11.19 59.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.344 -1.092 . . . . 0.0 109.01 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.49 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -79.46 127.02 31.6 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.678 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 p -114.46 154.56 27.96 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.94 -166.23 1.33 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.235 -1.386 . . . . 0.0 111.12 -177.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.82 -30.99 1.99 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.165 -0.96 . . . . 0.0 109.274 -178.666 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.719 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 -177.9 133.11 0.16 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 109.74 -179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' CD2' HD22 ' A' ' 23' ' ' LEU . 49.3 m-85 -61.93 112.51 2.35 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.397 -0.815 . . . . 0.0 109.818 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.85 -177.44 24.23 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.95 130.61 34.49 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.462 -1.022 . . . . 0.0 108.718 178.774 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HB3' ' ND2' ' A' ' 28' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.811 -179.5 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.716 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.4 tp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 81.32 -70.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.576 -0.703 . . . . 0.0 109.559 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 177.53 147.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.371 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -114.22 109.17 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.714 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 -160.55 0.94 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.885 . . . . 0.0 109.059 179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.683 HG13 ' N ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -117.9 -167.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.086 -1.009 . . . . 0.0 109.754 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.683 ' N ' HG13 ' A' ' 6' ' ' VAL . 13.2 t0 -117.84 128.12 54.54 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 6' ' ' VAL . 7.9 m -146.69 51.08 1.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.001 . . . . 0.0 109.992 -179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 t -90.43 17.8 6.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.253 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -134.09 24.21 3.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.88 ' O ' HG21 ' A' ' 42' ' ' VAL . 94.8 m-85 -111.16 160.27 29.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.6 Cg_endo -74.45 157.88 99.18 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.632 2.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.2 tttt -110.21 144.57 30.36 Favored Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -78.49 14.24 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.498 2.132 . . . . 0.0 111.033 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.29 107.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' THR . 69.2 m -84.11 140.75 31.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.741 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -55.66 -167.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 108.682 179.522 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 19' ' ' GLU . 6.0 mt -115.83 -21.85 9.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.068 . . . . 0.0 109.636 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -42.23 145.63 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.145 179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -106.05 93.91 4.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.015 . . . . 0.0 109.731 -179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 13.6 mtp180 -122.53 95.46 46.77 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.398 -0.814 . . . . 0.0 108.811 179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -69.97 101.73 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.046 1.831 . . . . 0.0 110.255 -179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' A' ' 37' ' ' PHE . 2.0 mt -99.21 125.79 44.88 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 59.2 m -91.0 121.21 32.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 118.787 -1.165 . . . . 0.0 110.597 -178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.726 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -48.44 179.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 15.3 t -85.29 -2.24 57.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.556 . . . . 0.0 109.1 179.03 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.672 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -104.57 -30.35 10.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.312 179.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.672 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 35.9 t30 130.96 37.98 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 121.2 0.524 . . . . 0.0 110.328 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -99.91 172.82 6.99 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.736 -1.228 . . . . 0.0 108.15 178.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.459 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 60.5 m -139.0 124.46 19.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.902 -1.124 . . . . 0.0 110.041 179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.727 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 43.7 m-85 -116.51 129.04 55.98 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -40.63 -58.49 2.55 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.192 -1.004 . . . . 0.0 111.305 -177.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -136.66 -165.5 1.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.752 -1.44 . . . . 0.0 110.843 -179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -64.81 -33.45 76.02 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.736 -178.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.588 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.3 t -71.79 -38.44 70.28 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.692 -1.255 . . . . 0.0 109.883 -178.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.467 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 19.1 m-80 -71.16 -45.91 62.51 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.999 -1.063 . . . . 0.0 108.642 179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.2 t80 -66.9 -30.29 70.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.741 1.258 . . . . 0.0 109.581 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.3 m -73.72 -39.07 64.58 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.566 -178.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 91.4 m-20 -58.91 -56.16 25.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -53.89 -26.32 24.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.652 -0.655 . . . . 0.0 109.447 179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 37' ' ' PHE . 43.1 t -77.87 -37.95 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.17 -0.956 . . . . 0.0 110.215 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.88 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -85.9 -11.02 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.182 -0.949 . . . . 0.0 110.509 -178.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.698 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.51 -15.02 29.4 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 120.95 -1.094 . . . . 0.0 108.299 178.797 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.827 ' O ' HG23 ' A' ' 47' ' ' THR . 1.4 p -110.71 12.44 22.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.602 -0.686 . . . . 0.0 109.648 -179.123 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 66.15 13.83 9.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.298 -0.876 . . . . 0.0 109.129 -179.518 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.99 15.92 60.33 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 44' ' ' SER . 31.5 p -79.65 -11.14 59.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.295 -1.121 . . . . 0.0 108.096 178.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.726 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.5 tp -80.07 -73.38 0.36 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.543 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.542 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 60.53 174.34 0.1 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.41 156.03 39.46 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.16 -0.963 . . . . 0.0 109.644 -178.826 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.657 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 28.1 p -98.8 -53.19 3.36 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.657 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 8.6 p80 -130.25 140.5 50.69 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.365 0.602 . . . . 0.0 109.732 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HA ' HD11 ' A' ' 50' ' ' LEU . 61.3 m-85 -80.06 116.18 20.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 109.274 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 137.71 174.6 13.44 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 107.862 -2.095 . . . . 0.0 107.862 -179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 145.18 49.96 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.163 -1.198 . . . . 0.0 109.033 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.72 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 3.2 m . . . . . 0 C--N 1.297 -1.71 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.01 -177.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.98 -92.15 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -0.841 . . . . 0.0 109.493 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.32 61.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.937 . . . . 0.0 109.503 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG12 HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -128.62 66.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.3 p -131.46 153.42 49.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.429 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 6' ' ' VAL . 77.0 t -108.13 15.1 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.371 -0.831 . . . . 0.0 109.875 -179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' VAL . 5.9 t70 59.86 126.68 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 13.9 m -150.56 49.64 0.88 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.137 -0.977 . . . . 0.0 109.931 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.91 14.65 13.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.001 . . . . 0.0 109.979 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -126.32 -7.27 6.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.139 -0.976 . . . . 0.0 109.82 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.851 ' O ' HG21 ' A' ' 42' ' ' VAL . 61.8 m-85 -84.88 159.97 56.47 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.784 . . . . 0.0 108.899 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -73.34 161.93 92.95 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.877 -1.718 . . . . 0.0 111.645 2.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.5 mtpt -121.47 141.98 34.56 Favored Pre-proline 0 N--CA 1.487 1.39 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.37 14.99 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.525 2.15 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.9 99.35 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.258 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 95.0 m -83.55 136.6 34.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.108 -0.995 . . . . 0.0 109.754 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.284 -0.885 . . . . 0.0 108.689 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -114.18 -23.16 9.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 -179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.1 mt-10 -45.03 120.5 2.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 108.805 179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 29.1 t80 -81.48 83.77 6.89 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.358 -0.839 . . . . 0.0 110.352 -179.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.5 mtp180 -109.71 92.33 12.1 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.2 Cg_endo -68.14 104.32 1.03 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.039 1.826 . . . . 0.0 110.539 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.8 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -100.31 125.42 46.52 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.163 -0.961 . . . . 0.0 108.739 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.112 ' O ' HD12 ' A' ' 50' ' ' LEU . 14.1 t -87.13 130.36 34.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.872 -1.131 . . . . 0.0 108.878 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.887 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -56.94 -178.22 0.46 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 178.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' THR . 40.5 t -92.39 40.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.371 -1.664 . . . . 0.0 108.765 178.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.599 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.2 p-10 -151.98 -40.99 0.11 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.599 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.6 p30 144.62 39.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 120.734 0.302 . . . . 0.0 110.307 179.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.849 ' CE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -122.12 94.96 4.47 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.7 -1.25 . . . . 0.0 109.112 179.533 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 m -71.39 151.15 44.34 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.953 0.883 . . . . 0.0 111.214 -178.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 37.3 m-85 -131.73 133.52 44.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.63 -56.34 3.63 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.54 -177.088 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 11.9 p-10 -141.75 -166.53 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.376 . . . . 0.0 110.564 -179.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.29 -29.31 70.06 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.705 -0.622 . . . . 0.0 111.65 -178.737 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 44.5 t -73.47 -34.92 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.689 -1.257 . . . . 0.0 109.978 -179.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.6 m-80 -80.08 -37.87 32.92 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.992 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.8 ' CB ' HD12 ' A' ' 23' ' ' LEU . 41.9 t80 -69.22 -34.81 75.43 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.494 1.14 . . . . 0.0 109.476 179.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.647 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.7 m -75.49 -54.29 7.26 Favored 'General case' 0 C--N 1.276 -2.608 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.365 -178.339 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 12' ' ' PRO . 32.1 m-20 -43.42 -34.74 1.37 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 179.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.28 -45.13 61.38 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 37' ' ' PHE . 53.6 t -51.99 -57.72 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.564 -0.71 . . . . 0.0 109.147 179.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.851 HG21 ' O ' ' A' ' 11' ' ' TYR . 1.7 p -64.67 -29.15 46.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.803 -0.561 . . . . 0.0 110.548 -179.346 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.94 0.63 57.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 109.249 179.627 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.893 ' O ' HG22 ' A' ' 47' ' ' THR . 3.1 t -117.81 24.81 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.753 -179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 1.5 p-10 43.87 50.96 6.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 0.0 109.394 -179.525 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 41.26 46.14 4.25 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.763 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.893 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -116.07 -10.68 11.51 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.637 -0.919 . . . . 0.0 108.525 178.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.887 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -78.91 -59.52 2.75 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.971 0.891 . . . . 0.0 108.704 179.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 58.36 175.69 0.06 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.808 179.866 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.112 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.1 tp -119.14 161.6 20.04 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.655 0.74 . . . . 0.0 109.341 -177.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.43 -20.37 9.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.778 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.6 p80 177.31 147.28 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CE2' HG22 ' A' ' 6' ' ' VAL . 42.8 m-85 -75.7 114.27 14.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 138.71 -178.87 19.05 Favored Glycine 0 C--N 1.298 -1.555 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 6.5 ttpt -76.72 142.68 40.38 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.589 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.808 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.771 -179.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -169.61 0.39 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.219 -0.926 . . . . 0.0 109.561 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.03 141.04 19.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.413 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -129.11 67.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.34 179.891 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.455 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER 167.1 123.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 109.432 179.943 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 53' ' ' PHE . 24.2 t -86.04 159.56 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.857 . . . . 0.0 109.439 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' HG12 ' A' ' 6' ' ' VAL . 13.0 t0 -83.95 136.55 34.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.229 -0.919 . . . . 0.0 109.11 179.726 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.4 m -121.55 42.54 3.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.154 -0.966 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.414 ' C ' ' OE1' ' A' ' 10' ' ' GLU . 3.2 t -89.77 12.71 16.31 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.396 -0.815 . . . . 0.0 109.667 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 3.5 mp0 -143.56 29.28 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.879 179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.765 ' HB3' HG11 ' A' ' 42' ' ' VAL . 77.0 m-85 -126.43 159.65 61.97 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -82.23 161.49 77.5 Favored 'Cis proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.711 -1.787 . . . . 0.0 110.682 2.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.611 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -124.24 145.09 47.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.447 -0.783 . . . . 0.0 109.029 -179.871 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.51 15.18 1.46 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.674 2.249 . . . . 0.0 111.155 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.07 155.07 30.52 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.271 -0.893 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -120.05 139.1 53.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.527 179.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 16' ' ' CYS . 45.4 p -59.51 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.367 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.4 mt -126.44 -30.07 2.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.083 -1.01 . . . . 0.0 110.074 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mp0 -43.56 136.6 3.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.211 -0.931 . . . . 0.0 108.683 179.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.3 t80 -97.59 89.84 4.81 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.966 -1.084 . . . . 0.0 110.567 -178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -119.05 87.83 35.23 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.53 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.1 Cg_endo -67.55 111.75 2.42 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.481 2.121 . . . . 0.0 111.293 -178.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.018 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -107.15 120.16 41.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.535 179.388 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.018 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.4 t -78.27 132.63 37.58 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.783 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.1 -169.0 3.7 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 -179.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.554 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 5.1 t -89.69 4.08 50.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.648 -1.501 . . . . 0.0 108.633 178.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -108.24 3.43 23.6 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.875 . . . . 0.0 109.5 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 12.7 t-20 88.15 26.36 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.836 -0.54 . . . . 0.0 110.798 179.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.26 162.25 13.16 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.225 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 32.1 m -123.56 128.8 50.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.379 -1.451 . . . . 0.0 110.029 -179.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 30.8 m-85 -106.49 126.75 52.65 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.788 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.99 -59.46 0.72 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -177.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.9 p30 -140.54 -163.13 1.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.028 -1.277 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.987 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -70.86 0.17 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.896 -0.503 . . . . 0.0 111.149 -178.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.636 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 19.5 p -41.21 -43.51 2.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.843 -1.161 . . . . 0.0 110.206 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -59.49 -46.24 89.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.928 -1.107 . . . . 0.0 109.873 179.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.018 ' CB ' HD12 ' A' ' 23' ' ' LEU . 24.4 t80 -62.31 -49.46 75.52 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.842 0.829 . . . . 0.0 111.568 -178.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.7 t -67.08 -28.13 67.92 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.01 -177.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' C ' HG22 ' A' ' 42' ' ' VAL . 14.8 m-20 -62.12 -18.07 59.7 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.67 ' HB3' ' CD2' ' A' ' 48' ' ' LEU . . . -88.85 -45.28 9.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.53 -30.81 37.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.839 0.828 . . . . 0.0 108.892 179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -82.75 -39.58 15.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.698 -0.626 . . . . 0.0 109.667 -179.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -91.72 20.72 5.29 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.163 -0.961 . . . . 0.0 109.795 -179.457 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 91.7 p -137.35 10.58 2.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.049 -1.032 . . . . 0.0 110.221 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.9 m-20 67.69 7.19 5.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.162 -0.962 . . . . 0.0 109.643 -179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.03 10.57 71.59 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -79.69 -4.89 53.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -1.175 . . . . 0.0 108.98 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.783 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -79.04 -54.95 5.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.3 174.62 0.05 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.62 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.018 HD12 ' O ' ' A' ' 24' ' ' CYS . 4.5 tp -118.97 162.4 18.6 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.959 -1.088 . . . . 0.0 110.111 -178.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.654 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 89.9 p -109.99 -44.68 3.74 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.799 1.285 . . . . 0.0 107.674 -179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.9 154.8 4.35 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.981 -178.839 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.527 ' CE1' ' CD2' ' A' ' 50' ' ' LEU . 10.9 m-85 -80.64 105.66 12.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.812 -1.18 . . . . 0.0 109.116 178.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 152.7 -177.15 30.57 Favored Glycine 0 C--N 1.296 -1.681 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -80.04 138.34 36.99 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.405 -1.056 . . . . 0.0 108.645 178.872 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 15.4 m . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.56 -179.603 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.424 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.41 -38.01 8.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.669 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.25 121.02 7.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -129.15 98.14 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.917 . . . . 0.0 109.634 179.876 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.21 142.02 0.99 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG13 ' N ' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -106.67 -162.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.961 . . . . 0.0 109.581 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.68 ' N ' HG13 ' A' ' 6' ' ' VAL . 34.6 t0 -128.51 144.8 51.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.046 -1.034 . . . . 0.0 109.278 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 19.1 m -151.96 57.87 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.841 -179.396 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.99 19.73 4.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.047 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -141.21 25.43 2.07 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 109.183 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.883 ' CB ' HG11 ' A' ' 42' ' ' VAL . 96.6 m-85 -112.58 162.09 23.24 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 38.7 Cg_endo -76.82 -169.85 8.11 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.864 -1.723 . . . . 0.0 111.765 1.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -143.46 140.75 17.91 Favored Pre-proline 0 N--CA 1.492 1.645 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.67 14.96 1.72 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.591 2.194 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -177.21 147.93 0.58 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.385 -0.822 . . . . 0.0 108.932 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 28.5 m -154.68 118.11 4.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.849 -1.157 . . . . 0.0 111.662 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.3 p -83.27 -111.49 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 175.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.666 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER 59.15 93.2 0.04 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 118.727 -1.189 . . . . 0.0 108.296 177.916 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.666 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -39.6 -173.12 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.076 0.941 . . . . 0.0 110.972 -179.063 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' ' HE3' ' A' ' 55' ' ' LYS . 5.1 t80 -77.17 98.54 5.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.008 -1.683 . . . . 0.0 111.509 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.4 mtm180 -139.7 80.74 20.92 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CG ' ' HG2' ' A' ' 55' ' ' LYS . 28.3 Cg_endo -67.8 143.2 60.39 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.557 2.838 . . . . 0.0 114.261 -176.309 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -121.81 123.1 40.99 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -80.24 138.29 36.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.346 -0.846 . . . . 0.0 109.453 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.816 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -72.55 -177.58 31.39 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 178.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 23.4 t -89.57 12.41 16.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.409 -1.642 . . . . 0.0 108.27 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.8 p-10 -122.77 5.76 9.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.453 -0.779 . . . . 0.0 109.492 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 63.1 t30 86.65 35.38 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.811 -0.556 . . . . 0.0 110.512 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -110.63 107.21 16.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 108.922 179.082 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 55' ' ' LYS . 17.1 m -76.07 132.03 39.84 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.007 . . . . 0.0 110.753 -178.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 32.4 m-85 -115.13 142.57 46.47 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -38.75 -48.18 2.41 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -178.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.1 p30 -170.32 -146.16 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.273 . . . . 0.0 110.937 178.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.23 -41.29 81.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.573 -0.704 . . . . 0.0 112.273 -177.153 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 11.5 t -70.26 -43.94 69.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.275 -1.516 . . . . 0.0 110.16 -179.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.569 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 12.1 m-80 -71.19 -29.65 65.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.0 109.436 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 52.0 t80 -79.06 -29.46 43.44 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.758 1.266 . . . . 0.0 110.057 179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.2 m -74.88 -56.31 4.9 Favored 'General case' 0 C--N 1.269 -2.925 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.267 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -39.69 -31.66 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.041 -1.037 . . . . 0.0 108.817 -179.681 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.27 -49.76 18.25 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 38' ' ' CYS . 71.1 t -51.73 -55.82 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.671 0.748 . . . . 0.0 109.639 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -64.09 -30.08 49.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.77 -0.581 . . . . 0.0 110.779 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -91.8 7.06 43.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.719 -1.238 . . . . 0.0 109.392 179.836 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.766 ' O ' HG22 ' A' ' 47' ' ' THR . 43.5 p -126.51 1.97 6.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.005 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.9 t-20 73.22 7.61 5.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.046 . . . . 0.0 109.239 -179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.53 12.57 60.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 44' ' ' SER . 6.8 t -79.76 -6.36 57.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -1.23 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.816 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.2 tp -81.57 -64.19 1.24 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 26' ' ' SER . 16.6 p 58.1 168.59 0.05 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' CB ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.4 156.39 30.21 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.938 -1.101 . . . . 0.0 110.132 -178.095 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.629 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 11.1 p -91.03 -56.09 3.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.024 0.916 . . . . 0.0 108.643 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.8 p80 -139.68 158.7 43.67 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -81.02 113.3 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.833 -1.167 . . . . 0.0 108.828 178.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 141.95 -175.86 22.38 Favored Glycine 0 N--CA 1.477 1.404 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.548 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -82.19 110.07 17.05 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.744 -0.857 . . . . 0.0 109.766 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.595 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.488 179.44 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.8 tp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 70.72 -163.44 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.341 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -109.11 120.85 43.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.579 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 4' ' ' VAL . 14.6 p -106.16 99.46 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.296 -0.878 . . . . 0.0 109.213 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.2 OUTLIER 170.37 135.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.304 -179.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.677 HG21 HD13 ' A' ' 23' ' ' LEU . 2.3 t -88.88 152.69 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.969 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -79.12 145.86 33.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.542 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 m -132.58 31.57 3.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.159 -0.963 . . . . 0.0 109.429 179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 t -88.35 12.03 15.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.967 . . . . 0.0 109.558 -179.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 35.6 mp0 -137.76 29.16 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 0.0 108.876 179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.694 ' CB ' HG11 ' A' ' 42' ' ' VAL . 66.0 m-85 -125.94 161.18 52.88 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.763 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.06 156.52 74.83 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.922 -1.699 . . . . 0.0 110.466 2.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 4.8 mttm -112.75 140.85 24.46 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.015 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -80.31 14.53 1.94 Allowed 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.743 2.295 . . . . 0.0 110.572 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.52 114.29 1.85 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.422 -0.799 . . . . 0.0 109.134 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' O ' ' O ' ' A' ' 17' ' ' THR . 84.0 m -82.49 144.16 30.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.868 . . . . 0.0 109.863 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 16' ' ' CYS . 44.1 p -58.44 -156.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.245 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 19' ' ' GLU . 39.9 mt -122.29 -29.86 4.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.185 -0.947 . . . . 0.0 109.764 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -46.73 145.6 1.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.006 . . . . 0.0 108.828 179.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -102.64 88.54 3.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -116.61 89.22 27.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.869 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.16 109.33 1.95 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.34 2.027 . . . . 0.0 111.459 -178.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD12 ' CB ' ' A' ' 37' ' ' PHE . 3.1 mt -111.48 120.19 41.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.4 t -79.76 165.0 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.31 -1.356 . . . . 0.0 108.525 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -123.36 169.71 15.62 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.54 -1.314 . . . . 0.0 111.443 -178.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.7 t -72.1 8.25 1.35 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.361 -1.082 . . . . 0.0 111.517 -177.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.7 p30 -106.46 -1.61 22.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.569 -1.332 . . . . 0.0 109.71 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.3 t-20 85.38 42.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.679 -0.638 . . . . 0.0 111.005 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HD2' ' OH ' ' A' ' 31' ' ' TYR . 7.4 ptpt -139.96 142.71 36.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.851 -1.155 . . . . 0.0 109.201 178.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.677 HG21 ' HD2' ' A' ' 55' ' ' LYS . 17.1 m -93.68 138.0 32.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.374 -178.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.802 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.0 m-85 -105.36 121.35 43.7 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.55 -62.98 0.49 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -178.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.0 p30 -138.94 -168.04 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.141 -1.211 . . . . 0.0 110.601 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.63 -49.32 65.38 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.95 -178.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.559 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 11.0 t -57.03 -57.81 10.94 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.744 -1.223 . . . . 0.0 109.538 -179.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.1 m-80 -51.83 -29.48 19.59 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.06 -1.025 . . . . 0.0 109.704 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.721 ' CB ' HD12 ' A' ' 23' ' ' LEU . 8.4 t80 -71.64 -64.75 0.87 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.861 -1.15 . . . . 0.0 110.717 -179.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.1 t -54.36 -56.15 21.47 Favored 'General case' 0 C--N 1.286 -2.186 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.87 -178.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.519 ' C ' ' O ' ' A' ' 38' ' ' CYS . 2.9 m-20 -36.38 -32.37 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.71 -55.39 6.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.944 HG22 HD23 ' A' ' 48' ' ' LEU . 48.4 t -51.55 -53.1 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.468 -0.77 . . . . 0.0 109.587 179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 12' ' ' PRO . 34.7 m -59.82 -36.44 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.56 -0.712 . . . . 0.0 110.624 -179.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -91.91 7.17 43.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.032 -1.043 . . . . 0.0 110.673 -178.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.774 ' O ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -118.42 16.56 13.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.909 -1.119 . . . . 0.0 109.816 -179.88 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t30 73.08 3.55 4.7 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.051 -1.031 . . . . 0.0 109.167 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.4 9.74 73.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 44' ' ' SER . 2.3 t -79.3 -2.39 41.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.031 -1.276 . . . . 0.0 108.701 178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.944 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -80.04 -83.73 0.1 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.782 0.801 . . . . 0.0 109.344 -179.844 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.1 p 89.96 139.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -177.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 4.5 tp -52.98 163.2 0.53 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.587 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 52.4 p -111.09 -49.81 2.99 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -170.49 149.57 3.31 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.334 179.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.447 ' CE1' HG23 ' A' ' 4' ' ' VAL . 80.7 m-85 -73.78 111.58 9.06 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.884 -1.135 . . . . 0.0 109.529 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 137.5 -178.35 19.13 Favored Glycine 0 C--N 1.3 -1.47 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 -179.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.677 ' HD2' HG21 ' A' ' 30' ' ' THR . 0.5 OUTLIER -85.78 151.9 23.46 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.263 -1.139 . . . . 0.0 107.994 178.929 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.547 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 45.58 1.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.57 50.83 16.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.593 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.5 t -111.0 74.14 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.533 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.9 173.07 17.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.413 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.746 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -148.95 -178.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.537 179.949 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.746 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.8 t70 -114.53 141.99 47.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.166 179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 10.3 m -148.0 52.92 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.058 -1.027 . . . . 0.0 110.282 -179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.9 t -90.78 26.28 2.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 8.3 mp0 -142.09 25.13 1.94 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.999 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.921 ' CB ' HG11 ' A' ' 42' ' ' VAL . 74.2 m-85 -112.01 161.24 26.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 -179.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.43 -169.38 7.11 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.734 -1.777 . . . . 0.0 112.235 1.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.49 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -131.02 145.87 59.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.525 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.58 14.81 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.733 2.288 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.17 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.3 m -137.26 118.85 14.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.809 -1.182 . . . . 0.0 111.522 -179.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' LEU . 11.8 p -85.65 -118.97 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.13 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.726 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER 56.74 94.65 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.795 -1.191 . . . . 0.0 107.887 179.167 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -43.4 -162.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.921 -179.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.453 ' C ' ' HD3' ' A' ' 22' ' ' PRO . 3.6 t80 -78.52 84.42 4.66 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 119.39 -2.069 . . . . 0.0 111.524 -178.449 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 20.2 mtp180 -117.01 75.64 7.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 177.277 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 33' ' ' ASN . 23.2 Cg_endo -64.52 125.55 15.19 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 123.983 3.122 . . . . 0.0 115.544 -175.637 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.694 HD13 ' C ' ' A' ' 33' ' ' ASN . 6.6 mp -102.66 160.72 14.33 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 175.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.634 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -135.42 133.14 38.31 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 119.805 -1.809 . . . . 0.0 110.914 179.832 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.603 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -81.56 166.9 47.98 Favored Glycine 0 N--CA 1.495 2.62 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.308 -178.551 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OG ' ' A' ' 51' ' ' SER . 16.5 t -64.47 -24.4 67.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 122.027 -0.69 . . . . 0.0 110.488 -178.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' OD2' ' CD ' ' A' ' 29' ' ' LYS . 3.5 p30 -84.1 8.51 15.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.921 -1.112 . . . . 0.0 109.382 -179.917 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 17.4 t-20 75.22 31.21 0.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.563 -0.711 . . . . 0.0 109.857 179.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.772 ' HE2' ' HB1' ' A' ' 40' ' ' ALA . 8.7 ptmt -101.51 97.52 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.056 -1.027 . . . . 0.0 108.642 178.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 29.0 m -70.73 120.55 16.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.087 -1.008 . . . . 0.0 110.28 -179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.858 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -98.21 132.08 44.02 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.119 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -25.19 -52.89 0.05 OUTLIER Glycine 0 N--CA 1.502 3.034 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.063 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 23' ' ' LEU . 52.0 p-10 -167.43 -138.42 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.407 -1.055 . . . . 0.0 109.456 179.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -68.53 -63.14 1.12 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.278 -0.889 . . . . 0.0 110.426 -178.498 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.569 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 19.4 t -50.22 -43.14 52.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.513 -1.367 . . . . 0.0 110.542 -178.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.548 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 6.7 m-80 -68.71 -32.94 73.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.941 -1.099 . . . . 0.0 108.786 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.858 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.3 t80 -68.06 -67.89 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.239 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -40.95 -34.2 0.38 Allowed 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 87.5 m-20 -60.17 -57.71 11.66 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 177.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.772 ' HB1' ' HE2' ' A' ' 29' ' ' LYS . . . -47.75 -23.16 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.39 0.614 . . . . 0.0 109.438 178.579 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.625 HG22 HD23 ' A' ' 48' ' ' LEU . 29.7 t -86.31 -39.24 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.289 -179.298 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.921 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -86.62 -5.62 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.118 -0.989 . . . . 0.0 110.073 -178.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.656 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.97 -19.2 22.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.121 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.979 ' O ' HG22 ' A' ' 47' ' ' THR . 44.5 t -111.04 43.01 1.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.689 -0.632 . . . . 0.0 109.851 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 44' ' ' SER . 2.3 p-10 44.44 46.81 8.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.876 . . . . 0.0 109.736 -179.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.82 44.58 4.51 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.258 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 44' ' ' SER . 12.7 t -112.02 -16.95 12.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.395 -1.062 . . . . 0.0 108.386 178.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.786 HD21 ' HE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -77.78 147.27 35.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.416 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p -122.54 145.07 48.66 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.013 178.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 14.0 tp -65.76 169.74 6.09 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -129.03 -34.31 1.92 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.823 -1.173 . . . . 0.0 108.926 179.595 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.634 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.86 143.49 0.23 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.958 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -77.34 106.9 9.38 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.0 110.167 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 153.34 -177.37 30.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.99 129.1 37.03 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.411 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.61 -179.369 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.46 66.4 1.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.15 -172.32 3.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.323 179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.57 95.65 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 109.621 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 175.24 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.224 179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.13 135.9 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 -179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -91.53 136.21 33.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.106 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.9 m -140.98 50.64 1.63 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.125 -0.985 . . . . 0.0 109.923 -179.593 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.43 14.49 12.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 179.705 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 5.5 pm0 -114.33 -12.88 12.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.383 -0.823 . . . . 0.0 109.091 179.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.828 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.4 m-85 -79.8 160.61 68.8 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.589 -0.695 . . . . 0.0 109.302 -179.441 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -74.95 -177.45 20.54 Favored 'Cis proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.876 -1.718 . . . . 0.0 111.887 2.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -144.18 136.32 13.19 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.32 14.78 1.88 Allowed 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.522 2.148 . . . . 0.0 110.982 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.31 135.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -142.72 116.78 9.43 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.827 -1.171 . . . . 0.0 111.322 -179.449 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 3.1 p -71.41 -112.14 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD22 ' CG ' ' A' ' 34' ' ' LYS . 5.7 mt 58.74 90.72 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.574 177.71 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.649 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -42.46 -174.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.684 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -76.31 88.49 3.13 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 119.726 -1.859 . . . . 0.0 110.82 -178.827 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -127.1 84.61 63.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.04 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.7 Cg_endo -66.25 136.41 43.73 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.765 2.976 . . . . 0.0 114.432 -176.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.879 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.1 mt -118.76 113.48 21.21 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.214 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.843 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -80.43 135.42 36.15 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.027 -1.069 . . . . 0.0 108.599 -179.488 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -70.2 -163.74 4.51 Favored Glycine 0 C--N 1.298 -1.531 0 C-N-CA 118.893 -1.622 . . . . 0.0 109.09 -178.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.582 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -90.56 -13.99 33.43 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.674 -0.898 . . . . 0.0 108.685 178.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.1 p-10 -90.74 1.94 56.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 109.572 179.848 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.8 t30 85.39 29.02 0.05 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.641 -0.662 . . . . 0.0 110.761 179.513 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 9.6 ttmt -98.87 151.3 20.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -114.39 117.49 31.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.357 -1.464 . . . . 0.0 110.701 -178.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.633 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -99.59 140.67 33.44 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.24 -42.2 0.81 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -178.145 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.879 ' C ' HD12 ' A' ' 23' ' ' LEU . 55.7 p30 -173.47 -144.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.101 -1.235 . . . . 0.0 110.766 178.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.749 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.5 -36.49 68.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.15 -177.273 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.6 t -69.1 -54.72 13.5 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.698 -1.251 . . . . 0.0 108.737 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -60.19 -40.75 91.14 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 63.4 t80 -66.82 -32.49 73.8 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.058 1.408 . . . . 0.0 108.076 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.3 m -74.14 -22.94 59.24 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.264 -178.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 11.9 m-20 -69.78 -29.94 67.38 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.035 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.633 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.14 -28.98 38.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.744 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 48' ' ' LEU . 70.0 t -73.73 -34.27 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.742 -0.598 . . . . 0.0 109.91 179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.828 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.8 p -90.79 -21.68 6.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -178.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.88 0.51 57.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.992 -1.067 . . . . 0.0 108.55 178.973 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.936 ' O ' HG22 ' A' ' 47' ' ' THR . 86.9 p -122.51 37.48 4.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.395 -0.816 . . . . 0.0 109.128 -179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 45.87 46.99 12.3 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.436 -179.348 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.47 45.97 2.66 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.936 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -110.05 -10.85 14.68 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.63 -0.923 . . . . 0.0 109.112 179.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -86.02 124.24 32.24 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.325 -0.86 . . . . 0.0 110.033 -179.543 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 1.6 p -111.06 153.08 26.15 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 176.948 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -98.47 -175.08 2.99 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.386 -1.326 . . . . 0.0 111.063 -177.59 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -120.37 -33.21 3.93 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.225 -0.922 . . . . 0.0 109.371 -179.242 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.602 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.2 p80 -168.51 138.42 2.43 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.116 -0.99 . . . . 0.0 110.62 -178.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -69.9 110.41 5.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.407 -0.808 . . . . 0.0 109.408 179.392 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.65 -175.84 24.12 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -179.715 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.42 23.99 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.003 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 43.8 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.793 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 1' ' ' LEU . 45.9 mt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.4 35.11 10.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.282 179.908 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.02 167.51 24.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.337 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -152.54 66.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.191 -0.943 . . . . 0.0 109.488 -179.914 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 4' ' ' VAL . 32.2 t -45.08 141.8 2.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 109.216 179.885 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 7' ' ' ASP . 25.5 t -85.35 162.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.364 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.477 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.9 t0 -86.05 108.98 18.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.297 -0.877 . . . . 0.0 109.394 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 33.6 m -109.82 39.43 2.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.191 -0.943 . . . . 0.0 108.533 179.336 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.41 14.45 2.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.499 -0.751 . . . . 0.0 110.56 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -142.41 39.96 1.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.935 . . . . 0.0 108.547 179.415 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.936 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.4 m-85 -120.14 164.98 19.46 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.049 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.9 Cg_endo -85.72 167.16 51.62 Favored 'Cis proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.155 -1.602 . . . . 0.0 110.621 1.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.8 mtpp -116.28 138.37 24.22 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 0.0 109.682 -179.313 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.36 13.11 2.13 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.691 2.261 . . . . 0.0 110.708 179.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.73 105.14 1.39 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.8 m -86.93 134.14 33.54 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.336 -0.853 . . . . 0.0 109.612 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -54.34 -172.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -114.23 -14.24 12.3 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.031 -1.043 . . . . 0.0 109.62 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 18' ' ' LEU . 9.1 mp0 -45.05 159.11 0.05 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 108.559 179.594 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -107.3 97.92 7.61 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.909 -1.12 . . . . 0.0 110.64 -179.156 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -123.93 79.37 57.69 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.706 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 30.3 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.205 1.936 . . . . 0.0 110.891 -178.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.978 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -96.82 116.93 30.0 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.769 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.4 t -77.21 109.24 10.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.342 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -51.45 -177.43 0.03 OUTLIER Glycine 0 C--N 1.297 -1.638 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 49' ' ' THR . 2.2 p -79.48 -10.96 59.9 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.903 -1.351 . . . . 0.0 109.067 179.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.5 p-10 -100.3 6.6 44.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.615 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.0 t-20 82.59 34.25 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.659 -0.65 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 5.8 tttp -106.7 102.38 11.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.965 -1.084 . . . . 0.0 108.721 178.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.7 m -67.78 126.89 30.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.612 -178.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 71.3 m-85 -109.16 115.43 30.01 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -28.69 -60.75 0.14 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -177.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -135.43 -167.37 2.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.924 -1.339 . . . . 0.0 110.609 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.799 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.52 -30.97 71.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.367 -178.834 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 42.3 t -70.94 -29.41 65.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.673 -1.267 . . . . 0.0 109.427 -179.299 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.7 m-80 -79.25 -38.0 36.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.325 -0.86 . . . . 0.0 108.784 179.515 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.978 ' CB ' HD12 ' A' ' 23' ' ' LEU . 26.5 t80 -70.55 -40.43 73.41 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.648 1.213 . . . . 0.0 109.919 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 10.3 m -72.62 -37.81 67.94 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.765 -178.477 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 47.9 m-20 -60.55 -16.04 33.66 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -89.22 -42.46 11.62 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.665 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 62.1 t -58.11 -30.57 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.614 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.936 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.4 m -87.66 -31.2 5.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.272 0.558 . . . . 0.0 109.655 -179.783 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -91.72 17.77 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 179.79 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.68 ' O ' HG22 ' A' ' 47' ' ' THR . 17.1 p -137.2 21.02 2.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 109.705 -179.668 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 71.06 10.15 6.83 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 108.934 -179.591 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 72.5 6.97 67.41 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' O ' ' A' ' 44' ' ' SER . 11.3 t -79.73 2.41 22.9 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.203 -1.175 . . . . 0.0 108.958 179.209 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.1 tp -86.27 128.24 34.89 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.339 -0.851 . . . . 0.0 109.424 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 26' ' ' SER . 11.3 p -114.86 145.28 42.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.629 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 11.1 tp -76.87 168.0 20.86 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.039 -1.038 . . . . 0.0 109.351 -179.033 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.627 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -122.49 -33.62 3.4 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 108.523 -179.545 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p80 177.12 140.44 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 4' ' ' VAL . 29.4 m-85 -66.74 163.79 18.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 108.645 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 94.6 168.95 37.01 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 108.246 -1.941 . . . . 0.0 108.246 -178.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -76.58 126.63 31.33 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.418 -1.048 . . . . 0.0 109.032 179.354 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.633 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.632 -179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.315 0.579 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.47 -173.66 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 179.93 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.18 149.34 16.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.557 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 4' ' ' VAL . 32.1 m -121.9 110.58 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.49 -169.72 0.46 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.529 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.44 153.48 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.28 -0.887 . . . . 0.0 109.394 179.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.84 151.55 26.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 109.124 179.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.3 m -144.54 39.39 1.27 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 6.7 t -89.9 13.57 14.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.117 -0.99 . . . . 0.0 109.719 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 4.5 mp0 -146.5 32.92 0.96 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.067 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 37.6 m-85 -121.86 164.81 22.96 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.346 -0.846 . . . . 0.0 109.151 -179.4 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.978 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -86.27 169.19 44.92 Favored 'Cis proline' 0 C--N 1.306 -1.692 0 C-N-CA 123.212 -1.578 . . . . 0.0 110.682 1.467 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 10' ' ' GLU . 34.3 mttm -126.99 133.05 24.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 109.027 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.49 15.09 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.51 2.14 . . . . 0.0 111.267 -179.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' O ' ' SG ' ' A' ' 16' ' ' CYS . . . -170.99 134.79 0.97 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.822 . . . . 0.0 108.95 179.659 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 15' ' ' ALA . 9.3 m -159.4 121.6 3.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 111.472 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -70.3 -100.0 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.261 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD13 ' HG3' ' A' ' 34' ' ' LYS . 67.4 mt 61.81 96.7 0.03 OUTLIER 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 122.031 0.92 . . . . 0.0 109.222 177.565 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.612 ' O ' ' O ' ' A' ' 18' ' ' LEU . 2.0 mp0 -42.16 -179.63 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.789 -179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -77.76 84.15 4.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.347 -1.47 . . . . 0.0 111.477 -178.536 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mmm180 -121.59 75.72 35.23 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 177.373 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.1 Cg_endo -64.65 138.53 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 123.75 2.966 . . . . 0.0 114.945 -175.45 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.832 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -116.91 125.61 51.74 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.824 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -79.57 142.69 35.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 109.664 -179.152 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.779 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -73.81 179.09 41.85 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 178.374 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -92.84 1.02 57.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.664 -1.492 . . . . 0.0 109.307 178.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -110.0 -34.01 6.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.282 -179.966 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.9 m-20 142.76 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 122.373 -0.204 . . . . 0.0 111.536 179.024 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 1.5 mttt -99.35 118.03 35.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.179 -1.575 . . . . 0.0 110.145 -179.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.4 m -84.16 151.61 24.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 39.5 m-85 -127.08 154.19 45.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.551 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -56.37 -31.31 59.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.27 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.832 ' C ' HD12 ' A' ' 23' ' ' LEU . 48.7 p30 -178.72 -150.57 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.97 -1.312 . . . . 0.0 110.771 179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.82 ' HG3' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -71.22 -36.39 71.84 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.475 -0.766 . . . . 0.0 111.455 -177.578 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.698 ' HB2' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -72.26 -50.12 29.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.68 -1.263 . . . . 0.0 109.113 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -63.17 -38.33 90.75 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.39 -0.819 . . . . 0.0 109.257 179.338 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 42.7 t80 -71.08 -35.69 71.95 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.918 0.866 . . . . 0.0 111.028 -178.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 41.9 t -79.45 -24.79 42.19 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 118.284 -1.366 . . . . 0.0 109.165 -179.105 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' C ' HG22 ' A' ' 42' ' ' VAL . 8.7 m-20 -64.01 -18.72 64.58 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.184 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -90.75 -42.31 10.76 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.1 t -59.9 -24.44 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.898 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.978 HG21 ' HB3' ' A' ' 12' ' ' PRO . 29.7 m -89.44 -36.25 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.4 19.03 6.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 0.0 109.466 179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 47' ' ' THR . 6.4 t -138.89 11.83 2.66 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.0 -1.063 . . . . 0.0 110.352 -179.552 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.8 m-80 66.33 9.09 6.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.638 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 85.1 14.91 68.18 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 44' ' ' SER . 7.8 p -87.37 0.82 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -1.23 . . . . 0.0 109.384 179.686 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.779 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.7 tp -79.5 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.335 -0.853 . . . . 0.0 108.78 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 57.89 168.55 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.763 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.824 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -120.39 159.87 24.21 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.024 -1.047 . . . . 0.0 109.353 -178.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.64 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 9.8 p -100.11 -56.73 2.29 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.651 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 7.3 p80 -140.37 151.51 45.03 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.798 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -71.85 113.88 9.35 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.744 -1.222 . . . . 0.0 108.934 178.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 144.92 -175.91 24.28 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.452 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -87.55 100.71 12.98 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.669 -0.901 . . . . 0.0 109.248 179.244 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.587 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.843 179.841 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.33 -169.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.36 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.598 -179.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 4' ' ' VAL . 18.4 m -125.05 79.76 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.17 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.543 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 8.3 p -137.73 178.35 7.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.738 -179.687 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 7' ' ' ASP . 85.0 t -82.61 166.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.411 -0.806 . . . . 0.0 109.598 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 6' ' ' VAL . 59.5 t0 -105.82 125.5 51.06 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.217 179.976 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -116.76 40.03 3.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.237 -0.914 . . . . 0.0 109.445 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -83.1 8.72 12.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.916 . . . . 0.0 109.717 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.06 16.51 5.11 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.117 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 42' ' ' VAL . 21.2 m-85 -104.93 169.82 6.7 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.629 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.0 Cg_endo -87.39 158.39 47.49 Favored 'Cis proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.837 -1.318 . . . . 0.0 110.926 0.674 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 16.3 mttt -108.95 140.98 22.41 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.543 -0.723 . . . . 0.0 109.726 -179.373 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -79.81 14.33 1.9 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.524 2.15 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.48 109.86 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.524 -0.735 . . . . 0.0 109.2 179.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 17' ' ' THR . 75.9 m -90.95 137.49 32.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.191 -0.943 . . . . 0.0 109.788 -179.688 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 16' ' ' CYS . 34.0 p -58.25 -156.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.088 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 19' ' ' GLU . 28.8 mt -131.25 -22.81 2.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -179.658 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -42.97 159.6 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.995 -1.066 . . . . 0.0 108.613 179.786 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -106.73 107.02 17.82 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.791 -1.193 . . . . 0.0 110.808 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.6 mtp180 -133.39 80.16 58.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.2 Cg_endo -66.88 106.74 1.18 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.374 2.05 . . . . 0.0 111.405 -177.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.874 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.6 mt -100.49 124.26 45.8 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.86 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.677 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -79.75 131.05 35.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 108.552 179.743 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.803 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.59 179.77 9.5 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.139 -2.384 . . . . 0.0 107.139 177.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.526 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 25.8 t -90.19 12.54 17.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.157 -1.79 . . . . 0.0 108.628 178.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.668 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.4 p-10 -114.76 -32.51 5.79 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.457 -0.777 . . . . 0.0 109.08 179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.668 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 45.3 t-20 129.68 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.563 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 tptt -119.9 106.48 12.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.118 -0.989 . . . . 0.0 109.626 179.755 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 5.0 m -76.17 133.1 40.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.121 -0.987 . . . . 0.0 109.999 -179.846 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.678 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 31.4 m-85 -110.63 132.76 53.91 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.743 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.32 -56.36 2.36 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.33 -177.613 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.3 p-10 -143.47 -164.39 1.86 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.703 -1.469 . . . . 0.0 111.224 -179.399 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.794 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.01 -33.57 74.86 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.515 -178.478 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.627 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.9 t -72.88 -33.89 66.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.63 -1.294 . . . . 0.0 110.07 -179.146 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -77.84 -35.99 50.51 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.151 -0.968 . . . . 0.0 109.034 179.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.874 ' CB ' HD12 ' A' ' 23' ' ' LEU . 40.6 t80 -72.88 -34.99 67.06 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.441 1.115 . . . . 0.0 109.737 -179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.959 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -78.41 -34.92 47.68 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.906 -178.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.909 ' O ' HG22 ' A' ' 42' ' ' VAL . 55.7 m-20 -64.0 -39.13 93.43 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -70.44 -26.2 63.55 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.355 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 37' ' ' PHE . 25.9 t -73.51 -29.55 27.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.959 HG13 ' O ' ' A' ' 38' ' ' CYS . 2.6 m -84.07 -23.51 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.72 -0.612 . . . . 0.0 110.383 -179.336 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.75 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.71 -8.84 45.82 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.53 -179.634 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 47' ' ' THR . 35.7 t -111.21 13.62 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.439 -0.788 . . . . 0.0 110.397 -178.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 44' ' ' SER . 2.7 m120 65.88 10.11 6.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 0.0 109.451 -179.744 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.81 17.48 61.54 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 44' ' ' SER . 23.4 p -87.28 -3.24 59.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -1.106 . . . . 0.0 108.828 178.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.803 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.65 -71.64 0.44 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 63.04 176.19 0.15 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.733 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.803 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -121.08 166.35 14.02 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.126 -0.984 . . . . 0.0 109.543 -178.554 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -110.46 -21.29 12.24 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -179.523 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.803 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.9 p80 -178.88 138.11 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.729 -0.607 . . . . 0.0 109.396 179.488 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' N ' HD11 ' A' ' 50' ' ' LEU . 46.4 m-85 -64.4 115.03 4.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.279 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 147.02 -177.29 25.41 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -87.97 100.68 13.09 Favored 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.763 -0.845 . . . . 0.0 108.937 179.189 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.647 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.657 -179.612 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.691 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.3 0.571 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 76.27 -158.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.527 179.93 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.27 97.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 4' ' ' VAL . 17.2 m -104.85 68.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.542 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.4 t -165.39 153.08 10.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 7' ' ' ASP . 67.9 t -81.09 166.4 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.469 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' N ' HG12 ' A' ' 6' ' ' VAL . 2.4 t70 -85.55 120.81 27.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.069 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -114.36 33.74 5.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -90.32 10.0 26.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 110.138 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 13.6 pm0 -133.21 0.87 3.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.943 . . . . 0.0 109.928 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.731 ' CB ' HG11 ' A' ' 42' ' ' VAL . 81.9 m-85 -94.42 162.51 25.81 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.909 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.73 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -81.22 143.0 58.36 Favored 'Cis proline' 0 C--N 1.306 -1.706 0 C-N-CA 123.147 -1.605 . . . . 0.0 110.981 3.226 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.37 144.06 27.85 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.556 -0.715 . . . . 0.0 109.867 -179.257 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.96 14.43 1.9 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.711 2.274 . . . . 0.0 110.436 179.558 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.44 147.26 17.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.766 . . . . 0.0 109.041 179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 17' ' ' THR . 96.3 m -116.9 133.65 55.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 -179.699 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 16' ' ' CYS . 4.0 p -53.81 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 108.983 179.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -114.14 -25.25 8.58 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.072 -1.018 . . . . 0.0 109.712 179.851 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -44.11 137.42 3.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.496 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.509 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.2 t80 -94.7 80.78 3.79 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.922 -1.111 . . . . 0.0 110.453 -178.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.6 mtt180 -111.42 82.67 3.69 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.611 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 Cg_endo -65.74 119.54 6.59 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.591 2.194 . . . . 0.0 111.936 -178.412 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.668 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.3 mt -111.14 120.97 44.1 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.224 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.017 ' O ' HD12 ' A' ' 50' ' ' LEU . 36.4 t -79.49 150.25 31.26 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.048 -1.461 . . . . 0.0 107.843 179.759 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.494 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -88.14 176.17 45.22 Favored Glycine 0 N--CA 1.484 1.877 0 C-N-CA 119.369 -1.396 . . . . 0.0 110.148 -178.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -81.74 7.76 11.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -1.212 . . . . 0.0 109.479 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -110.44 -34.63 6.27 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.316 -0.865 . . . . 0.0 109.035 179.652 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.9 p-10 127.96 45.69 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.477 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -126.08 120.36 29.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.13 -0.981 . . . . 0.0 109.844 -179.446 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.2 m -84.54 128.02 34.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.045 -1.034 . . . . 0.0 109.941 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.595 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 44.2 m-85 -108.93 127.53 54.14 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.36 -58.31 1.08 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.576 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.6 p-10 -146.59 -165.22 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.839 -1.389 . . . . 0.0 110.727 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 23' ' ' LEU . 20.5 pttt -60.54 -36.53 78.64 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.957 -0.464 . . . . 0.0 111.682 -178.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.2 t -70.79 -33.21 70.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.665 -1.272 . . . . 0.0 110.071 -178.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.595 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.0 m-80 -80.59 -30.25 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.022 -1.049 . . . . 0.0 109.311 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.668 ' CB ' HD12 ' A' ' 23' ' ' LEU . 49.0 t80 -76.05 -37.81 57.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.454 1.121 . . . . 0.0 109.899 -179.785 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.584 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.0 t -79.01 -52.85 7.68 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.198 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' C ' ' O ' ' A' ' 38' ' ' CYS . 71.5 m-20 -40.09 -28.98 0.06 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.33 -50.86 11.9 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.693 HG13 ' HA2' ' A' ' 46' ' ' GLY . 54.7 t -51.53 -51.29 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 108.936 179.219 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.731 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.9 m -61.7 -40.55 87.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.697 -0.627 . . . . 0.0 109.747 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.47 ' N ' HG23 ' A' ' 42' ' ' VAL . 10.3 tt0 -92.09 17.16 9.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.2 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 47' ' ' THR . 84.9 p -132.06 1.76 3.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.808 -179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.1 t-20 71.43 9.18 6.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.113 -0.992 . . . . 0.0 109.193 -179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.693 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.48 14.15 71.62 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 44' ' ' SER . 9.6 t -81.46 4.46 20.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.114 -1.227 . . . . 0.0 109.044 179.229 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.661 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -88.74 -57.95 2.72 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.897 0.856 . . . . 0.0 108.744 179.923 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.544 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 57.96 157.3 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.718 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.017 HD12 ' O ' ' A' ' 24' ' ' CYS . 3.3 tp -101.0 158.62 15.87 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.839 -1.163 . . . . 0.0 109.637 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.666 ' OG ' ' CD2' ' A' ' 52' ' ' HIS . 82.1 p -105.43 -45.76 4.37 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 122.838 1.304 . . . . 0.0 107.948 -179.366 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.869 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -164.13 156.94 17.57 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.513 -179.35 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -81.76 107.61 14.63 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.18 179.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.08 -177.11 23.73 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 1.7 ttpp -78.36 148.44 33.72 Favored 'General case' 0 C--N 1.286 -2.16 0 O-C-N 121.405 -1.056 . . . . 0.0 108.365 179.107 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 13.9 m . . . . . 0 C--N 1.299 -1.622 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 3' ' ' ALA . 1.5 tt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.94 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 1' ' ' LEU . . . -156.74 178.1 10.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.502 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.507 ' O ' ' CB ' ' A' ' 5' ' ' SER . 2.0 t -101.61 72.75 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.412 179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 164.31 143.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.837 . . . . 0.0 109.363 -179.952 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.754 HG21 HD13 ' A' ' 23' ' ' LEU . 4.0 t -94.43 153.59 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -94.81 113.72 25.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 0.0 109.005 179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.3 m -122.21 44.2 2.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.267 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.9 11.99 4.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.821 -179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 10' ' ' GLU . 16.3 mp0 -133.92 22.16 3.85 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.297 -0.877 . . . . 0.0 108.929 179.698 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.83 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.8 m-85 -105.99 164.78 14.26 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HB3' HG21 ' A' ' 42' ' ' VAL . 30.9 Cg_endo -86.86 163.3 50.51 Favored 'Cis proline' 0 C--N 1.306 -1.689 0 C-N-CA 123.45 -1.479 . . . . 0.0 111.213 1.213 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.62 144.54 32.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.763 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.94 14.43 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.595 2.196 . . . . 0.0 110.927 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.67 108.21 1.03 Allowed 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 70.2 m -80.04 132.32 35.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.236 -0.915 . . . . 0.0 109.901 -179.415 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' CYS . 8.9 p -51.95 -178.73 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.379 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -109.44 -17.0 13.88 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.948 -1.095 . . . . 0.0 109.8 -179.954 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.16 133.37 6.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.959 . . . . 0.0 108.46 179.429 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -89.89 95.7 10.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.937 -1.102 . . . . 0.0 110.429 -178.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -125.55 85.53 58.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.781 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.0 Cg_endo -69.37 101.44 0.86 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.306 2.004 . . . . 0.0 111.712 -178.022 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.889 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.8 mt -99.06 112.65 24.73 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.595 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.625 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.8 118.1 20.54 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.417 -1.313 . . . . 0.0 107.551 -179.697 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.527 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.53 -161.65 0.05 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.525 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 5.0 p -90.99 -21.03 21.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.514 -0.992 . . . . 0.0 108.358 178.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.23 6.36 37.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.411 -0.806 . . . . 0.0 109.75 -179.643 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.9 t30 80.5 31.9 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.567 -0.708 . . . . 0.0 110.017 179.65 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.561 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -104.43 96.88 6.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 108.856 179.163 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.443 ' OG1' ' SG ' ' A' ' 24' ' ' CYS . 46.2 m -64.6 128.36 35.47 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.95 . . . . 0.0 110.158 -179.372 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 74.7 m-85 -108.09 117.99 35.58 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.148 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.26 -61.29 0.25 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -178.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -134.86 -165.24 1.64 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.319 . . . . 0.0 110.343 179.507 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.717 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -68.6 -27.53 66.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.563 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.645 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 20.1 t -73.69 -26.21 60.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.583 -1.323 . . . . 0.0 108.973 179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 8.7 m-80 -80.48 -42.09 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.889 ' CB ' HD12 ' A' ' 23' ' ' LEU . 36.1 t80 -67.33 -36.6 81.78 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 122.785 1.278 . . . . 0.0 109.312 179.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 9.6 m -75.77 -38.46 58.31 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.675 -178.15 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.635 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 79.4 m-20 -59.79 -31.1 69.38 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.447 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.87 -40.16 61.13 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.92 HG22 HD23 ' A' ' 48' ' ' LEU . 60.3 t -63.68 -29.78 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.463 -0.773 . . . . 0.0 109.133 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG11 ' CB ' ' A' ' 11' ' ' TYR . 26.8 m -84.27 -23.57 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.358 -0.839 . . . . 0.0 110.516 -179.316 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.705 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 8.1 pt-20 -90.68 -10.34 43.49 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.27 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 44' ' ' SER . 11.5 t -107.99 35.54 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.382 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.778 ' O ' HG23 ' A' ' 47' ' ' THR . 2.2 t30 54.3 35.6 23.22 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.857 1.313 . . . . 0.0 108.143 179.719 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 42.59 39.28 3.34 Favored Glycine 0 N--CA 1.492 2.404 0 O-C-N 121.288 -0.882 . . . . 0.0 111.071 179.456 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 45' ' ' ASN . 33.3 p -113.39 2.11 15.34 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 108.502 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD23 HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -78.86 138.07 37.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.111 179.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.3 161.63 20.12 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 177.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.5 -176.3 3.04 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 120.29 -1.506 . . . . 0.0 109.532 -178.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.575 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.81 -23.61 5.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 108.938 -179.319 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.625 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 176.58 140.12 0.07 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 179.898 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 6' ' ' VAL . 19.6 m-85 -72.29 110.44 6.73 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.302 -0.874 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.68 -176.04 24.88 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 -179.549 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.2 149.42 25.52 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.468 ' SG ' ' OD1' ' A' ' 28' ' ' ASN . 37.1 m . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.021 -1.049 . . . . 0.0 109.486 -179.536 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.71 -5.33 45.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.823 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -48.48 118.92 2.72 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.292 -0.88 . . . . 0.0 109.715 -179.762 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 4' ' ' VAL . 27.7 m -91.73 85.54 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 p 178.86 128.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.535 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.839 HG21 HD22 ' A' ' 23' ' ' LEU . 2.5 t -93.04 155.99 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 109.36 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -108.56 138.61 44.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 4.9 m -136.57 49.63 2.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.321 -179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.0 t -81.52 6.83 13.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.107 -0.996 . . . . 0.0 109.977 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.6 mp0 -119.87 8.77 11.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.379 -0.826 . . . . 0.0 108.874 179.248 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.029 ' CB ' HG11 ' A' ' 42' ' ' VAL . 23.9 m-85 -92.72 169.37 10.71 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.732 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.5 Cg_endo -89.35 152.47 29.38 Favored 'Cis proline' 0 C--N 1.307 -1.657 0 C-N-CA 123.769 -1.346 . . . . 0.0 110.961 0.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -119.82 144.12 36.58 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.847 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.38 14.1 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.523 2.149 . . . . 0.0 111.077 -179.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -138.22 115.35 10.96 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.192 -0.942 . . . . 0.0 109.567 179.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.1 m -104.25 127.14 51.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.127 -0.983 . . . . 0.0 109.453 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.3 p -51.26 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.116 -0.99 . . . . 0.0 108.607 179.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -110.79 -22.77 11.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.025 -1.047 . . . . 0.0 110.048 -179.642 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mp0 -44.37 128.98 6.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.953 . . . . 0.0 108.673 179.673 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.514 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 9.9 t80 -82.57 83.28 7.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.792 -178.617 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -112.83 80.46 3.88 Favored Pre-proline 0 C--N 1.301 -1.505 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 178.091 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.53 111.02 1.74 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.774 2.316 . . . . 0.0 112.424 -177.301 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.839 HD22 HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -99.15 115.0 28.04 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.053 -1.029 . . . . 0.0 108.46 179.121 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 3.5 t -77.79 128.13 33.52 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.413 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -69.29 -167.61 5.43 Favored Glycine 0 C--N 1.297 -1.587 0 C-N-CA 117.462 -2.304 . . . . 0.0 107.896 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.615 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 6.3 t -92.91 -6.97 47.4 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.136 -1.214 . . . . 0.0 109.945 179.766 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.633 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 11.7 p-10 -99.09 -32.54 11.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.098 -1.001 . . . . 0.0 109.615 -179.625 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.633 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.7 m-20 133.69 29.02 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 C-N-CA 122.255 0.222 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -110.76 111.62 22.92 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.444 -1.41 . . . . 0.0 109.637 179.281 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 55' ' ' LYS . 30.9 m -79.48 123.35 27.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.352 -0.842 . . . . 0.0 110.102 -179.802 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 51.8 m-85 -101.76 128.2 48.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.054 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.05 -58.41 1.23 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.6 p30 -144.26 -163.21 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.778 -1.424 . . . . 0.0 110.637 179.499 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.36 -35.84 81.36 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.912 -0.492 . . . . 0.0 111.232 -178.363 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.687 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 23.8 t -64.4 -28.55 69.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.442 -1.411 . . . . 0.0 109.146 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -81.67 -60.03 2.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.131 179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' O ' HG23 ' A' ' 41' ' ' VAL . 50.3 t80 -51.63 -32.24 28.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 122.781 1.277 . . . . 0.0 109.377 179.217 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.743 ' O ' HG22 ' A' ' 42' ' ' VAL . 45.7 m -75.02 -37.64 61.72 Favored 'General case' 0 C--N 1.272 -2.785 0 CA-C-N 114.354 -1.294 . . . . 0.0 108.982 -179.087 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 1.1 m120 -59.29 -19.3 45.0 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -89.32 -42.4 11.6 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 HD23 ' A' ' 48' ' ' LEU . 34.7 t -62.06 -25.66 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.14 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.029 HG11 ' CB ' ' A' ' 11' ' ' TYR . 28.7 m -91.37 -32.2 5.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.793 -0.567 . . . . 0.0 110.177 -179.441 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.51 15.75 10.21 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.174 -179.928 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 p -134.72 22.01 3.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 0.0 109.64 -179.777 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.5 m-80 65.06 19.58 11.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.0 108.858 -179.465 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 64.44 24.13 69.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -91.61 -8.38 47.44 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -1.06 . . . . 0.0 109.173 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.9 131.7 35.91 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.297 -0.877 . . . . 0.0 109.956 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.505 ' O ' ' HB2' ' A' ' 26' ' ' SER . 11.1 p -117.31 149.73 39.98 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 177.607 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -97.75 -179.19 4.35 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.682 -1.262 . . . . 0.0 110.296 -178.28 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -113.07 -43.66 3.36 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.969 -1.082 . . . . 0.0 109.07 -179.973 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.9 p80 -168.05 142.09 3.4 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' CE2' HG22 ' A' ' 6' ' ' VAL . 50.2 m-85 -57.53 172.02 0.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.77 168.16 42.15 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -79.88 122.66 26.95 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.793 -0.828 . . . . 0.0 109.014 179.399 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.655 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.466 -179.771 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 1' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.308 0.575 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.47 -79.98 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.74 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.21 167.35 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.149 -0.97 . . . . 0.0 109.677 -179.808 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.1 75.66 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 175.07 126.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.254 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 7' ' ' ASP . 39.3 t -95.62 167.8 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.3 t70 -97.11 132.72 42.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.87 -179.661 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 4.5 m -148.85 47.02 1.01 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.244 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -89.87 18.92 5.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.246 -0.909 . . . . 0.0 109.643 -179.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.4 4.27 3.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.595 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.003 ' O ' HG21 ' A' ' 42' ' ' VAL . 54.3 m-85 -84.34 162.23 51.93 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.699 -179.379 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.4 Cg_endo -74.91 164.49 88.22 Favored 'Cis proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.785 -1.756 . . . . 0.0 111.593 2.658 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -111.79 144.48 30.74 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.07 14.78 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.58 2.187 . . . . 0.0 110.952 -179.663 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.9 107.16 0.84 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.632 179.93 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 71.3 m -97.66 129.67 44.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 109.546 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.6 p -55.28 -179.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.278 -0.889 . . . . 0.0 109.383 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.9 OUTLIER -111.8 -17.45 12.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.236 -0.915 . . . . 0.0 109.722 -179.985 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -44.86 128.09 6.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 108.53 179.703 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 11.3 t80 -87.33 77.39 8.95 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.143 -0.973 . . . . 0.0 110.86 -178.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -111.27 85.49 5.57 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.768 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.7 Cg_endo -65.62 121.37 8.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.457 2.105 . . . . 0.0 112.264 -177.003 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -106.4 122.42 46.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.512 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.641 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.6 OUTLIER -79.42 132.79 36.49 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 -179.531 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.864 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.86 -178.59 8.24 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 107.621 -2.192 . . . . 0.0 107.621 177.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' OG1' ' A' ' 49' ' ' THR . 17.8 t -90.99 7.31 40.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.187 -1.772 . . . . 0.0 109.325 178.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.617 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -115.8 -30.06 6.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.351 -0.843 . . . . 0.0 109.071 179.849 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 25.0 p-10 132.26 34.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.814 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 tttp -110.63 98.65 7.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.876 -1.14 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 8.1 m -74.51 135.62 42.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.327 -0.858 . . . . 0.0 109.945 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 35.5 m-85 -118.52 143.75 46.53 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.586 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.89 -49.89 22.04 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.995 -1.097 . . . . 0.0 111.473 -177.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -152.19 -163.94 1.85 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.654 -1.498 . . . . 0.0 111.174 -179.418 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.4 -29.79 70.54 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.952 -0.467 . . . . 0.0 111.388 -178.397 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 49.1 t -76.9 -40.6 46.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.734 -1.228 . . . . 0.0 109.673 -179.442 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.59 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.3 m-80 -74.15 -27.79 61.0 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 108.965 179.662 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t80 -83.56 -31.85 26.13 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.795 1.284 . . . . 0.0 109.277 179.69 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.1 m -75.53 -31.18 60.0 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 114.693 -1.14 . . . . 0.0 108.103 -179.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 82.7 m-20 -64.17 -50.59 67.55 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.424 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.761 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -59.66 -26.4 65.5 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.209 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 37' ' ' PHE . 54.6 t -75.97 -40.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 -179.714 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.003 HG21 ' O ' ' A' ' 11' ' ' TYR . 3.3 p -82.6 -14.64 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.294 -0.879 . . . . 0.0 110.305 -178.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.761 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.27 -20.23 22.12 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.911 -1.118 . . . . 0.0 108.183 178.846 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 35.6 p -101.8 -9.83 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.619 -0.676 . . . . 0.0 109.675 -179.655 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.1 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.7 OUTLIER 85.94 1.08 0.65 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.698 -0.626 . . . . 0.0 109.674 -179.698 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 10.26 33.55 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.1 HG23 ' OD1' ' A' ' 45' ' ' ASN . 62.0 p -79.47 -11.89 59.89 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.327 -1.102 . . . . 0.0 108.519 178.583 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.2 tp -79.06 -67.7 0.73 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.548 ' OG1' ' CB ' ' A' ' 26' ' ' SER . 6.3 p 58.06 173.56 0.06 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -122.11 158.41 29.34 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.741 -1.225 . . . . 0.0 110.516 -178.116 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.656 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 12.0 p -94.61 -55.71 3.05 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.015 0.912 . . . . 0.0 108.801 -179.576 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.656 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.7 p80 -140.55 154.74 46.64 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.654 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -78.55 110.26 13.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.858 -1.151 . . . . 0.0 108.696 178.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 151.11 -176.76 29.48 Favored Glycine 0 C--N 1.298 -1.55 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -84.7 100.35 11.43 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.61 -0.935 . . . . 0.0 109.477 -179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.625 179.706 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.9 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 60.76 -179.37 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.928 . . . . 0.0 109.26 -179.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.65 121.33 9.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 0.0 109.55 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.695 HG13 ' O ' ' A' ' 4' ' ' VAL . 13.3 p -117.24 66.86 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.7 163.27 24.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.445 -0.785 . . . . 0.0 109.038 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.766 HG21 HD13 ' A' ' 23' ' ' LEU . 90.1 t -102.19 12.47 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 6' ' ' VAL . 8.7 t70 52.72 112.35 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.432 0.634 . . . . 0.0 109.986 179.504 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 12.7 m -137.54 51.93 1.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.0 109.574 179.785 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.39 11.98 11.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -0.897 . . . . 0.0 109.704 -179.917 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -124.18 -4.79 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.309 -0.869 . . . . 0.0 109.403 179.785 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.954 ' CB ' HG11 ' A' ' 42' ' ' VAL . 84.4 m-85 -84.55 164.52 42.37 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.369 -0.832 . . . . 0.0 109.231 -179.464 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.807 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -82.52 155.82 76.94 Favored 'Cis proline' 0 C--N 1.308 -1.583 0 C-N-CA 123.428 -1.488 . . . . 0.0 111.273 1.677 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.8 mtpp -118.52 141.42 29.75 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.591 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -79.8 14.72 1.8 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.507 2.138 . . . . 0.0 110.877 -179.707 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.49 137.23 13.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.368 -0.832 . . . . 0.0 109.247 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 93.7 m -124.78 139.53 53.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.113 -0.992 . . . . 0.0 109.763 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.3 p -58.1 -167.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.326 -0.859 . . . . 0.0 108.81 179.606 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.49 -14.39 6.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 0.0 110.053 179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -49.9 157.41 0.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.059 -1.026 . . . . 0.0 108.458 179.414 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -99.37 115.48 29.33 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.892 -1.13 . . . . 0.0 110.292 -179.431 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.5 mtt180 -139.98 80.75 20.03 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.103 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.1 Cg_endo -67.38 102.17 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.256 1.971 . . . . 0.0 111.453 -178.108 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 HG21 ' A' ' 6' ' ' VAL . 1.2 mt -101.78 122.88 44.77 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.452 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.2 t -78.4 134.98 37.34 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.886 -1.134 . . . . 0.0 108.102 -179.668 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -80.23 -166.33 33.88 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 179.548 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.499 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.3 t -88.29 -17.29 31.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.744 -1.445 . . . . 0.0 109.33 179.128 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 10.4 p-10 -90.43 21.69 3.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.751 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' ASP . 59.2 t-20 68.6 32.48 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.497 -0.752 . . . . 0.0 109.996 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.5 tttt -99.82 177.85 5.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.152 -0.967 . . . . 0.0 108.703 179.196 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 m -145.7 120.49 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.104 -0.997 . . . . 0.0 109.308 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.744 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.0 m-85 -100.11 134.31 43.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 179.719 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -42.53 -58.0 3.63 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 120.089 -1.053 . . . . 0.0 110.742 -177.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -135.14 -161.97 1.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.009 -1.289 . . . . 0.0 110.03 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.68 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.96 -55.94 5.86 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.747 -0.595 . . . . 0.0 111.234 -178.74 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.607 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 52.1 t -48.57 -24.45 1.33 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 119.938 -1.726 . . . . 0.0 109.443 -179.492 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -83.61 -51.85 6.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.059 -179.709 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.768 ' CE1' HD21 ' A' ' 48' ' ' LEU . 33.0 t80 -57.22 -39.27 75.13 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.933 1.349 . . . . 0.0 109.754 -179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 17.5 m -68.34 -43.79 76.73 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.788 -179.248 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -52.84 -20.82 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.252 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.744 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -83.86 -41.44 17.47 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.91 -32.29 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.954 HG11 ' CB ' ' A' ' 11' ' ' TYR . 24.8 m -85.64 -27.7 6.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.802 -0.561 . . . . 0.0 109.625 -179.601 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.82 12.21 22.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.295 179.508 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 36.3 p -135.43 8.99 3.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.877 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.9 m-80 66.09 13.35 9.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.483 -0.76 . . . . 0.0 109.639 -179.806 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 9.68 81.21 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.326 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 44' ' ' SER . 28.7 p -79.68 -2.12 41.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.078 -1.248 . . . . 0.0 109.061 179.35 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.768 HD21 ' CE1' ' A' ' 37' ' ' PHE . 8.8 tp -79.85 -77.2 0.19 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.445 -0.784 . . . . 0.0 109.298 -179.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.1 p 72.63 154.07 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -110.52 163.65 13.49 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 117.659 -1.616 . . . . 0.0 111.117 -177.093 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.662 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 2.0 p -90.63 -62.82 1.37 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.48 0.657 . . . . 0.0 109.715 -178.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.662 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 6.0 p80 -143.61 152.5 41.46 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 0.0 109.44 -179.319 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -73.02 113.92 10.6 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.072 -1.018 . . . . 0.0 108.656 178.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 144.54 179.61 21.08 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -179.563 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.45 103.49 12.85 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.52 -0.988 . . . . 0.0 109.19 179.738 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.538 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.537 -179.872 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . -179.61 -77.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 179.992 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.34 166.61 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.653 -179.886 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.41 95.35 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.397 -0.814 . . . . 0.0 109.381 -179.836 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m -122.22 167.09 13.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.968 . . . . 0.0 109.865 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 23' ' ' LEU . 86.5 t -111.49 16.14 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 19.0 t70 62.77 143.1 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.778 -0.576 . . . . 0.0 109.763 179.999 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 m -153.36 19.0 0.56 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 23.0 t -84.85 14.89 4.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.17 -0.956 . . . . 0.0 109.755 -179.756 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.44 ' OE2' ' OD2' ' A' ' 7' ' ' ASP . 3.0 mp0 -141.6 26.1 1.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.163 179.911 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 28.6 m-85 -116.75 165.25 15.72 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.628 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -89.35 176.81 20.06 Favored 'Cis proline' 0 C--N 1.305 -1.722 0 O-C-N 123.848 1.447 . . . . 0.0 111.323 1.633 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.1 130.14 16.12 Favored Pre-proline 0 N--CA 1.488 1.456 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.63 16.01 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 122.466 2.111 . . . . 0.0 111.22 -179.374 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.16 86.67 2.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 109.406 179.78 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 4.4 m -96.79 131.03 43.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.886 -179.695 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -55.28 -165.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.5 pp -124.33 1.65 8.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.78 -1.2 . . . . 0.0 110.686 -179.558 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -53.78 -176.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.331 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -133.36 104.98 6.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.667 -1.271 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -136.21 81.09 38.92 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 178.053 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -64.65 117.56 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.618 2.212 . . . . 0.0 112.532 -177.026 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -108.45 123.91 49.6 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.142 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.089 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -81.91 147.44 29.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.217 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.514 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -86.09 173.69 46.85 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 178.4 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 49' ' ' THR . 2.0 p -82.66 9.1 10.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.0 -1.294 . . . . 0.0 108.698 179.51 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.594 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.3 p-10 -112.3 1.99 16.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.362 -0.836 . . . . 0.0 109.543 179.796 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.594 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 t-20 88.59 39.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.914 -0.491 . . . . 0.0 110.528 179.728 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -118.91 171.29 8.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.019 -1.051 . . . . 0.0 108.901 178.905 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 56' ' ' CYS . 3.6 m -132.69 138.88 47.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.843 -1.16 . . . . 0.0 110.009 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.64 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 33.1 m-85 -119.3 133.96 55.46 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.894 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.27 -56.88 3.25 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.67 -177.499 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 36.0 p30 -146.26 -160.52 1.16 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.876 -1.367 . . . . 0.0 110.476 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.37 -37.02 84.33 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.645 -0.66 . . . . 0.0 111.479 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 24.7 t -65.82 -31.55 72.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.681 -1.262 . . . . 0.0 110.189 -179.029 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 13.3 m-80 -85.1 -42.2 15.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.253 -0.905 . . . . 0.0 109.627 -179.754 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 37.8 t80 -62.95 -40.46 97.73 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.439 1.114 . . . . 0.0 110.045 -179.625 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 44.7 t -78.71 -42.49 28.19 Favored 'General case' 0 C--N 1.276 -2.626 0 C-N-CA 118.733 -1.187 . . . . 0.0 108.874 -178.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' C ' HG22 ' A' ' 42' ' ' VAL . 33.7 m-20 -47.36 -26.29 1.25 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.747 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -46.37 16.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.591 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 46.9 t -58.47 -24.06 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.643 0.735 . . . . 0.0 109.527 179.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG11 ' HB3' ' A' ' 11' ' ' TYR . 29.2 m -90.51 -37.2 9.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.533 -179.262 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' N ' HG23 ' A' ' 42' ' ' VAL . 3.5 tt0 -91.4 15.11 12.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.829 . . . . 0.0 109.248 -179.826 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.564 ' O ' HG22 ' A' ' 47' ' ' THR . 94.3 p -127.87 20.56 6.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.309 -0.869 . . . . 0.0 109.613 -179.578 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 68.61 21.82 7.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.057 -1.027 . . . . 0.0 108.388 -179.519 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 56.07 33.89 61.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 44' ' ' SER . 13.2 t -96.99 -6.8 34.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.438 -1.036 . . . . 0.0 108.789 179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 49' ' ' THR . 5.3 tp -92.98 129.33 38.93 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 179.883 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.589 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.5 p -126.11 138.71 53.71 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.089 HD12 ' O ' ' A' ' 24' ' ' CYS . 1.5 tp -61.36 154.74 23.2 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.184 -0.948 . . . . 0.0 109.464 -179.31 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.15 -21.47 10.48 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.42 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 4.7 p80 178.99 136.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.669 -0.644 . . . . 0.0 109.525 179.45 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CD2' HD23 ' A' ' 23' ' ' LEU . 55.9 m-85 -67.57 111.48 4.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.849 -179.728 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 154.29 -176.95 31.95 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 179.771 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.597 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -88.91 101.06 13.68 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.03 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.642 -179.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.688 ' N ' HD23 ' A' ' 1' ' ' LEU . 2.4 pt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.244 0.545 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.39 75.47 1.63 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.564 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.06 99.17 3.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.211 -0.93 . . . . 0.0 109.348 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 4' ' ' VAL . 36.0 m -114.12 88.35 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.552 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 t 179.63 120.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.525 -179.816 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.49 159.55 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 179.777 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -97.52 113.99 25.8 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.197 -0.939 . . . . 0.0 109.587 -179.904 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 10.7 m -127.25 46.09 2.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 0.0 108.948 179.657 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 12.81 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 109.991 -179.697 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 24.1 pm0 -128.67 0.06 5.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.845 . . . . 0.0 109.458 179.732 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.836 ' CB ' HG11 ' A' ' 42' ' ' VAL . 58.2 m-85 -82.63 163.68 50.66 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -86.29 156.62 54.01 Favored 'Cis proline' 0 C--N 1.307 -1.65 0 C-N-CA 123.361 -1.516 . . . . 0.0 110.762 2.017 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.579 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.95 146.78 36.87 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.496 -0.752 . . . . 0.0 109.277 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.63 13.65 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.649 2.233 . . . . 0.0 110.838 179.884 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.62 142.01 20.65 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 91.6 m -112.97 136.38 52.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.952 -179.528 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 18.6 p -50.04 179.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.341 -0.849 . . . . 0.0 109.037 179.891 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.2 mp -110.25 -33.43 6.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.0 109.663 -179.966 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 18' ' ' LEU . 2.8 mt-10 -44.79 137.82 3.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.448 179.358 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.6 t80 -85.68 89.99 7.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.931 -1.106 . . . . 0.0 110.511 -178.996 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 mmm180 -113.75 79.15 4.28 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.545 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -67.33 106.64 1.25 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.323 2.015 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 37' ' ' PHE . 2.2 mt -110.93 119.94 40.73 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.762 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 26.9 t -79.31 159.37 27.24 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.364 -1.334 . . . . 0.0 107.708 179.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -121.06 169.7 14.38 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.442 -1.361 . . . . 0.0 111.152 -178.416 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -66.99 -4.22 9.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.342 -1.093 . . . . 0.0 110.155 -178.322 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.4 p30 -88.15 -3.58 58.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.035 . . . . 0.0 109.798 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.1 m-20 82.14 18.15 0.36 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.44 -0.788 . . . . 0.0 110.836 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 1.5 ptpt -115.38 147.45 40.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.734 -1.229 . . . . 0.0 109.493 179.409 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.413 HG23 ' HA ' ' A' ' 55' ' ' LYS . 90.0 m -91.28 136.88 32.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.031 -179.654 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 54.3 m-85 -106.13 113.97 27.83 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.734 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.86 -63.14 0.25 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 -178.202 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -135.86 -165.12 1.65 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.115 -1.227 . . . . 0.0 110.182 179.546 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.535 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.01 -50.27 73.24 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.954 -178.82 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 12.2 t -55.52 -37.16 67.53 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.471 -1.393 . . . . 0.0 110.09 -179.52 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.3 m-80 -70.05 -31.04 68.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.539 -179.816 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' CB ' HD12 ' A' ' 23' ' ' LEU . 14.8 t80 -73.89 -53.76 9.45 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.303 1.049 . . . . 0.0 110.231 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 79.6 m -58.65 -50.97 71.88 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.629 -178.765 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.498 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 5.9 m-20 -44.92 -24.55 0.22 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.179 179.62 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -82.55 -46.35 13.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 HD23 ' A' ' 48' ' ' LEU . 48.1 t -58.35 -29.0 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.869 0.842 . . . . 0.0 109.11 179.485 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.836 HG11 ' CB ' ' A' ' 11' ' ' TYR . 34.8 m -87.58 -27.55 5.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.381 0.61 . . . . 0.0 109.443 -179.365 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.1 tm-20 -90.8 10.29 26.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 75.0 p -132.88 11.95 4.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 110.064 -179.809 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.3 m-20 67.3 8.28 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 0.0 109.541 -179.9 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.97 11.95 75.33 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.648 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -82.12 -3.03 53.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -1.166 . . . . 0.0 108.911 179.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.57 -80.1 0.13 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.479 -0.763 . . . . 0.0 109.244 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 3.7 p 92.3 140.33 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.182 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 6.2 tp -61.45 153.22 27.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.492 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.612 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 16.5 p -101.3 -52.99 3.11 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.762 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER -171.06 153.51 3.79 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.764 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -77.5 109.1 11.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.832 -1.167 . . . . 0.0 109.416 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 146.92 -178.02 24.84 Favored Glycine 0 C--N 1.298 -1.57 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -85.85 139.5 31.22 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 121.491 -1.005 . . . . 0.0 108.974 179.124 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 55' ' ' LYS . 16.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.653 ' N ' HD23 ' A' ' 1' ' ' LEU . 2.5 pt? . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.705 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -98.45 -155.86 0.52 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.58 -179.794 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.13 139.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.597 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.5 t -104.55 86.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.471 -179.908 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.0 p -172.05 145.78 1.86 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 179.991 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 7' ' ' ASP . 43.7 t -80.83 163.99 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.183 -0.948 . . . . 0.0 109.407 -179.98 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.515 ' N ' HG12 ' A' ' 6' ' ' VAL . 17.3 t70 -103.41 124.86 49.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.24 31.1 5.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.092 -1.005 . . . . 0.0 109.753 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 10.3 t -86.9 12.44 11.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.065 -1.022 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.9 mp0 -137.17 24.77 2.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.636 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -125.54 161.65 49.24 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.823 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.3 Cg_endo -84.06 158.71 70.29 Favored 'Cis proline' 0 C--N 1.304 -1.771 0 C-N-CA 123.035 -1.652 . . . . 0.0 110.699 1.803 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 37.1 mtpt -128.11 139.04 34.28 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.479 -0.763 . . . . 0.0 109.268 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -79.59 13.47 2.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.296 1.997 . . . . 0.0 110.599 -179.872 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.62 104.6 4.23 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.467 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.1 m -94.98 136.23 35.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.015 -179.384 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -58.94 171.83 0.63 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.215 -0.928 . . . . 0.0 108.628 179.306 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.92 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -97.44 -19.43 18.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.023 -1.048 . . . . 0.0 109.81 -179.229 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 1.6 mp0 -41.87 140.05 1.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.001 179.981 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -100.91 97.17 7.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.06 -1.025 . . . . 0.0 110.165 -179.33 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.3 mtm180 -121.89 95.02 47.98 Favored Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.6 Cg_endo -69.07 96.9 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 121.718 1.612 . . . . 0.0 110.644 -178.924 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -97.36 123.26 41.12 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.593 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.596 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -90.36 124.53 35.01 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.278 -178.53 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.94 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.77 176.89 0.05 OUTLIER Glycine 0 N--CA 1.481 1.668 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 179.854 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 7.9 t -87.24 9.04 21.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.522 -1.575 . . . . 0.0 108.281 178.585 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.4 p-10 -117.73 -30.75 5.36 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.506 -0.746 . . . . 0.0 109.101 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 28.2 t-20 131.4 41.93 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.856 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.72 94.14 4.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.843 -1.16 . . . . 0.0 109.679 179.904 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.4 m -72.11 135.51 46.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -0.941 . . . . 0.0 110.816 -179.392 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.4 m-85 -125.87 136.3 52.91 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' ARG . . . -45.09 -53.28 7.69 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.069 -176.945 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p-10 -141.59 -167.49 2.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.544 -1.563 . . . . 0.0 111.33 -179.322 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -65.74 -32.14 73.52 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.438 -178.336 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 53.9 t -77.09 -27.8 54.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.583 -1.323 . . . . 0.0 109.15 -179.955 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 8.4 m-80 -84.77 -23.69 29.1 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 0.0 109.083 179.55 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.566 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 64.0 t80 -85.31 -37.26 20.16 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.603 1.192 . . . . 0.0 109.299 -179.903 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 48.9 t -79.72 -32.48 41.25 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.349 -179.409 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' C ' HG22 ' A' ' 42' ' ' VAL . 57.0 m-20 -59.04 -19.9 48.2 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.532 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -88.45 -36.3 16.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.462 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' PHE . 85.8 t -69.2 -21.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.519 0.676 . . . . 0.0 109.251 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.823 HG21 ' HB3' ' A' ' 12' ' ' PRO . 32.9 m -91.88 -38.73 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 -179.295 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.61 14.13 15.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.208 -0.933 . . . . 0.0 109.578 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 47' ' ' THR . 52.1 p -126.71 10.39 7.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 110.146 -179.464 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 75.11 -0.7 3.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.666 -179.989 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.19 13.49 65.96 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.789 HG22 ' O ' ' A' ' 44' ' ' SER . 5.0 t -82.05 -4.64 57.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.116 -1.226 . . . . 0.0 109.182 179.521 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.94 HD11 ' HA3' ' A' ' 25' ' ' GLY . 3.9 tp -79.84 -72.09 0.42 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.376 -0.827 . . . . 0.0 108.915 179.813 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 25' ' ' GLY . 1.7 p 59.71 177.71 0.08 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -179.479 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -126.74 167.03 16.31 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.015 -1.053 . . . . 0.0 110.051 -178.852 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.593 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.6 -19.46 11.11 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.174 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.596 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -172.88 142.85 1.15 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.477 -0.764 . . . . 0.0 109.993 -179.268 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -76.34 113.15 13.6 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.035 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 143.57 -175.64 23.43 Favored Glycine 0 C--N 1.297 -1.633 0 N-CA-C 108.086 -2.005 . . . . 0.0 108.086 -179.098 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 150.46 24.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.425 -1.044 . . . . 0.0 108.567 178.63 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.7 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.645 -179.403 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.711 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 2.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 76.31 -176.65 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.588 179.968 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -64.4 163.37 13.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.304 -0.872 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.726 HG12 ' CE1' ' A' ' 53' ' ' PHE . 2.1 t -143.49 102.02 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.32 179.48 6.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.174 -0.953 . . . . 0.0 109.719 -179.896 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 6' ' ' VAL . 41.4 t -107.02 14.31 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.89 . . . . 0.0 109.849 -179.938 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' VAL . 6.1 t0 39.14 94.03 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.179 0.514 . . . . 0.0 109.977 179.773 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 m -105.08 32.02 4.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.548 179.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.14 -1.4 22.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.107 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 19.2 mp0 -118.31 32.73 5.99 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.214 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.908 ' HB3' HG11 ' A' ' 42' ' ' VAL . 63.1 m-85 -125.92 164.89 30.44 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.094 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.106 ' HB3' HG21 ' A' ' 42' ' ' VAL . 31.2 Cg_endo -84.48 155.94 66.39 Favored 'Cis proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.227 -1.572 . . . . 0.0 111.819 1.356 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -103.33 146.1 31.83 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.963 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.3 Cg_endo -77.99 13.21 1.79 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.541 2.161 . . . . 0.0 111.026 -179.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.75 122.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.82 . . . . 0.0 108.939 179.642 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.0 m -94.71 132.32 39.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.07 -1.019 . . . . 0.0 110.317 -179.341 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 16' ' ' CYS . 71.6 p -49.79 176.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.375 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 18' ' ' LEU . 13.4 mt -114.67 8.55 16.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.984 -1.072 . . . . 0.0 109.928 -179.588 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -63.0 -172.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.47 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.502 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t80 -129.96 81.8 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.748 -1.22 . . . . 0.0 110.653 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 9.5 mmt180 -111.04 85.82 5.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.683 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.3 Cg_endo -69.02 96.35 0.53 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.076 1.851 . . . . 0.0 111.054 -178.497 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -98.41 119.91 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 118.994 -1.083 . . . . 0.0 108.255 179.798 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 56.6 m -83.37 112.6 20.06 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.575 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.576 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -55.19 -162.64 0.01 OUTLIER Glycine 0 N--CA 1.477 1.408 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -178.643 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 p -90.47 -12.3 37.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -1.185 . . . . 0.0 108.746 178.835 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.1 p-10 -104.3 11.03 35.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 109.931 -179.56 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 61.9 t30 80.73 34.34 0.12 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 110.397 179.562 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 31' ' ' TYR . 10.6 tttm -102.17 109.32 20.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.938 -1.101 . . . . 0.0 108.987 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 25.3 m -78.15 125.36 29.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 111.106 -178.754 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.767 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 23.1 m-85 -109.02 121.47 45.21 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.03 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -36.17 -61.36 0.81 Allowed Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -177.582 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 10.5 p30 -131.51 -158.07 0.87 Allowed 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 109.994 178.822 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.42 -63.32 1.14 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.279 -178.245 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 44.9 t -43.64 -25.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 119.988 -1.695 . . . . 0.0 110.443 -178.472 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.1 m120 -80.19 -43.23 21.89 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.062 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.958 ' CB ' HD12 ' A' ' 23' ' ' LEU . 33.2 t80 -68.66 -48.74 63.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.203 1.002 . . . . 0.0 109.948 179.754 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.797 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.3 m -63.51 -35.17 79.59 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.47 -179.126 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.752 ' O ' HG22 ' A' ' 42' ' ' VAL . 33.8 m-20 -58.81 -43.28 90.55 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.914 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.767 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -63.17 -26.76 68.96 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 178.379 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 38' ' ' CYS . 40.9 t -75.72 -29.74 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.217 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.106 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.3 m -89.06 -17.38 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.803 . . . . 0.0 110.856 -178.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.751 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.85 -10.87 41.12 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.011 -1.056 . . . . 0.0 108.943 -179.968 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 88.4 p -110.82 26.33 10.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.532 -0.73 . . . . 0.0 109.714 -179.599 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.7 m120 64.65 15.07 9.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.0 109.052 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 74.49 22.69 77.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 44' ' ' SER . 29.8 p -90.57 -6.58 54.52 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.366 -1.079 . . . . 0.0 108.622 178.921 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD23 ' CG2' ' A' ' 41' ' ' VAL . 4.1 tp -82.63 130.07 35.06 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.311 -0.868 . . . . 0.0 109.718 -179.73 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.477 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -122.19 156.61 33.36 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.833 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -104.59 171.9 7.08 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 120.292 -1.505 . . . . 0.0 109.862 -178.859 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.734 ' OG ' ' HD2' ' A' ' 52' ' ' HIS . 15.6 p -109.21 -56.3 2.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.416 -0.803 . . . . 0.0 110.06 -178.47 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.734 ' HD2' ' OG ' ' A' ' 51' ' ' SER . 2.1 p80 -140.32 138.02 34.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.395 -0.816 . . . . 0.0 110.724 -179.026 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.726 ' CE1' HG12 ' A' ' 4' ' ' VAL . 45.7 m-85 -74.04 116.72 15.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.275 179.265 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' SG ' ' A' ' 24' ' ' CYS . . . 140.13 -176.72 21.13 Favored Glycine 0 N--CA 1.478 1.439 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 147.33 30.42 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.557 -0.967 . . . . 0.0 108.662 178.764 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.733 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 m . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.035 -176.917 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 58.29 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.347 179.964 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.72 166.37 11.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.428 179.879 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 4' ' ' VAL . 5.3 m -142.09 109.55 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 p -124.77 176.23 6.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.373 -0.83 . . . . 0.0 109.201 179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG22 ' CZ ' ' A' ' 53' ' ' PHE . 13.2 t -125.2 12.08 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 179.978 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' VAL . 56.7 t0 57.78 120.7 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.299 0.571 . . . . 0.0 109.948 179.675 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 14.9 m -149.39 51.44 0.95 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.38 16.93 7.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 109.771 -179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.95 -5.36 6.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 -179.906 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.919 ' CB ' HG11 ' A' ' 42' ' ' VAL . 86.9 m-85 -83.2 156.85 66.33 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.214 -0.929 . . . . 0.0 109.713 -179.547 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -74.29 164.44 87.83 Favored 'Cis proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.642 -1.816 . . . . 0.0 111.631 1.857 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -118.97 147.45 42.52 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.741 -0.599 . . . . 0.0 109.416 -179.271 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -78.48 13.47 1.84 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.502 2.135 . . . . 0.0 110.861 179.812 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.78 123.81 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.443 -0.785 . . . . 0.0 109.193 179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -80.9 143.12 32.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.002 . . . . 0.0 109.11 179.682 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.56 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.345 -0.847 . . . . 0.0 108.962 179.787 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mp -120.7 -29.23 4.73 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.996 -1.065 . . . . 0.0 109.71 179.901 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 12.4 pm0 -46.45 157.59 0.13 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.055 -1.028 . . . . 0.0 108.434 179.245 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.3 t80 -107.36 117.46 34.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.917 -1.114 . . . . 0.0 110.169 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.6 mtt180 -141.79 84.12 12.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -68.6 98.03 0.56 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.089 1.859 . . . . 0.0 110.945 -178.8 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.9 mt -98.56 112.65 24.62 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.677 179.753 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.601 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -78.03 110.4 12.94 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.385 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -53.95 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.479 1.518 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -177.924 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.544 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 41.0 t -87.92 -8.71 55.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.28 -1.129 . . . . 0.0 108.887 178.426 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 17.3 p30 -101.85 6.39 41.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.566 179.786 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.9 m120 80.72 28.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.401 -0.812 . . . . 0.0 110.047 179.866 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -100.07 105.62 17.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.117 -0.989 . . . . 0.0 108.574 179.043 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -73.89 121.29 20.7 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.449 -0.782 . . . . 0.0 110.624 -178.904 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 42.5 m-85 -99.51 124.24 44.5 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.17 -60.2 0.46 Allowed Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.352 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.0 p30 -138.74 -166.04 1.94 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.982 -1.304 . . . . 0.0 110.721 179.877 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.924 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.16 -45.09 89.98 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.425 -177.8 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 21.4 p -62.1 -43.33 99.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.496 -1.377 . . . . 0.0 109.322 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.54 -53.63 56.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.979 -1.075 . . . . 0.0 109.19 179.237 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.97 ' CB ' HD12 ' A' ' 23' ' ' LEU . 42.8 t80 -55.32 -35.68 65.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 123.051 1.405 . . . . 0.0 109.266 179.678 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.688 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.6 m -66.36 -38.37 87.43 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.15 -177.769 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.4 m-20 -54.65 -49.52 70.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.57 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -58.96 -31.87 69.12 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.347 0.594 . . . . 0.0 109.806 179.497 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 48' ' ' LEU . 87.8 t -73.5 -37.94 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.369 -0.832 . . . . 0.0 110.72 -179.026 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.919 HG11 ' CB ' ' A' ' 11' ' ' TYR . 14.6 p -90.51 -10.45 10.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.105 -0.997 . . . . 0.0 110.661 -178.465 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.16 -17.17 25.27 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 120.945 -1.097 . . . . 0.0 108.776 179.504 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 62.4 p -106.05 24.49 12.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.57 -0.706 . . . . 0.0 110.022 -178.97 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 44' ' ' SER . 1.4 m120 65.26 20.43 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 108.571 -179.452 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 68.94 25.18 75.52 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.503 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 m -91.44 -14.3 30.78 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.372 -1.075 . . . . 0.0 108.348 179.461 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -79.63 128.61 33.61 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.324 -0.86 . . . . 0.0 109.084 179.865 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.8 p -116.08 149.66 38.6 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.62 -176.76 4.37 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.741 -1.183 . . . . 0.0 109.381 -178.825 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.582 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -120.8 -27.37 5.05 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.021 -1.05 . . . . 0.0 108.983 -179.58 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.601 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.0 p80 177.65 139.45 0.08 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.29 -179.157 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 46.6 m-85 -64.33 162.14 15.45 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.275 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.537 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 91.02 -178.31 42.0 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.11 150.76 23.76 Favored 'General case' 0 C--N 1.285 -2.197 0 O-C-N 121.733 -0.863 . . . . 0.0 109.121 178.647 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 22.5 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.578 179.877 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 167.55 97.12 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 -179.952 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.96 143.0 30.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.443 -179.993 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.402 ' O ' ' OG ' ' A' ' 5' ' ' SER . 2.4 m -145.56 100.08 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.326 -179.98 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 6.0 m -167.11 115.16 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.301 -0.875 . . . . 0.0 109.362 179.961 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.77 HG21 HD22 ' A' ' 23' ' ' LEU . 94.7 t -90.91 164.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.365 179.993 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.572 ' N ' HG12 ' A' ' 6' ' ' VAL . 23.8 t0 -70.3 136.02 49.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 108.964 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.4 t -152.97 17.19 0.57 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 0.0 109.879 -179.507 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 t -90.82 18.89 5.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 109.971 179.957 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 43.2 mp0 -139.25 32.01 2.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.047 -179.626 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.6 m-85 -131.07 160.1 68.49 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -69.82 167.62 70.57 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.081 -1.633 . . . . 0.0 112.086 3.645 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE3' ' CZ ' ' A' ' 11' ' ' TYR . 1.1 mtmt -131.28 144.73 54.68 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.178 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.87 13.9 1.83 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.468 2.112 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.33 107.0 0.32 Allowed 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.59 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 17' ' ' THR . 91.8 m -83.22 141.33 31.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 110.067 -179.371 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -49.08 177.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.429 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.6 -5.53 12.19 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.776 -1.203 . . . . 0.0 110.02 -179.737 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 19' ' ' GLU . 9.2 mm-40 -58.04 -176.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.941 -1.099 . . . . 0.0 108.558 179.467 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -131.37 85.01 2.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 179.871 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 11.9 mmt180 -113.0 89.31 13.49 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.897 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.7 Cg_endo -68.28 101.98 0.77 Allowed 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.774 1.65 . . . . 0.0 109.872 -179.193 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.78 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -97.8 122.65 41.16 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.629 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.74 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 22.1 m -89.58 120.38 30.83 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.828 -178.615 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.031 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -50.91 -179.99 0.03 OUTLIER Glycine 0 N--CA 1.482 1.723 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.764 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.572 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -86.88 -0.28 56.21 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.022 -1.281 . . . . 0.0 108.665 179.238 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 6.8 p-10 -102.78 -26.12 13.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.678 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 24.4 t-20 120.75 33.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 CA-C-O 121.094 0.473 . . . . 0.0 110.186 179.194 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.3 tptm -99.77 168.29 10.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' SG ' ' A' ' 56' ' ' CYS . 83.4 m -131.56 131.5 43.38 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.604 -1.31 . . . . 0.0 110.783 -179.746 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 45.6 m-85 -119.52 129.08 54.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.44 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -41.44 -57.98 3.06 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 120.043 -1.075 . . . . 0.0 110.995 -177.637 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.9 p-10 -139.01 -164.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.732 -1.452 . . . . 0.0 110.567 -179.766 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -66.57 -33.86 76.61 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.85 -0.531 . . . . 0.0 111.743 -178.541 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -66.94 -33.01 74.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.625 -1.297 . . . . 0.0 109.871 -178.828 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -83.96 -42.5 16.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.172 -0.955 . . . . 0.0 109.355 -179.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.778 ' O ' HG23 ' A' ' 41' ' ' VAL . 51.6 t80 -64.94 -31.76 73.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.556 1.169 . . . . 0.0 109.651 -179.985 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.782 ' O ' HG12 ' A' ' 42' ' ' VAL . 4.5 t -82.22 -57.71 3.26 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.94 -178.908 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.3 m-20 -41.54 -29.5 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.848 -1.157 . . . . 0.0 108.477 179.876 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.609 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.88 -46.95 17.45 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 37' ' ' PHE . 76.3 t -59.01 -63.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.647 0.737 . . . . 0.0 109.397 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.6 p -55.82 -32.42 32.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 O-C-N 121.61 -0.681 . . . . 0.0 111.502 -179.097 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -92.0 -8.09 47.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.372 -1.455 . . . . 0.0 109.484 179.816 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.884 ' O ' HG22 ' A' ' 47' ' ' THR . 49.3 p -108.94 30.8 6.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.349 -0.844 . . . . 0.0 109.916 -179.522 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 44.47 49.49 8.26 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.934 . . . . 0.0 109.661 -179.744 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 40.53 45.88 3.52 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 44' ' ' SER . 14.9 t -106.02 -13.68 15.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.679 -0.895 . . . . 0.0 108.686 179.056 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.031 HD11 ' HA3' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -79.84 -52.28 8.09 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.42 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.571 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER 51.85 173.63 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.37 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.643 ' HA ' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -131.0 158.79 39.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.299 -0.875 . . . . 0.0 108.932 -179.963 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.552 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -118.93 -20.5 8.12 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.27 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.623 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 5.8 p80 -169.53 131.99 1.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 110.081 -179.131 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.78 ' CD2' HD23 ' A' ' 23' ' ' LEU . 30.6 m-85 -66.02 174.58 2.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 22' ' ' PRO . . . 85.03 176.56 50.84 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -179.148 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.04 153.69 26.03 Favored 'General case' 0 C--N 1.287 -2.152 0 O-C-N 121.594 -0.945 . . . . 0.0 109.094 178.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.74 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.9 m . . . . . 0 C--N 1.298 -1.658 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.7 -177.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.288 0.566 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -91.21 -69.15 0.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.412 179.804 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 168.39 154.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.335 179.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.37 79.02 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.37 -179.99 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 t -122.98 -168.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.436 179.986 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.685 HG22 ' H ' ' A' ' 7' ' ' ASP . 1.3 p -112.01 -163.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.204 -179.87 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.685 ' H ' HG22 ' A' ' 6' ' ' VAL . 20.7 t70 -115.19 132.08 56.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 0.0 109.164 179.758 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.7 m -146.51 48.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 0.0 109.7 -179.764 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 t -89.78 18.3 5.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.324 -0.86 . . . . 0.0 109.288 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.9 mp0 -133.41 14.12 4.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.85 . . . . 0.0 109.111 -179.979 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.059 ' O ' HG21 ' A' ' 42' ' ' VAL . 82.4 m-85 -98.36 159.15 31.31 Favored Pre-proline 0 C--N 1.307 -1.279 0 O-C-N 121.441 -0.787 . . . . 0.0 109.173 -179.755 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -76.05 150.72 94.32 Favored 'Cis proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.441 -1.9 . . . . 0.0 111.061 1.736 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.6 tttm -99.68 146.22 31.46 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.877 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.2 Cg_endo -78.02 13.47 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.484 2.122 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.13 107.74 0.35 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.692 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 67.8 m -79.34 140.23 37.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.077 -1.015 . . . . 0.0 109.583 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -47.78 174.33 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.9 mt -109.73 -36.73 5.85 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.059 -1.025 . . . . 0.0 109.601 -179.927 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.471 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -44.57 156.32 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.176 -0.953 . . . . 0.0 108.592 179.705 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -96.63 121.16 38.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.98 -1.075 . . . . 0.0 110.368 -179.188 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.7 mtt-85 -142.24 83.35 12.36 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.459 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -68.54 97.26 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.392 2.061 . . . . 0.0 111.422 -178.865 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.841 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.2 mt -98.12 115.56 28.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.509 -1.276 . . . . 0.0 107.763 178.906 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -77.58 119.19 20.79 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.793 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.83 -161.95 0.13 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.667 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.53 ' N ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 p -90.25 -15.53 31.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.326 -1.102 . . . . 0.0 108.904 178.716 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.1 p-10 -95.88 5.65 50.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.103 -179.487 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.5 t30 84.6 27.54 0.07 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.713 -0.617 . . . . 0.0 109.841 179.927 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -100.16 102.5 13.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.149 -0.969 . . . . 0.0 108.947 179.419 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.9 m -69.76 122.09 18.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.97 . . . . 0.0 110.411 -179.25 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.622 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 60.9 m-85 -100.37 125.97 46.67 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.785 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.02 -61.21 1.43 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -177.871 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.4 p30 -134.98 -166.5 1.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.9 -1.353 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.801 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -66.95 -30.24 70.32 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.795 -178.223 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 12.9 t -73.41 -26.56 61.02 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.44 -1.412 . . . . 0.0 108.732 179.884 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 7.6 m-80 -78.78 -46.08 19.6 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.333 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' CB ' HD12 ' A' ' 23' ' ' LEU . 30.6 t80 -64.39 -38.11 89.87 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 122.965 1.364 . . . . 0.0 108.978 179.352 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -68.33 -45.25 73.39 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 79.9 m-20 -51.89 -42.16 62.5 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.155 -0.966 . . . . 0.0 108.644 179.599 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -63.55 -34.62 78.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.567 -0.708 . . . . 0.0 109.14 179.475 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' PHE . 94.3 t -67.19 -48.87 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -0.822 . . . . 0.0 109.994 179.763 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.059 HG21 ' O ' ' A' ' 11' ' ' TYR . 8.8 p -79.29 -12.2 13.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 111.631 -178.245 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.1 pp20? -91.66 -16.64 26.69 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.618 -1.301 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.1 t -109.5 46.68 0.98 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.596 -0.69 . . . . 0.0 109.193 -179.692 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 2.5 p-10 45.87 46.45 12.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.506 -0.746 . . . . 0.0 109.291 -179.195 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 39.22 45.9 2.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 44' ' ' SER . 4.7 t -115.91 -6.38 12.03 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.568 -0.96 . . . . 0.0 109.048 179.085 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.488 HD22 ' HB1' ' A' ' 40' ' ' ALA . 1.3 tp -78.19 131.51 37.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.417 -0.802 . . . . 0.0 109.392 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 p -112.21 167.69 10.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.882 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.654 HD11 ' C ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.75 172.9 6.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.481 -1.387 . . . . 0.0 111.346 -178.036 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.534 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 20.8 t -100.06 -24.02 14.72 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.817 0.818 . . . . 0.0 109.254 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.654 ' C ' HD11 ' A' ' 50' ' ' LEU . 9.4 p80 159.55 159.83 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.949 0 CA-C-O 121.545 0.688 . . . . 0.0 110.252 178.882 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 8.9 m-85 -82.18 113.25 19.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.469 -0.769 . . . . 0.0 109.593 179.651 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 138.05 -176.88 20.43 Favored Glycine 0 C--N 1.3 -1.435 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -179.741 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 149.37 29.93 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.324 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 29.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.792 -179.447 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.298 0.571 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -161.65 -167.98 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.274 -179.975 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 75.66 154.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.9 t -94.09 70.18 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.278 -0.889 . . . . 0.0 109.202 179.838 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -158.88 114.48 2.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.766 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 53' ' ' PHE . 3.1 t -84.44 152.54 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.601 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -67.7 139.36 56.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.371 -0.83 . . . . 0.0 109.096 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.1 t -153.67 15.67 0.5 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 110.284 -179.437 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -91.44 18.74 6.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.12 -0.987 . . . . 0.0 110.242 -179.969 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 12.6 pm0 -133.39 -1.46 3.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.146 . . . . 0.0 110.401 -179.462 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 72.9 m-85 -92.87 163.5 25.43 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.159 -0.963 . . . . 0.0 108.691 -179.767 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.572 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -70.76 153.85 95.68 Favored 'Cis proline' 0 C--N 1.307 -1.617 0 C-N-CA 123.294 -1.544 . . . . 0.0 112.044 3.318 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -114.53 146.33 35.69 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -77.91 14.46 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.603 2.202 . . . . 0.0 111.385 -179.14 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.34 115.16 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.205 -0.935 . . . . 0.0 109.556 179.686 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 35' ' ' CYS . 76.7 m -90.77 134.87 34.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 109.538 -179.997 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.501 ' OG1' ' ND2' ' A' ' 33' ' ' ASN . 16.7 p -46.68 171.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 108.808 179.62 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 19' ' ' GLU . 37.6 mt -111.79 -37.63 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 109.848 -179.666 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.7 pm0 -44.16 153.58 0.14 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.238 -0.914 . . . . 0.0 108.891 179.921 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -99.58 94.48 6.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.01 -1.056 . . . . 0.0 110.411 -179.172 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 ptm180 -123.97 92.42 48.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.395 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -68.27 111.99 2.65 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.396 2.064 . . . . 0.0 112.039 -177.637 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -102.14 121.94 43.18 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 121.253 -0.904 . . . . 0.0 108.794 179.321 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.705 ' O ' HD12 ' A' ' 50' ' ' LEU . 1.1 t -80.19 134.31 36.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.12 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.936 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -65.78 -171.94 3.85 Favored Glycine 0 N--CA 1.481 1.671 0 N-CA-C 107.517 -2.233 . . . . 0.0 107.517 178.007 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 4.4 t -92.53 7.46 43.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.478 -1.601 . . . . 0.0 109.564 179.023 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.5 p-10 -122.36 -22.4 5.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.664 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.2 t30 131.73 18.29 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 120.836 0.35 . . . . 0.0 110.741 178.99 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.064 ' HE2' HD13 ' A' ' 48' ' ' LEU . 9.0 mtmt -99.85 101.59 12.76 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.268 -1.52 . . . . 0.0 109.788 179.712 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -75.41 149.88 38.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.906 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.639 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 48.0 m-85 -129.29 140.02 51.57 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.608 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -46.64 -55.7 7.91 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.357 -177.681 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.9 p30 -142.15 -160.25 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.923 -1.339 . . . . 0.0 110.244 179.508 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -67.63 -52.12 41.98 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.901 -0.499 . . . . 0.0 112.154 -177.82 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 32.5 t -53.32 -35.03 59.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.207 -1.558 . . . . 0.0 109.709 -178.989 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.6 m-80 -78.58 -36.41 44.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.389 -0.82 . . . . 0.0 110.55 -179.347 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 14.5 t80 -69.7 -53.72 17.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.002 -1.061 . . . . 0.0 110.936 -178.92 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.6 t -62.33 -53.28 57.34 Favored 'General case' 0 C--N 1.278 -2.513 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.776 -178.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 26.0 m-20 -40.82 -29.83 0.11 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.923 -1.111 . . . . 0.0 108.673 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -75.5 -50.03 16.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.008 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' CYS . 95.4 t -57.09 -62.49 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.437 0.637 . . . . 0.0 110.159 179.233 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 38' ' ' CYS . 4.1 p -57.88 -30.46 38.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.31 -0.869 . . . . 0.0 111.705 -178.496 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -93.31 -5.01 50.67 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.456 -1.403 . . . . 0.0 109.969 -179.924 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 9.8 t -109.96 29.03 8.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.159 -0.963 . . . . 0.0 110.656 -178.9 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m120 55.53 34.19 22.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.812 -1.18 . . . . 0.0 109.17 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.93 37.17 21.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.964 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.8 p -100.84 -7.88 23.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.395 -1.062 . . . . 0.0 108.605 178.711 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.064 HD13 ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -82.15 -56.24 4.05 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.936 0.874 . . . . 0.0 108.854 179.938 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 0.2 OUTLIER 56.69 -176.65 0.06 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.186 0.517 . . . . 0.0 109.886 179.698 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.705 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -123.77 155.95 36.96 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.269 -0.895 . . . . 0.0 110.036 -178.027 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.555 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -113.94 -24.89 8.84 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.999 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 3.4 p80 -179.6 144.59 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.501 -0.749 . . . . 0.0 109.234 179.956 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' HG22 ' A' ' 6' ' ' VAL . 29.5 m-85 -72.9 115.53 12.31 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.203 -0.935 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 145.92 179.69 22.33 Favored Glycine 0 N--CA 1.478 1.452 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -179.917 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -83.52 100.53 10.83 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.577 -0.955 . . . . 0.0 109.142 179.435 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.676 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.757 -179.747 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.206 0.527 . . . . 0.0 109.583 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.535 ' O ' HG23 ' A' ' 4' ' ' VAL . . . -59.69 179.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.308 -0.87 . . . . 0.0 109.483 179.894 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -44.91 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 179.845 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 2' ' ' ALA . 22.0 t -84.59 68.91 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.993 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.36 121.05 0.85 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 34' ' ' LYS . 86.9 t -98.02 14.47 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.944 -179.779 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' VAL . 30.5 t0 59.2 119.13 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.699 -0.626 . . . . 0.0 109.655 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 9.4 m -150.66 43.74 0.83 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 t -90.67 19.09 5.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 110.01 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -133.17 2.51 3.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 0.0 109.908 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.77 ' O ' HG21 ' A' ' 42' ' ' VAL . 65.4 m-85 -82.09 162.66 56.2 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.496 -0.752 . . . . 0.0 109.458 -179.639 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -74.56 -178.1 22.12 Favored 'Cis proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.001 -1.666 . . . . 0.0 112.135 2.408 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 8.9 tttt -128.91 144.71 53.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.805 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.57 14.97 1.51 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.606 2.204 . . . . 0.0 111.627 -179.42 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 174.33 139.36 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 179.737 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' SG ' ' C ' ' A' ' 15' ' ' ALA . 7.9 m -148.54 118.63 7.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.029 -1.044 . . . . 0.0 111.004 -179.645 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 1.4 p -92.43 -110.24 0.1 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.67 ' O ' ' O ' ' A' ' 19' ' ' GLU . 6.9 mp 59.11 95.76 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 O-C-N 120.9 -1.125 . . . . 0.0 108.252 178.522 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.67 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -43.34 -163.74 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.685 -179.003 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.449 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 3.3 t80 -77.51 121.29 23.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 119.744 -1.848 . . . . 0.0 111.823 -178.22 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -160.23 76.86 2.74 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.717 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.7 Cg_endo -64.45 125.32 14.8 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 123.538 2.825 . . . . 0.0 114.608 -175.623 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.864 HD12 ' C ' ' A' ' 33' ' ' ASN . 1.3 mt -112.42 122.1 46.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.962 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.893 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.98 167.19 13.92 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.286 -178.188 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -113.73 171.24 13.7 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.216 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.493 ' HB2' ' OG1' ' A' ' 49' ' ' THR . 42.0 t -77.56 -1.74 32.19 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.314 -1.354 . . . . 0.0 109.044 -179.734 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' OD2' ' HB2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -91.94 5.39 50.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 109.477 179.764 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.5 m120 75.95 28.49 0.86 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.851 . . . . 0.0 110.336 179.601 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -116.64 147.62 41.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.079 -1.013 . . . . 0.0 108.965 179.41 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 m -106.05 137.14 44.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.0 110.502 -179.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 67.8 m-85 -115.66 136.42 53.08 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.311 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.17 -52.18 2.76 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.011 -1.09 . . . . 0.0 110.473 -177.659 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.864 ' C ' HD12 ' A' ' 23' ' ' LEU . 42.9 p30 -162.18 -147.14 0.12 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.639 -1.507 . . . . 0.0 111.915 179.348 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HB2' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -63.4 -41.98 98.77 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.731 -0.606 . . . . 0.0 112.333 -176.751 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 20.1 t -74.4 -38.49 63.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.295 -1.503 . . . . 0.0 110.107 -178.935 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.5 m-80 -74.68 -24.37 58.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.018 -179.453 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.797 ' CE1' HD11 ' A' ' 48' ' ' LEU . 52.0 t80 -82.46 -33.97 28.28 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 123.041 1.401 . . . . 0.0 108.363 178.467 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.705 ' O ' HG12 ' A' ' 42' ' ' VAL . 9.3 m -71.37 -39.49 71.21 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 113.844 -1.526 . . . . 0.0 109.958 -178.335 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 89.7 m-20 -58.09 -35.11 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.59 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.789 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.95 -29.18 60.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.246 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 37' ' ' PHE . 40.6 t -71.78 -33.88 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.607 -0.683 . . . . 0.0 109.527 -179.945 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -89.68 -18.15 7.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.324 -0.86 . . . . 0.0 110.132 -178.449 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.789 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.99 -20.04 21.77 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.908 -1.12 . . . . 0.0 108.642 178.908 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 88.8 p -97.54 6.95 47.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.543 -0.723 . . . . 0.0 109.849 -179.385 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.4 OUTLIER 75.74 11.52 3.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.085 -179.694 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.05 18.89 68.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.4 t -99.2 8.16 45.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.333 -1.098 . . . . 0.0 108.922 179.325 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD11 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.83 -50.85 9.92 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.986 0.898 . . . . 0.0 108.799 179.986 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.0 p 59.85 135.81 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 121.763 0.792 . . . . 0.0 109.502 -179.603 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.916 HD11 ' O ' ' A' ' 52' ' ' HIS . 3.0 tp -73.67 126.5 30.44 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.909 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.577 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 39.8 t -77.95 -11.56 59.91 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.063 0.935 . . . . 0.0 110.281 -178.889 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.916 ' O ' HD11 ' A' ' 50' ' ' LEU . 9.0 p80 159.93 149.71 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.042 179.279 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CD1' HD21 ' A' ' 50' ' ' LEU . 53.6 m-85 -73.5 110.94 8.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.043 -1.035 . . . . 0.0 109.247 179.762 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 136.37 -175.82 20.71 Favored Glycine 0 C--N 1.298 -1.528 0 N-CA-C 108.501 -1.84 . . . . 0.0 108.501 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 154.84 23.91 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.648 -0.913 . . . . 0.0 108.992 178.646 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 42.8 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.516 -179.978 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.667 ' N ' HD23 ' A' ' 1' ' ' LEU . 1.8 pt? . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 161.71 41.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.938 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.0 171.69 8.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 110.064 -179.821 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.134 HG23 ' CD2' ' A' ' 50' ' ' LEU . 2.8 p -151.22 125.57 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.275 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.563 ' C ' ' CE1' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -73.4 18.33 0.12 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.683 -0.636 . . . . 0.0 111.972 -178.987 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.818 ' H ' HG22 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -119.57 -167.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.369 -1.457 . . . . 0.0 110.354 -179.844 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.728 ' N ' HG13 ' A' ' 6' ' ' VAL . 28.5 t70 -148.45 175.38 11.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.48 -0.762 . . . . 0.0 109.242 -179.84 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.7 m -154.78 41.42 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 0.0 110.403 -179.888 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 7.1 t -91.14 8.2 36.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.011 -1.056 . . . . 0.0 110.441 -179.663 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.6 mp0 -152.04 52.93 0.8 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.185 -0.947 . . . . 0.0 110.688 -179.755 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.816 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.5 m-85 -141.42 148.12 49.33 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 120.867 -1.145 . . . . 0.0 109.149 179.293 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.5 Cg_endo -77.1 154.43 96.62 Favored 'Cis proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.227 -1.989 . . . . 0.0 111.355 1.57 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.58 ' HD3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -103.24 178.49 1.17 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.962 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 34.4 Cg_endo -73.12 11.92 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.165 0 C-N-CA 121.821 1.681 . . . . 0.0 111.804 -179.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.23 161.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.914 -1.116 . . . . 0.0 109.816 179.499 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 89.9 m -109.43 130.28 55.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.32 179.692 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 16' ' ' CYS . 28.9 p -43.8 151.4 0.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.085 179.772 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -90.34 -29.73 17.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.126 -0.984 . . . . 0.0 109.907 -179.43 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -45.14 138.16 4.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.069 -1.02 . . . . 0.0 108.409 179.526 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.518 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 12.8 t80 -89.05 79.95 7.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.927 -1.108 . . . . 0.0 110.716 -178.903 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.659 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 28.9 mmm-85 -111.45 83.75 4.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.118 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -64.86 131.3 28.61 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.593 2.862 . . . . 0.0 113.436 -177.319 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -115.12 127.14 55.4 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.88 178.176 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.649 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.9 t -78.07 126.37 30.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 -179.554 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.645 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -61.27 -162.58 0.18 Allowed Glycine 0 C--N 1.298 -1.579 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 179.081 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' THR . 4.8 p -92.72 -24.35 18.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.787 -1.419 . . . . 0.0 109.063 178.245 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.6 p-10 -96.79 18.82 13.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.455 -0.778 . . . . 0.0 109.745 -179.583 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.6 t-20 80.91 28.56 0.2 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.467 -0.77 . . . . 0.0 109.965 179.897 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tptm -99.25 88.75 4.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.469 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 m -61.52 136.34 57.99 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.698 0.761 . . . . 0.0 110.231 -179.305 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' A' ' 32' ' ' GLY . 9.3 m-85 -114.6 140.47 48.77 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.483 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -39.22 -41.05 1.37 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -178.049 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -173.42 -162.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.425 -1.044 . . . . 0.0 109.39 178.897 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.818 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.58 -73.36 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 113.161 -176.761 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 38.7 t -39.38 -26.62 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.318 -1.489 . . . . 0.0 110.904 -178.09 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' CG ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -82.64 -42.98 17.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.302 -0.873 . . . . 0.0 109.947 -179.594 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.645 ' CE1' ' HA2' ' A' ' 25' ' ' GLY . 26.6 t80 -70.39 -44.78 67.31 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.465 1.126 . . . . 0.0 110.662 -179.288 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 42.7 t -72.55 -56.24 5.67 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.534 -177.783 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 37.5 m-20 -42.27 -34.84 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.922 -1.111 . . . . 0.0 108.471 -179.713 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.89 -49.47 61.8 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.924 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' CYS . 52.9 t -51.89 -58.36 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.784 -0.572 . . . . 0.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG21 ' O ' ' A' ' 11' ' ' TYR . 0.9 OUTLIER -65.15 -21.68 29.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.435 -0.79 . . . . 0.0 110.811 -178.842 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.5 tm-20 -92.28 -0.81 57.38 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.609 -1.307 . . . . 0.0 109.328 179.556 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' THR . 6.3 p -120.51 34.17 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.088 -179.211 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.508 ' CG ' ' O ' ' A' ' 44' ' ' SER . 3.5 p30 58.5 17.63 5.06 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.775 0.798 . . . . 0.0 109.486 -179.423 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.38 28.38 73.0 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 178.989 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 44' ' ' SER . 8.7 t -86.49 -18.72 30.89 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.133 -1.216 . . . . 0.0 108.448 178.829 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.6 tp -81.08 128.19 33.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.598 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' SER . 9.0 p -111.77 172.02 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 108.883 179.597 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.134 ' CD2' HG23 ' A' ' 4' ' ' VAL . 1.0 OUTLIER -109.61 158.4 18.08 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -178.696 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.59 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.89 -32.62 7.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.285 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 6.0 p80 174.72 143.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.563 ' CE1' ' C ' ' A' ' 5' ' ' SER . 3.3 m-85 -52.29 -170.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.014 -1.054 . . . . 0.0 109.637 178.306 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 69.78 178.14 21.01 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.83 113.27 25.39 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.966 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.504 179.848 . . . . . . . . 2 2 . 1 stop_ save_